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Abstract
Sleep affects a person’s health and is, therefore, assessed if health problems arise.
Sleep behaviour is monitored for abnormalities in order to determine if any treat-
ments, such as medication or behavioural changes (modifications to sleep habits),
are necessary. Assessments are typically done using two methods: polysomnography
over short periods and four-week retrospective questionnaires. These standard meth-
ods, however, cannot measure current sleep status continuously and unsupervised
over long periods of time in the same way home-based sleep behaviour assessment
can. In this work, we investigate the ability of sleep behaviour assessment using IoT
devices in a natural home environment, which potential has not been investigated
fully, to enable early abnormality detection and facilitate self-management.
We developed a framework that incorporates different facets and perspectives to
introduce focus and support in sleep behaviour assessment. The framework con-
siders users’ needs, various available technologies, and factors that influence sleep
behaviours. Sleep analysis approaches are incorporated to increase the reliability
of the system. This assessment is strengthened by utilising sleep stage detection
and sleep position recognition. This includes, first, the extraction and integra-
tion of influence factors of sleep stage recognition methods to create a fine-grained
personalised approach and, second, the detection of common but more complex
sleep positions, including leg positions. The relations between medical conditions
and sleep are assessed through interviews with doctors and users on various top-
ics, including treatment satisfaction and technology acceptance. The findings from
these interviews led to the investigation of sleep behaviour as a diagnostic indica-
tor. Changes in sleep behaviour are assessed alongside medical knowledge using
data mining techniques to extract information about disease development; the fol-
lowing diseases were of interest: sleep apnoea, hypertension, diabetes, and chronic
kidney disease. The proposed framework is designed in a way that allows it to be
integrated into existing smart home environments. We believe that our framework
provides promising building blocks for reliable sleep behaviour assessment by in-
corporating newly developed sleep analysis approaches. These approaches include a
V
modular layered sleep behaviour assessment framework, a sleep regularity algorithm,
a user-dependent visualisation concept, a higher-granularity sleep position analysis
approach, a fine-grained sleep stage detection approach, a personalised sleep pa-
rameter extraction process, in-depth understanding on sleep and chronic disease
relations, and a sleep-wake behaviour-based chronic disease detection method.
VI
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Glossary
HCHS is a dataset provided by the national sleep research
resourche (NSRR) containing sleep-related data from
polysomnograhpy (PSG) and actigraphy from individ-
uals with different backgrounds.
HRV is a measure which indicates changes in the time in-
terval between consecutive heartbeats.
LSTM is a neural network for time series data analysis.
MESA is a dataset provided by the NSRR containing sleep-
related data from PSG and actigraphy from individu-
als with different backgrounds.
PPG is an optical technique to measure blood volume
changes from the skin surface.
PSG is the gold standard of sleep assessment usually under-
taken in a hospital, including multiple sensor sources
attached to the human body.
Shimmer3 sensor is an intertial measurement unit, providing the possi-
bility to collect data with 9 degrees of freedom from
integrated accelerometer, gyroscope and magnetome-
ter sensors.
SOL is the duration of sedentary time, i.e., the time from
light-outs till the time of falling asleep.
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Chapter 1
Introduction
1.1 Background
Sleep behaviour is a key factor in health and influences the daily lives of all people.
Sleep is a recovery mechanism during which heart rate and breathing are slowed,
the body approaches a state of paralysis, and the brain processes experiences from
throughout the day and relaxes. Sleep is necessary to sustain life, though the evolu-
tionary reasons behind this process have yet to be fully explored. Sleep status can
be assessed using physical or physiological measurements, such as respiration rate,
heart rate, temperature, and body movement [19]. Based on these measurements,
sleep behaviour can be determined in terms of sleep duration, sleep-onset latency
(SOL), arousal, wake after sleep onset (WASO), and sleep efficiency (SE) [6]. Good
rest benefits overall well-being and enhances the ability to cope with pressure and
stress [20].
Everyone has fluctuations between good and bad rest due to several different factors,
including lifestyle changes, stress, illness, and environmental conditions. Persistently
poor sleep is a severe problem and is likely indicative of chronic disorders and sleep
issues. Such a problem should be monitored to avoid these consequences. The
importance of sleep analysis must be addressed, as poor sleep is an issue that affects
everyone, including those living with a chronic disease, such as diabetes [21], chronic
kidney disease (CKD) [22], cardiovascular disease [23], and depression [24,25]. Sleep
issues initially emerge as difficulty falling or staying asleep, restless legs, and daytime
sleepiness [26]. The extent of sleep issues among those with chronic diseases is
substantial: arthritis affects one in five adults, 80% of whom are living with sleep
issues [26–28]. In 2013, 16% of all adults were affected by CKD [29, 30], many
suffer from conditions such as restless leg syndrome (RLS) and sleep apnoea [31,32];
between 30 and 50% of people diagnosed with cancer deal with sleep issues during
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treatment—for several years after treatment, insomnia symptoms persist for 23 to
44% of all patients [33].
Insufficient sleep leads to a loss in productivity and a higher risk of mortality, which
result in economic costs of about 2.92% of the gross domestic product (GDP) for
Japan, 2.28% for the US, 1.35% for Canada, 1.86% for Germany, and 1.56% for
the UK [34]. It is a pervasive issue that can be targeted by maintaining a healthy
sleep routine and avoiding sleep deprivation. Sleep disorders are usually related to
inadequate sleep quality. They are quite common and result in significant costs to
the health care and economic system [19,35]. They are a seriously under-recognised
issue, and this lack of recognition leads to direct and indirect healthcare costs af-
fecting a variety of factors, such as inpatient hospital costs, pharmaceuticals, and
work-related injuries [35].
One social consequence of sleep issues is fatigue, which results in a reduction in
quality of life. Affected individuals feel unable to actively participate in daily life;
they are exhausted and unable to adequately perform tasks. Their mental health is
affected by memory loss, concentration issues, drowsiness, and mood changes. Their
physical health is affected by a worsened immune system, balance issues, weight gain,
high blood pressure, and a higher risk of diabetes and heart disease [36].
Essentially, many problems arise from insufficient or inadequate sleep. The daily
lives of individuals are considerably impacted both mentally and physically. The
economic costs stemming from sleep issues are a burden for society. As a result,
it is necessary to automatically monitor and assess sleep, ideally in a natural sleep
environment, without intervening in people’s sleep routines. To conduct this home-
based sleep assessment, we must employ sensor technology and data analytics.
Sleep behaviour has traditionally been studied in clinical environments.
Polysomnography (PSG) is considered the medical gold standard for sleep disorder
classification [6]; it monitors brain waves, respiration, heart rate, sleep positions,
movement, and sounds. These data are used to assess SE, SOL, arousal index, sleep
stages, and other sleep disorder-related parameters. An alternative to PSG is non-
invasive actigraphy, which monitors acceleration of movements [19]. Clinicians use
these technologies despite their restrictions. The restrictions for PSG include exclu-
sively short-term sleep monitoring, expensive equipment, and the necessary presence
of an expert at all times. Additionally, a first-night effect results from sensors in-
fluencing sleep behaviour, meaning two consecutive recording nights are necessary,
especially for patients with insomnia [37]. For actigraphy, the available information
is limited to movement data. Automated processes would provide faster diagnoses
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of sleep disorders and insight into new aspects of night behaviour. The development
of Internet of Things (IoT) technology would make this possible: sleep trackers for
home-usage are reaching the market as both wearables (e.g., smartwatches [38]) and
non-wearables (e.g., pressure mats [39]). These trackers are currently limited by the
accuracy when compared to PSG.
Current technologies used for sleep assessment (1) interfere with sleep due to the
number of necessary sensors, (2) are often not comparable with the gold standard,
(3) are misinterpreted by users (e.g., the amount of deep sleep), and (4) are gen-
erally costly. For individuals with medical conditions, managing their own health
is essential [40, 41], and sleep management is an important part of health monitor-
ing. Individuals suffering from or likely to develop a sleep disorder could seriously
benefit from sleep-monitoring systems. These systems allow for self-assessment and
self-management on a daily basis and, in turn, the ability to detect anomalies ear-
lier. Medical experts believe that there is a need for reliable home-based systems to
monitor natural sleep behaviour [42]. The comprehensive information that would
come from such innovations would benefit (1) doctors by helping them facilitate
personalised advice and treatment to their patients as well as (2) researchers by
enabling them to investigate connections and correlations between various relevant
factors (e.g., day and night behaviours) [43]. Evidently, an adaptable system that
incorporates doctors’ recommendations and users’ changing needs is necessary; sleep
research seeks to build a reliable sleep-tracking system that enables people to gain
insights into their sleep behaviour at home. Computational methods could likely
address more complex problems such as the diagnosis of sleep disorders, recurrent
sleep patterns, and how sleep influences other areas. Data are analysed and assessed
through data mining and machine learning techniques to extract key sleep param-
eters and indicators. An IoT solution would save costs relative to standard sleep
assessment using a PSG [44].
Many studies have investigated the use of various technologies in sleep monitoring
and assessment as well as the ways other factors influence sleep. Although substan-
tial progress has been made in this research field, challenges and gaps remain. An
overall framework is missing—the lack of a clear guideline or basis for future re-
search and assessment that accurately and understandably represents the many as-
pects of sleep that is necessary to avoid misinterpretation—and more investigations
on sleep-related disease detection during early and advanced stages are necessary.
Limitations persist in terms of the accuracy and validity of the proposed methods
towards the gold standard—the lack of objective and reliable sleep assessment— (1)
reliability being limited to laboratories; (2) investigations on single parameters; (3)
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one-model-fits-all approaches; (4) only considering healthy individuals; (5) focusing
on one type of domain knowledge; and (6) the lack of adequate comparative out-
comes and standards. The field must work towards a defined and reliable system
that presents sleep behaviour in a straightforward manner to avoid misinterpretation
and clearly highlight ways to improve.
1.2 Research Problem and Issues
In recent years, sleep behaviour analysis has advanced considerably through the
introduction of new devices and computational methods; nevertheless, there are still
limitations and challenges that must be addressed. These are (1) current reliable
assessment and diagnostics being limited to laboratory settings; (2) investigations
focusing on single parameters; (3) shortcomings of current sleep behaviour analysis
methods because of the use of one-model-fits-all approaches; (4) computational sleep
assessment methods considering only healthy individuals; (5) the limitation to one
type of domain knowledge either computational or medical; and (6) the lack of
adequate comparative outcomes and standards.
The first problem is that current reliable assessment and diagnostics are limited
to laboratory settings. Usually, individuals who inform their doctors of their sleep
issues are either provided medication or referred to specialists to undergo tests. The
usually applied tests are either subjective questionnaires or an expensive and time-
limited PSG. Sensor technology is increasingly receiving attention as a way to ob-
jectively assess natural sleep behaviour at home. Additionally, home-based sleep as-
sessment are done to make people aware of their sleep status, monitor trends over an
extended period of time, detect anomalies, and provide a basis for self-management.
Even though several approaches have been investigated for home-based assessment,
they are not designed to be used as diagnostic tools and consequently, not actively
used by medical people. The main reasons are the reliability and the lack of real-
world tested methods. Home-based assessment faces variations in environments and
sensors, therefore, reaching a good performance compared to the gold standard is
challenging. Other issues in home-based assessment are (1) the users’ adherence
whom potentially attach sensors incorrectly or prematurely stop the collection, and
(2) environmental difficulties due to sensor failures and loss of data in transmission.
As sleep is highly influenced by medical conditions, there is an application for proper
sleep assessment to be used as a diagnostic tool. Advances in data analysis tools
provide the foundation to conduct complex time-series analysis which enable sleep
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behaviour-based diagnostics.
The second problem is that current research focuses on single sleep parameters. The
main evaluated factors are sleep stages and sleep positions. These investigations do
not account for the bigger picture of sleep assessment that limits the detection of
changes to one parameter. It is evident that, first, methods needed to assess sleep
parameters reliably, but with the increasing interest and methods available, it is a
huge challenge to develop a system which can bring different aspects together in one
place and present them understandably. These aspects should not only relate to
sleep assessment but also to environmental influence factors. This can be achieved
with a sleep behaviour assessment framework which can act as a guideline. The main
element of such an overall framework is to be still applicable to the specific scenarios
and context researchers and users want to investigate. The requirements for such
a framework are immense as it is to be adaptable to existing environments, and
flexible to users’ needs. The benefit of such a framework supersedes the drawback
of its challenges, because when available, behavioural interventions can easier be
developed and assessed.
The third problem is shortcomings of current sleep behaviour analysis methods be-
cause of the use of one-model-fits-all approaches that exclude differences in subject
groups. As sleep can be interpreted very subjectively [45] and influence people dif-
ferently, individuality should be addressed and considered by assessment systems.
The currently available systems do not take into account different influence factors,
which may have an effect on the performance compared to the gold standard (PSG).
Including new features in the training process to develop tailor-made training mod-
els for different groups can address this issue. These new features should either
include knowledge of the user’s condition or more accurately represent behavioural
differences.
The fourth problem is that computational sleep assessment methods consider only
healthy individuals. In sleep behaviour analysis, there is a need to distinguish
healthy individuals from those with a medical condition. However, current research
mainly targets healthy individuals. The performance on individuals with a medical
condition have shown to be lower which shows that current methods do not gener-
alise well. The investigation of diverse datasets could overcome this issues and reveal
currently unknown problems in sleep research. Improving home-use technology for
healthy individuals and those with a medical condition can enable the considera-
tion of individual factors and the investigation of more complex problems, such as
higher-granularity sleep positions.
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The fifth problem is the limitation to one type of domain knowledge either com-
putational or medical. While medical research on sleep behaviour has established
significant knowledge of the relations and structure of sleep over the last few decades,
it has yet to be sufficiently incorporated in computational analysis methods. Com-
putational investigations lack the fusion with medical knowledge in terms of sleep
structure, relations, and influence factors. Medical knowledge can be advantageous
when establishing computational sleep behaviour methods. Current sleep research
in the medical field concentrates on exploring features that provide potential hints
about specific diseases through qualitative analysis. Today, these features can easily
be measured continuously at home using sensor technology. Combining quantitative
measurements with known relations could help diagnose diseases in the early stages.
Early disease detection is important, as people often learn about sleep issues quite
late, which prevents preventive approaches. Therefore, to constantly update users
on their daily sleep habits [45] and anomalies, data analytics could provide in-depth
and important insights by using the available knowledge from the computational
and medical field.
The sixth problem is the lack of adequate comparative outcomes and standards. It
is not yet standard in sleep research to provide the validation method used; repeated
cross-validation (CV) and user-independent validation are critical in providing a re-
liable outcome for the investigated population. Usually, the target is a generalised
approach. As a result, users who are used during training cannot be used for test-
ing; otherwise, the performance ability of the method is invalid. No performance
measure has been standardised, but overall accuracy is commonly used. In cases of
imbalance in the data, however, further measurements, such as recall and precision,
are required. Therefore, we recommend standardising the performance metrics used
in sleep behaviour analysis to allow for accurate comparative studies. Comparative
studies must be performed to investigate methods using the same datasets to bench-
mark available approaches and determine the most promising methods. A dynamic
framework that incorporates technological advances from various fields could prove
helpful for effective comparative assessment.
The outlined problems must be addressed to attain a reliable sleep assessment—
data-driven approaches can provide valuable input. The primary motivation for
this thesis is to develop solutions for all of the aforementioned problems.
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1.3 Aims and Objectives
The overarching aim of the thesis is to develop a home-based modular sleep be-
haviour assessment framework that is adaptable to individuals’ needs and doctors’
recommendations. The framework is designed for those who are interested in learn-
ing about their sleep behaviour, individuals affected by a medical condition, and
medical professionals. The sleep assessment within our standardised framework will
allow (1) individuals to actively improve their daily lives and well-being and (2) doc-
tors to provide accurate assessments and recommendations. This framework is built
upon adaptive data analysis models and domain knowledge to support a flexible
sleep assessment. A layered structure is used to ensure adaptability.
To support sleep parameter extraction, the framework uses a sleep stage recognition
process that incorporates influence factors of sleep and a sleep position detection
approach for higher-granularity positions. Additionally, an individual regularity
assessment per parameter is used to provide in-depth information on consistent sleep
routines. Chronic disease detection is also integrated to adapt to changes in users’
health status. A visualisation concept provides users and doctors with appropriate
information. Finally, experiments and evaluations are performed for all developed
technologies.
The key objectives are:
1. To develop a framework that can be used as a guideline for future research by
integrating sleep behaviour parameters that are relevant and appropriate for
home-based monitoring.
2. To develop a sleep regularity algorithm that reflects the regular sleep habit for
individual sleep parameters by measuring differences within multiple days.
3. To design a visualisation concept to ensure information is presented to users
accurately and understandably by providing different levels of abstraction.
4. To develop a higher-granularity sleep position analysis that can detect complex
positions accurately.
5. To develop a sleep stage recognition approach that incorporates influence fac-
tors from clinical history and genetic information to detect personal sleep/wake
patterns.
6. To develop a sleep parameter extraction concept that facilitates personalised
assessment by introducing dynamic thresholds.
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7. To develop an in-depth understanding of relevant stakeholders on the relations
between chronic diseases and sleep.
8. To develop a chronic disease detection approach using sleep-wake behaviour
and clinical history data while exploiting the temporal aspects of the data.
1.4 Scope and Methodology
The main goal of sleep behaviour analysis is to reliably extract information about
sleep parameters and present them easy interpretable to users. Despite the number
of opportunities for sleep research, the scope of this thesis is limited to the analysis in
a natural home environment in order to address the topics presented in Section 1.3.
We restrict our work to analytical data investigations combining sensor data with
clinical history data.
To achieve this goal, we adopted the following methodology:
First, we performed a literature review on sleep behaviour analysis related to
topics such as sleep characteristics, sleep monitoring, and data collection. Moreover,
we conducted an in-depth survey on state-of-the-art computational analysis for sleep
stage classification, sleep position recognition, and medical condition investigation;
and identified some of the open issues.
Second, we performed several sleep behaviour analysis studies wherein
wearable devices were attached to individuals throughout the night and their sleep
behaviour was monitored. The studies entail the development of a framework for
sleep behaviour assessment at home, relying on domain knowledge. Domain knowl-
edge is represented by a layered structure incorporating data analysis techniques to
support the detection of sleep behaviour parameters.
The framework consists of eight layers and four main components: circadian rhythm,
regularity, sleep quality, and potential for improvement. The investigation pursues
the following steps:
• Based on the literature, extract the most important parameters for objective
sleep behaviour assessment.
• Include knowledge from medical researchers about the importance of each
parameter and the relevance of specific influence factors on sleep, such as age
and gender.
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• Determine appropriate parameters for in-home use and test, using national
sleep research resource (NSRR) datasets, if the extracted parameters are sig-
nificantly different within groups (health status, sleep disorders, and chronic
diseases).
• Develop a method to calculate regularity for individual sleep parameters
• Establish a sleep behaviour assessment framework that improves upon cur-
rent approaches and provides an overall picture of important aspects within
a modular structure that adapts to technological possibilities, available data
sources, and user preference.
• Propose a method to present data to users in an accessible way to avoid mis-
interpretation and to present data to doctors with a comprehensive picture of
users’ sleep behaviour status.
The studies we conducted focus on individual aspects of the framework components.
A higher-granularity sleep position detection was developed to recognise more com-
plex positions:
• Investigate (1) common positions, especially those that are related to specific
diseases; (2) appropriate signal sources; and (3) optimal sensor positions.
• Collect and pre-process the dataset from a simulated and real-world setting on
the common positions using three Shimmer3 sensor (accelerometer data used).
• Establish a process of detecting higher-granularity positions by applying gen-
eralised matrix learning vector quantisation (GMLVQ).
A fine-grained sleep stage recognition process was developed that is capable of pro-
viding dynamic, individual-specific sleep-wake detection, which can be used to detect
sleep parameters in a personalised manner:
• Assess which influence factors are affecting sleep and wake stages.
• Propose a fine-grained sleep stage detection approach
• Develop an adaptive sleep parameter extraction process with a personalised
threshold-based calculation
Moreover, the perceptions of doctors and individuals with a medical condition are
gathered to provide the basis for the development of a chronic disease detection
approach:
• Assess which individuals with a medical condition are affected by poor sleep
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quality by conducting interviews with affected individuals and specialists. This
assessment will underline the importance of sleep for chronic disease affected
individuals and the variety of views on the matter.
• Analyse sleep-wake behaviour and determine which clinical history factors are
related to symptoms and useful for chronic disease diagnosis.
• Propose a method, including relevant information sources from actigraphy and
clinical history, to detect chronic diseases.
• Start preliminary work on forecasting chronic disease development by applying
early-stage detection mechanisms.
• Extract clinical history factors that are significant for misclassification.
Third, we performed experiments to evaluate individual approaches for sleep
position detection, sleep stage recognition, chronic disease detection, and regular-
ity assessment. Performance was compared to the gold standard of PSG where
applicable.
Our investigations were restricted to wearable devices in a home environment and did
not take into consideration electroencephalography (EEG). We conducted our data
analysis using objective measurements and excluded experiments and comparisons
on a subjective level. Further details on the different aspects of our data-driven
approach are presented in the subsequent chapters.
1.5 Knowledge Contributions
In addressing the needs of and gaps in sleep behaviour analysis, we made the fol-
lowing knowledge contributions:
• Modular layered sleep behaviour assessment framework
We developed an adaptable sleep behaviour assessment framework that consid-
ers individuals’ needs and doctors’ recommendations. The unique framework
characteristics permit personalisation, adaptable presentation, flexibility (to-
wards data sources, needs, and layer integration), and the combination of four
main sleep aspects: sleep quality, regularity, circadian rhythm, and the po-
tential for improvement with respect to changes in environmental and sleep
hygiene factors. The layered structure can serve as a guideline for future
research, as building blocks facilitate smooth integration of technological ad-
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vances. This knowledge contribution also includes a sleep regularity algorithm
and a user-dependent visualisation concept.
– Sleep regularity algorithm
We developed a sleep parameter-specific regularity algorithm that con-
siders multiple continuous days to represent individuals’ regular sleep
habits.
– User-dependent visualisation concept
We designed a visualisation concept that is adaptable to doctors and
users. A layered structure providing different levels of abstraction is
followed by a set of rules, providing simple visualisation to avoid mis-
interpretation by daily users while still allowing for an in-depth view for
doctors.
• Higher-granularity sleep position analysis approach
We have developed and tested an approach to detect higher-granularity sleep
positions. Real-time assessment at a low computational cost is reached by
using a GMLVQ. Representative patterns for individual positions are extracted
from real-world data, providing a mobile solution for position detection.
• Fine-grained sleep stage detection approach
We have developed and evaluated a fine-grained sleep stage detection approach
that combines sensor data with information from clinical history and genetics.
Influences on sleep-wake detection can, therefore, be captured in the models
configured for specific groups. This approach is adaptable to available data
sources and supersedes current one-model-fits-all approaches. This contribu-
tion also involves a personalised sleep parameter extraction process.
– Personalised sleep parameter extraction process
We developed a process to approach a flexible sleep parameter assess-
ment for groups of individuals. Dynamic thresholds are used to reach
personalised sleep parameters and provide a better fit towards the gold
standard.
• Sleep-wake behaviour-based chronic disease detection method
We developed and tested a method that uses sleep-wake behaviour to detect
chronic disease. This method is designed to deal with temporal data and
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multi-dimensional features constructed from clinical history and sensor data—
this guarantees a robust model. This knowledge contribution is based on our
findings on sleep and chronic disease relations.
– In-depth understanding on sleep and chronic disease relations
We performed a thematic analysis on sleep and chronic disease relations
by considering how doctors and affected individuals perceive sleep prob-
lems (e.g., their thoughts on causes, impacts, assessment, treatment, and
technology usage). In-depth understanding of this topic was achieved and
the findings encourage further investigation of technological advances in
sleep assessment and chronic disease diagnosis.
1.6 Outline of the Thesis
The remaining chapters are structured as follows.
Chapter 2 reviews the literature on sleep behaviour, including sleep monitoring,
measurements, and computational analysis methods. It examines in detail sleep
stage detection, sleep position recognition, and medical condition classification—its
strengths, weaknesses, and the state of the art. Furthermore, challenges and issues
for current sleep behaviour analysis are presented and addressed in this thesis.
Chapter 3 addresses the current gap for a guideline in sleep assessment that fuses
different aspects of sleep and discusses how this is a knowledge contribution by
providing a modular layered sleep behaviour assessment framework and proposing
novel approaches to address the one-model-fits-all issue. First, Chapter 3 introduces
the overall sleep behaviour assessment framework for home use (i.e., its layered
structure, components, and characteristics). Second, we present a sleep regularity
algorithm and data visualisation concept for both users and doctors. Third, we look
at the opportunities and difficulties of sensor integration as well as the challenges
it faces in existing environments (e.g., smart homes). Finally, we evaluate specific
aspects with tests and discussions on objective measurements, emphasising, sleep
regularity, visualisation, integration aspects, limitations, and implications.
Chapter 4 targets stable state analysis by addressing the lack of a more complex
sleep position analysis and contributing to knowledge with a higher-granularity sleep
position classification approach. It integrates stable state detection and feature ex-
traction for learning vector quantisation (LVQ). The dataset collected for evaluation
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is described, and the position-detection approach is applied in a real-world and sim-
ulated setting.
Chapter 5 focuses on sleep stage detection and its application on sleep parameter
extraction. It closes the accuracy gap with PSG measurements, addresses the issue
of imbalanced datasets and one-model-fits-all approaches, and provides adequate
comparative outcomes. By doing so, Chapter 5 contributes to knowledge with (1)
fine-grained sleep stage detection through the investigation of influence factors and
(2) a proposed personalised sleep parameter extraction process. Additionally, the
evaluation steps are described and results are presented and discussed.
Chapter 6 establishes user and doctor opinions on sleep issues and their effects from
a chronic disease perspective. Thereby, we contribute to knowledge by investigat-
ing themes amid a currently underrepresented population and looking at differences
among our sample groups. A summary of the correlation between sleep issues and
chronic diseases is provided. The data collection process is described and thematic
analysis is performed, in which fundamental sleep problems, causes, impacts, assess-
ment, treatment, and differences are discussed.
Chapter 7 addresses the issue of fusing existing medical knowledge about relations
between sleep issues and chronic diseases with computational analysis. It discusses
chronic disease detection at early and advanced stages using wake and sleep be-
havioural data. As a result, it contributes to knowledge with a novel deep-learning
approach by incorporating the vital component of time and medical knowledge.
It presents the architecture of the long short-term memory network (LSTM) for
chronic disease detection, evaluates the approach on a diverse dataset, and discusses
the results. In addition, it analyses the features relevant for misclassification.
Chapter 8 reflects on the presented work by providing a summary of the research
process and activities, a description of the main research contributions, and a revisit
to the success criteria. The chapter concludes with opportunities for future research
and concluding remarks.
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Chapter 2
Literature Review
2.1 Introduction
In the previous chapter, we gave a brief introduction to sleep behaviour analysis and
placed the aim of this thesis in context. In this chapter, we establish a profound
understanding of the state of the art of sleep behaviour analysis while concentrating
on the computational aspect.
IoT devices are steadily advancing, creating new opportunities and attracting in-
creased attention in home-based sleep assessment. Recent developments, in sensing
and data analysis have led to new approaches for sleep monitoring and assessment,
leading to an emerging role for personalised smart healthcare options. We exam-
ine the current state of technology-based sleep research. We first characterise sleep
behaviour and key areas of sleep assessment and introduce a general review of the
methodologies used in this domain. We then review the major technological methods
and trends associated with sleep monitoring, data collection, and sleep behaviour
analysis, from which strengths and weaknesses are extracted. Finally, we highlight
and discuss existing issues.
This chapter is structured as follows. Section 2.2 characterises common sleep be-
haviours in terms of movement, stable states, abnormalities, and how they relate
to sleep disorders. Section 2.3 discusses sleep monitoring and data collection and
introduces key measurements and devices. The main piece of this chapter is Sec-
tion 2.4, which reviews computational methods for sleep behaviour analysis in the
fields of sleep stage classification, sleep position recognition, and disease diagnostics.
Figure 2.1 presents a structural overview.
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Figure 2.1: Survey structure on sleep behaviour analysis.
2.2 Sleep Behaviour Characterisation
Sleep behaviour can basically be divided into movement and stable states. Move-
ment states contain information about sleep and wake episodes from which sleep
stages can be extracted. Conversely, stable states mainly describe sleep positions
during periods without movement. Accordingly, normal and abnormal behaviours
can be characterised, possibly leading to the diagnosis of sleep disorders and chronic
diseases.
2.2.1 Movement Behaviour
Sleep is a relaxed state that still contains self-induced movements, mainly to prevent
pressure ulcers [44]. These self-induced movements are defined as movement states
that form behaviour over time. Movement is the primary information source for
most sensors. An exception is PSG, which is based on a combination of motion and
non-motion information.
Movement behaviour can be used to distinguish sleep from wake episodes [13,46–48].
Based on this information, objective sleep features can be extracted (e.g., sleep
continuity [49], SE [48], and time [50]). Combinations of motion and non-motion
information constitute sleep motion behaviour, which can be further correlated with
sleep stages. Sleep stages describe different levels of sleep, provide hints about
patient health, and are one of the most significant parameters considered during a
PSG visit.
Many disorders exhibit correlations with specific anomalies in sleep cycles or amount
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of time in specific sleep stages. Normally, sleep stages are measured with and defined
by brain-wave data but are considered difficult to classify and, therefore, can only
be distinguished by trained technicians [19]. Abnormal movement during sleep can
often be indicative of certain diseases. This includes movement from the eyes, chin,
limbs, chest wall, and upper abdomen [51]. Many sleep-related movement disorders,
including periodic limb movement disorder, RLS, and sleep-related bruxism [51], can
be diagnosed based on irregular sleep movement. These irregular movements can
also help to diagnose other disorders, such as rapid eye movement (REM) disorders
and sleep apnoea. Sleep apnoea is indicated through respiration effort over abnormal
abdomen movement during apnoeas [51]. Abnormal wake-sleep behaviour during the
day is used to diagnose circadian rhythm sleep-wake disorders [51]. Additionally,
this knowledge can potentially help investigate the severity of insomnia by observing
wake and sleep periods during the night. Movement behaviour offers a significant
amount of information, but more still can be found by also observing periods with
no motion.
2.2.2 Stable State Behaviour
Stable states are the periods in rest with no movement (i.e., the periods while a
person does not move); they are mainly related to sleep positions. Sleep positions
are entirely independent of sleep stages [52], meaning they provide additional insights
into sleep behaviour.
During periods without movement, four basic sleep positions can be measured:
supine, prone, right lateral, and left lateral. Sleep position tracking is predomi-
nantly motivated by the prevention of pressure ulcers [39, 53] or the influence of
position on sleep apnoea [54]. Additionally, certain sleep positions can result in
back pain when the hip is rotated [55]. For sleep apnoea, sleeping on the back
(i.e., in the supine position), is associated with a higher apnoea-hypopnoea index
(AHI) compared to laying on the side [54]. Moreover, numerous sleep parameters,
including sleep quality, are influenced by sleep positions [56].
Research mainly concentrates on the four basic sleep positions, but as the influ-
ence on different conditions is varied, positions with a higher granularity, including
specific arm and leg positioning, are also of interest. Sensors in this field can be
(1) wearables [56,57], (2) imaging devices [58], and (3) sensors applied in or on the
bed [39,53,59–61]. These approaches will be discussed in more detail later.
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2.2.3 Sleep and Health Correlations
Sleep behaviour is manifested in established sleep parameters. These parameters
have proven useful in investigating abnormal sleep behaviour. Consequently, abnor-
mal sleep behaviour can determine sleep disorder classifications and can also indicate
risk of developing certain chronic diseases.
(a) Sleep Disorders
Certain sleep patterns are used to define several sleep disorders, such as sleep ap-
noea [62] and insomnia [18]. Currently, the diagnosis of sleep apnoea relies on sensors
in a sleep clinic while the diagnosis of insomnia is often based on subjective sleep
questionnaires [6]. Sleep apnoea is diagnosed using AHI, which represents the num-
ber of apnoea and hypopnoea events per hour [63] (see Table 2.3). An AHI of less
than 5 is classified as normal; whereas an AHI between 5 and 15 is classified as mild
obstructive sleep apnoea; an AHI between 15 and 30 is classified as moderate sleep
apnoea; and an AHI higher than 30 is classified as severe sleep apnoea [64]. For
insomnia assessment, experts use the Insomnia Severity Index and Bergen Insomnia
Scale [6]. Sleep disorders are generally related to poor sleep quality [64]. Despite be-
ing quite common and constituting a significant burden on health care costs and the
overall economy, they are underdiagnosed [19, 64]. A chronic lack of sleep can lead
to impulsive behaviour, depression, and chronic illnesses. However, when people are
able to rest well, their overall mental and physical well-being improves and they are
more able to handle pressure and stress [20, 65]. Therefore, monitoring social and
sleep behaviours can help with early diagnosis of a wide array of issues, including
mental illnesses like major depressive disorder [66].
Insomnia Insomnia can be a cause and a consequence of sleep disorders and is
known to seriously affect people’s lives. Regarding neurological diseases, such as
Parkinson’s and Alzheimer’s, insomnia can be caused by (1) the disorder itself, (2)
secondary symptoms (e.g., pain), and (3) medicinal side effects. There are also
associations between insomnia and physical illnesses, such as arthritis. Overall, in-
somnia is associated with many disorders [67]. Despite its prevalence, however, it is
often underdiagnosed and undertreated. A common issue is that of early diagnosis,
because of the social stigma attached to sleep. People tend to ‘normalise’ insomnia;
they relate it to ageing or hormonal changes. On the other hand, the perception of
people who do report insomnia cannot always be trusted, as they tend to overesti-
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mate SOL and underestimate sleep time [68]. The perception of insomnia often dif-
fers between patients and healthcare professionals as well. Furthermore, healthcare
providers are often unaware of alternatives to non-pharmacological interventions ex-
cept of sleep hygiene education [69]. Patients concentrate on daytime impairments
and self-medication, whereas clinicians concentrate on quantitative descriptors of
insomnia instead of the qualitative experiences of patients. This difference leads to
the feeling of being misunderstood. As a result, there is a strong need to improve
the ability to personalise management of insomnia [69].
(b) Chronic Diseases
Sleep behaviour is related to chronic diseases [26]. Chronic disease is a leading cause
of death and disability and, therefore, a significant factor for quality of life of patients
and relatives. As populations age, the rate of chronic disease will continue to rise and
cause difficulties for society due to the high cost of treatment [70]. Currently, chronic
diseases are significantly underdiagnosed, described as the percentage of patients
without diagnosis among all patients estimated to have the disease: hypertension
up to 40%; diabetes up to 50% [71]; and for CKD up to 74% are undiagnosed [72].
The diagnoses of chronic diseases are currently based on (1) invasive methods, such
as blood sugar screening [73]; (2) clinical history, including symptoms and risk
factors; or (3) sensor-based data, such as with blood pressure measurements [74].
These methods can also be combined to attain fast and trustworthy results, e.g., by
combining clinical history, physical exam, and results from a sleep study to diagnose
obstructive sleep apnoea syndrome (OSAS) [64]. For early detection, two main
methods are currently used: (1) marker-based clinical analysis and (2) sensor-based
behavioural analysis. In method (1), early detection of chronic diseases is based
on bio-markers, neuropsychological-markers, or structural-image-markers. Research
using this method has been done on many diseases, including Alzheimer’s disease
[75], diabetes [73], and CKD [76]. Method (2) uses data mining on sensory data,
such as actigraphy, to investigate Alzheimer’s [77], Parkinson’s disease [78], diabetes,
and hypertension [18].
It has been clinically observed that people suffering from chronic diseases such as di-
abetes [21,26], CKD [32], hypertension [79], arthritis, and strokes [26] generally have
trouble with their sleep, such as difficulty falling or staying asleep and daytime sleepi-
ness [26]. Patients report that these sleep issues negatively impact their daily lives
(e.g., daytime sleepiness) [80]. Research on 2,416 elderly Chinese people indicated
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that chronic disease is a primary predictor of poor sleep quality using multiple ques-
tionnaires, such as the Pittsburgh sleep quality index (PSQI) [81]. Numerous studies
have associated sleep problems with the presence of chronic diseases, including heart
disease, hypertension, stroke, and nocturia [81–83]. Hayashino et al. [84] found that
the global PSQI score increased as the rate of comorbidity increased. The European
Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study investi-
gated 23,620 middle-aged participants and found that people with lower sleep dura-
tion (<6h) have a significantly increased risk of stroke, cancer, and chronic diseases
generally [85]. Short sleep duration positively correlates with chronic diseases in
the Chinese population [86]. In Foley et al. [26], older adults self-reported question-
naires. The results showed that arthritis, obesity, lung disease, diabetes, strokes, and
osteoporosis were associated with sleep-related problems, such as breathing pauses,
snoring, daytime sleepiness, restless legs, and insufficient sleep [26].
In general, research methods in this field are primarily questionnaires such as PSQI.
Semi-structured interviews are seldom applied but have been used to investigate
patients’ perspectives on sleep [87].
Objective assessment of the relationship between sleep and chronic disease was per-
formed by Herdegen [88]. Medical conditions were associated with sleep architecture
changes. Increased awakenings were associated with cancer, while reduced sleep du-
ration, SE, slow-wave, and REM sleep were associated with Parkinson’s disease.
Several primary sleep disorders affected chronic diseases; OSAS were related with
hypertension, while OSAS and RLS were related with diabetes.
Poor health is generally considered to be a risk factor for poor sleep quality. Never-
theless, it is challenging to firmly determine the causal direction. A person’s health
status is an influence factor for sleep problems that may, in turn, negatively effect
an individual’s health—the relationship may be bidirectional and complex [81].
Strokes Strokes and sleep are strongly related. There is evidence that sleep issues
can increase the stroke risk [89] and that post-stroke sleep disorders impact the reha-
bilitation and quality of life—if these sleep issues are left untreated, another stroke
is more likely to occur [89]. Strokes can influence sleep architecture by reducing the
amount of NREM sleep and overall sleep time. Insomnia affects 20–56% of stroke
patients; 18% reported that their insomnia began after the stroke. Strokes are also
associated with circadian rhythm changes, which results in sleep fragmentation and
decreased SE [89].
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Cancer Breast cancer is generally associated with significant sleep problems, ac-
cording to a PSQI assessment [90]. Decreased sleep time and sleep disturbances were
associated with pain, nocturia, feeling hot, coughing, and snoring. The treatment
of sleep problems in those with cancer is inadequate. Standard treatment involves
sleep medication but no cognitive behavioural therapy for sleep, which is known to
be an effective approach. Moreover, the study showed that pain-related low quality
of life is correlated with poor sleep [90].
Arthritis One study with a sample of 23,134 patients investigated the relationship
between arthritis and sleep disturbances. It showed that arthritis and insomnia are
connected via joint pain and that both are associated with age. This relationship
was especially prevalent in those with depression and anxiety [91].
(c) Discussion on Sleep and Health Correlations
In the field of sleep research, we encountered a lack of (1) semi-structured interviews
evaluating influence factors, symptoms, and assessment practices, (2) investigations
from the perspective of doctors and patients living with medical conditions, and (3)
discussions of varying perspectives. Chapter 6 presents our research, which aims to
rectify this issue.
Previous research based on objective and subjective measurements suggests that
there are strong relationships between medical conditions and sleep issues, meaning
that the use of this knowledge would help to detect chronic disease. In Chapter 7,
we investigate this.
2.3 Sleep Monitoring and Measurements
In this section, we discuss home-based technologies, medical devices for sleep assess-
ment, sleep parameters, and influence factors.
2.3.1 Sleep Monitoring in the Medical Domain
The gold standards for assessing sleep disorders and issues are currently PSG and
actigraphy.
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(a) Polysomnography
PSG is a method that collects sensory data from devices applied to the human body
and in the surrounding environment. The wearable devices that can be used in a
PSG setting are EEG, electrooculogram (EOG), electromyogram (EMG), electrocar-
diogram (ECG), pulse oximeters, respiratory monitors, capnogram, transcutaneous
monitors, thermometers, oesophageal monitors, nasal and oral airflow sensors, gas-
troesophageal monitors, and blood pressure monitors [6, 92]. The application areas
of these sensors are shown in Figure 2.2(a). The non-wearable sensors applied in
the environment are microphones, video cameras, and light intensity sensors [6].
(a) (b)
Figure 2.2: Application area of sensors in the medical field for (a) PSG and (b)
actigraphy. Figures adapted from [1].
PSG monitors brain signals, heart signals, and movement. This method is predom-
inately used for assessing sleep disorders such as sleep apnoea and RLS. Parame-
ters such as sleep stages, SE, SOL, and arousal index can be extracted from the
data [45]. To extract knowledge from the data, complex scoring methods are used.
The clinical gold standards for sleep scoring with PSG are the Rechtschaffen and
Kales method (R-K) method [4, 43] and an alternative method from the American
Academy of Sleep Medicine (AASM) [3]. The scoring is generally based on 30-second
epochs [45]. The R-K assesses six sleep stages [4]: wake, REM, S1, S2, S3, and S4;
AASM [3] assesses five stages: wake, REM, N1, N2, and N3. Results from these two
methods are generally compared by simply combining the S3 and S4 (R-K) stages
into what AASM considers to be N3. Table 2.1 presents a description of the sleep
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stages and the differences between the two methods. This process requires trained
technicians who visually inspect data which is time-consuming.
Table 2.1: Sleep stages for the AASM [3] and R-K methods [4].
R-K AASM Description
Wake Alert Wakefulness to Drowsiness
REM Rapid Eye Movement, Few Movements, Dreams
NREM
S1 N1 Indicates Sleep Onset, Shallow, Quick Transition
S2 N2 Spindle Sleep, Light Sleep, Lower Heart Rate and
Body Temperature [93]
High Amplitude
S3 N3 Moderate Amount Slow-Wave-Sleep, Deep-Sleep, Body Relaxes,
S4 Large Amount Rebuilds, and Repairs [93,94]
High numbers of body-worn sensors often result in misleading sleep behaviour, as
it does not represent natural habits. This leads to the advice that at least two
consecutive nights of data collection should be performed [37]. PSG is also expensive
due to the laboratory setting and the fact that an observer is required to ensure
the proper functioning of the applied devices throughout the night [44]. Research
on PSG is currently looking to reduce the number of sensors while automatically
recognising the main sleep behaviour parameters. This leads to studies with single-
channel EEG in sleep stage classification [95–97], which can more easily be applied
at home.
(b) Actigraphy
An actigraph unit is a wearable device that is meant to attach to the non-dominant
wrist and provide information on sleep-wake cycles [44]. Actigraph units can measure
activity over 24 hours, and, therefore, are also used in sleep assessments. The device
is widely used for objective sleep quality measurements. The device can be used at
home, which means it interferes less with natural sleep behaviour.
Actigraph units are mainly based on accelerometer data but can also include gyro-
scopes and magnetometers. Ambient light is generally collected to help with wake-
sleep recognition. Furthermore, personal inputs can be given that tell the device
when the sleeping period starts. The standard assessment involves seven consecutive
days to obtain a representative picture of the patient’s sleep habits. This can also be
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considered the recommended amount of days [98]. This method is an unsupervised
wearable approach for sleep analysis. The application area of the sensor is shown in
Figure 2.2(b). Current research largely concentrates on extracting knowledge from
already-processed data coming from medically-approved devices such as ActiGraphs
or Actiwatches. These systems provide activity levels with wake and sleep labels.
Activity levels provide the intensity of movement within 30-second intervals.
2.3.2 Home-Based Sleep Monitoring
Sleep monitoring at home is accomplished through wearable or non-wearable devices.
(a) Wearable Technology
Wearable devices are attached to the human body. Small sensors are typically at-
tached to one of the following areas: wrist, chest, ankles, or hip. The advantage
of these sensors is their low cost and easy application at home. Data are gathered
from sensors such as 3-axis accelerometers, thermostats, or pulse oximeters (perform-
ing photoplethysmography (PPG)). Knowledge is generally obtained by using data
mining for sleep position detection [57,99], sleep stage classification [43,47,48,100],
heart rate analysis [20], respiration rate [99] analysis, and body temperature moni-
toring [20,101].
Accelerometer data are extensively used in the analysis of people’s daily activities
and behaviour. Accelerometers can measure gravity, thus making it possible to rep-
resent the orientation of an object and, therefore, investigate sleep. Sleep position
detection is usually investigated using either accelerometers [99] or other wearable
wireless devices [57] on the chest or ankles. In general, sleep stage classification uses
either one accelerometer on the wrist [47, 48, 100] or a combination of sensors, e.g.,
two accelerometers (one on the wrist, one on the ankle) and a chest strap [43]; alter-
natively, such classification can use PPG [46,102]. Other sensors include thermome-
ters that measure body temperature to extract sleep-wake data [101]. Researchers
also sometimes employ wearables that are available on the market, mainly smart-
watches, for sleep behaviour analysis under the assumption that automated self-
management tools reduce burdens and increase efficiency [103]. Various devices are
available and have already been analysed in terms of performance [38,45,50,104–107]
and user perception [45, 108]. The devices considered in these performance inves-
tigations are Actiwatch, ActiGraph GT3X+, FitBit Flex/One, FitBit Charge 2,
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FitBit Alta HR, Misfit Shine, Basis Health Tracker, Withings Pulse O2, GENE-
activ, Jawbone Up3 [38, 45, 50, 104, 108–112], ResMed S+ [107], EarlySense [106],
Smart Eye Masks [14], and Microsoft Band I [92]. A summary of the Bland-Altman
mean difference and error percentage is shown in Table 2.2—insignificant values are
excluded (α = 0.05). This output shows that most of the considered sleep devices
overestimate total sleep time (TST). For healthy participants, Actigraph GT3X+ (4
min) provided the most relevant output compared to the Z-machine [50] while the
FitBit Charge 2 (-9 min) provided the most relevant output compared to PSG [38].
For SE, Actiwatch (4.8%) performed with the highest accuracy [112] for healthy
individuals while the FitBit Alta HR (2%) performed best for individuals with spe-
cific diseases. FitBit Charge 2 (24.5 min) represents WASO the most accurate [111]
for healthy individuals while Actiwatch (-21.6 min) [112] is the most accurate for
participants with medical conditions. FitBit Charge 2 (4 min) represents SOL the
best [38] for healthy individuals while FitBit Flex (2.4 min) [112] does so for indi-
viduals with medical conditions. The differences between these investigations are
also dependent on the participants, meaning that for healthy individuals and those
with medical conditions, agreement changes [113]. Both Misfit Shine and Basis
Health can distinguish between light and deep sleep, though a comparison reveals
that Basis Health performs more accurately [105]. Additionally, accelerometer data
extraction is overestimating or underestimating certain sleep parameters relative to
PSG [49]. Ravichandran et al. [45] reviewed different sleep-sensing devices and their
performance in relation to the opinions of experts and end-users. They investigated
Misfit Shine, Jawbone UP3, FitBit One, and FitBit HR. Overall, experts are con-
cerned that the sleep quality information given to end-users is inaccurate. Design
recommendations based on level of automation, understandable visualisation, and
emotional influence factors were investigated in Vandenberghe and Geerts [108],
which considered Polar Loop, Jawbone Up3, Misfit Shine, and FitBit Flex. Van-
denberghe and Geerts recommend that (1) people label their data, which is limited
by forgetting as people fail to remember to provide the necessary labels; therefore,
it is essential to automatically detect sleep parameters accurately as we propose in
Chapter 5 for SOL; (2) visualisations should be understandable and daily comparison
available, we target this limitation by user-dependent visualisation and presentation
of regularity for the important sleep aspects in Chapter 3; and (3) emotions play a
role, therefore, sleep duration should not be referred to as being perfect. This relates
to misinterpretation of sleep parameters, which we try to overcome by: providing
an overall picture, developing algorithms which are more accurate, and visualising
in a layered structure (compare Chapter 3).
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Table 2.2: Wearables validated against PSG if not otherwise indicated with Z-
machine (Z). Bland-Altman Mean Difference is given in percentage (%B) or minutes
(m).
Wearable TST* SE* SOL * WASO Research
Healthy
FB* Charge 2 -9.0 m 4.0 m [38]
-12.3 m -11.1 m 24.5 m [111,113]
Actiwatch 17.8 m 4.8 %B [112,113]
5.8 %* 10.4 %* [105]
FB* FlexS∗ 3.0 %* [105]
Basis Health 7.8 %* [105]
Pulse O2 6.0 %* [105]
Misfit Shine 15.3 %* [45,105,108]
GT3X+ 4.0 m/Z [50]
Diseased
Actiwatch 40.6 m 7.0 %B -13.5 m -27.1 m [104]
43.9 m 7.5 %B -12.9 m -33.9 m [110,113]
-21.6 m [112,113]
FB* FlexN∗ 32.9 m 7.9 %B -2.4 m 30.5 m [112,113]
46.0 m 8.1 %B -44.0 m [104,108]
FB* FlexS∗ -86.3 m -16.0 %B 11.5 m 74.8 m [104,108]
FB* Alta HR 11.6 m 2.0 %B [109]
Jawbone Up3 39.6 m 6.8 %B -5.1 m -34.3 m [110,113]
*N-Normal; S-Sensitive; %-Percentage of Error; TST-Total Sleep Time;
SE-Sleep Efficiency; SOL -Sleep Onset Latency; FB-FitBit
(b) Non-Wearable Technology
Non-wearable devices are not attached to the human body, meaning they are the
least interfering sleep assessment method because they do not disturb a person’s
regular sleeping habits. In general, techniques are based on either single devices,
such as Kinect sensors, or multiple devices, like those integrated into smart beds.
Movement investigations use data collected from sleep trackers. There are already
applications on the market that provide insight into user sleep habits to promote
sleep self-management with smart devices.
Non-wearable sensors are widely used by researchers. These include load cells, force
sensors, air cushions, pressure pads, water-filled vinyl tubes [44], smartphones [66,
114], Shimmer sensors [13], Doppler radar signals [115,116] also with sound signals
[116,117], pressure sensors [39,53,53,59–61,118], and radio signals [119]. Air cushions
under the bed, as well as water-filled tubes under a pillow, can be used to collect data
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such as respiration rate, heart rate, and body movement to estimate sleep stages.
Additionally, pressure pads can be used to evaluate those same three measures as
well as snoring and sleep apnoea events [44]. Load cells are often employed to detect
body movement and sleep-wake patterns in addition to estimating deep sleep stages.
Pressure sensors integrated into mats, beds, or bedsheets typically perform well
detecting body locations and positions in the bed [39, 53, 59–61, 118] and can even
extract sleep stage information [57]. Imaging devices, such as Kinect sensors [58]
and depth cameras [65,120], are also used to detect sleep positions. Shimmer sensors
applied on the bed [13], Doppler radar signals [115], and sound signals [116,117] have
all been used in sleep-wake detection and sleep stage recognition.
Sleep trackers that are applied within the environment include smartphones, smart
mats, and smart beds. Smartphone applications are the most easily accessible for
users and, therefore, an inexpensive method for sleep tracking. Such sleep-tracking
applications monitor behaviour and environmental influence factors during sleep,
including audio, ambient light, and movement [114]; lower mobility and phone usage
leads to better sleep [66]. Several applications attempt to provide insights into daily
sleep cycles, SE, and duration [121, 122]—some even allow for users to self-report
moods and daily habits alongside measuring their sleep behaviour [121].
Bed-mounted sensors are not only good sources of information, but they are easily
applied into a user’s bed and more accurate than smartphones. There are several
devices on the market that use smart mat technology to extract data on body
movement, heart rate, and respiration rate [44]. Various sensors can be integrated
into smart mats, such as force, piezoelectric, and pressure sensors [44]. Some devices
combine this technology with environmental sensors (e.g., Beddit), with which users
can see a wide array of statistics, including number of bed exits, sleep quality, body
movement, noise levels, and light levels [44]; this information could be useful for
various reasons (e.g., pain management and fall prevention) [44]. The locations of
non-wearable devices in a sleep environment are depicted in Figure 2.3.
2.3.3 Discussion and Suggestions on Sleep Monitoring
Every approach has advantages and disadvantages that must be carefully considered;
the ultimate decision on which sensors to use should vary based on the area of
exploration.
Actigraphy and PSG are used for different areas of investigation. PSG offers the
highest level of accuracy but is also expensive, restricted to a supervised laboratory
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Figure 2.3: Placement of non-wearable sensors in home environments. The figure of
the bed is adapted from [2].
setting, and interrupts natural sleep behaviour. PSG requires two days of data
collection using more than three sensors while home-based actigraphy requires at
least seven days of data collection but only one wearable sensor. Actigraphy is far
lower in cost, interferes less with natural sleeping habits, and provides intermediate
accuracy. Non-wearable devices applied in the home environment involve the least
interference but are less accurate and typically immobile compared to wearables.
Regarding sleep positions recognition, non-wearable devices are generally unable
to distinguish between supine and prone positions. While imaging can effectively
recognise sleep positions, it leads to privacy concerns and cannot accurately recog-
nise movements through blankets [58]. In contrast, wearable devices offer a mobile
solution with few privacy issues that is able to distinguish between multiple people
in one bed. However, wearable sensors can lead to discomfort and potentially dis-
rupt natural sleep behaviours. Sleep stage recognition depends on more advanced
technology measuring EEG data. Currently, researchers are working to further
develop wearable technologies, such as actigraph units, to make home-based self-
management more accessible. Details can be found Section 2.4. Which approach
to take and devices to use depends on the sleep parameters of interest; for details,
see Table 2.2. The easiest devices to start with are smartwatches, as they are rea-
sonably accurate relative to smartphone applications and are more accessible than
smart beds. While numerous ready-to-use smartphone applications are available
with different collection processes and outputs, issues such as accuracy and validity
remain. When choosing the ideal device for investigation, researchers must consider
the target group, as this can influence accuracy of wearable devices [113].
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2.3.4 Sleep Parameters
The main measurements describing sleep are respiration rate, heart rate, temper-
ature, body movement [19], and brain waves [6]. Considering various hypotheses,
different important parameters can be extracted from these measurements and vary
in importance per individual. The two ways of measuring sleep are subjective and
objective, which present different insights into the sleep of individuals, depends on
the aim of research; for details, refer to Table 2.3.
(a) Sleep Parameters from Objective Measurements
Objective sleep parameters are drawn from sensor data. These parameters include
sleep stages, disturbances, sleep regularity, SE, duration, SOL, arousals, and spin-
dles, among others. Sleep stages, for example, are determined by heart or respiration
rate using the knowledge of existing relations between them [123] while skin tem-
perature is used for estimating disturbances [101]. Sleep continuity is based on SE,
arousal index, and the percentage of TST in each sleep stage [49]. Sleep quality,
regularity, sleepiness level, and chronotype are considered new insight indicators
investigated with wearable devices as opposed to traditional parameters, such as
time falling asleep, number of awakenings, and sleep duration [5]. Sleep regularity
measures the affinity between sleeping periods from consecutive days [5, 7]. Wake-
sleep episodes are the fundamental basis when objectively measuring sleep param-
eters at home with actigraphy. This means that, with sleep duration, for example,
the extracted sleep periods are analysed in relation to wake episodes. Generally,
static thresholds are used to define certain parameters. For example, for SOL, the
15-minutes rule is commonly applied [124], despite research having shown that age-
based variable thresholds improve the agreement with PSG [125]. These extracted
sleep parameters do not compare well with established gold standards. We will
propose an approach with dynamic thresholds in Chapter 5.
(b) Sleep Parameters from Subjective Measurements
Subjective sleep parameters are typically assessed by sleep questionnaires that ex-
tract information from users by asking questions to assess sleep issues [6]. These
sleep parameters include nightmares, bedtime, and rise time; see Table 2.3 for de-
tails [5]. The extracted parameters can be assessed with different techniques, such
as the SATED assessment [45], Consensus Sleep Diary, PSQI, Mini Sleep Ques-
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tionnaire, Epworth Sleepiness Scale, Insomnia Severity Test, and Sleep Disorders
Questionnaire [51]. We refer to the work of Ibáñez et al. [51] for a thorough review
of subjective methods. Subjective sleep investigation has the advantage that experts
are not necessary, but the disadvantage of missing rigor in reported answers [5].
(c) Relevant Sleep Behaviour Assessment Parameters
In this section, we present currently explored parameters concerning sleep quality,
regularity, and the circadian rhythm.
Sleep Quality Important roles are played by SE, percentage of TST per sleep
stage, arousals [49], and time spent awake [126]; new indicators have also become
prominent, however, such as sleep quality, sleepiness level, and chronotype [5]. Self-
induced movements are also seen as relevant for good sleep [44] and are investi-
gated through body position measurements, which relate to sleep quality like waking
episode frequency [56] as well as sleep disorders, such as sleep apnoea [19] and pres-
sure ulcers [39]. Consequently, sleep positions should be monitored alongside sleep
stage and sleep time [127]. Most approaches use generalised methods, but sleep be-
haviour differs among individuals based on age, biological factors, and lifestyle [128].
Furthermore, irregularity between weekend and weekdays is common for sleep onset
time, bedtime, rise time, and sleep period [129].
Circadian Rhythm The circadian rhythm—sleep-wake cycle—responds to exter-
nal impact factors, such as light exposure [130,131]. Consequently, sleep-wake cycle
alterations imply changes in quality of life and health status [131]; abnormalities
help diagnose sleep-wake rhythm disorders [6]. Circadian rhythm analysis suggests
that there is a need to integrate circadian measures into medical and care deci-
sion processes [132]. Sensors (e.g., actigraphy) monitor circadian rhythm visually or
through computational methods, such as the hidden Markov model (HMM) [132].
Several non-parametric measures represent the circadian rhythm: intradaily variabil-
ity, interdaily stability, and relative amplitude [132]. Interdaily stability represents
synchronisation to the 24-hour cycle, intradaily variability represents rhythm frag-
mentation, and relative amplitude represents activeness during the day [132]. They
can be calculated as follows,
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Intradaily variability =
n
∑m
j=1(xj − x)2
m
∑n
i=1(xi − x)2
Interdaily stability = n
∑n
i=2(xi − xi−1)2
(n− 1)∑ni=1(xi − x)2
Relative amplitude = M10− L5
M10 + L5
where n is the number of samples; m is the number of samples per day, xj are
the hourly means; x is the overall average; xi describes the activity values for each
sampling point; M10 is the average activity over the ten consecutive hours with the
highest activity level; and L5 is the average activity over the five consecutive hours
with the lowest activity level [133].
Sleep Regularity Long-time visualisation (i.e., the regularity of a person’s sleep)
interests sleep experts [45]. Regular bed and rise times should be preserved through-
out the whole week [45,134]. In reality, however, sleep parameters are often irregular
between weekend and weekdays such as those for sleep onset time, bedtime, sleep
offset, and sleep period [129]. Currently, only day-to-day sleep timing is assessed
with a sleep regularity index [130]. Nevertheless, regularity should be assessed for
different parameters and included in new frameworks for several reasons, one be-
ing, e.g., that regularly high sleep fragmentation suggests underlying issues, such
as insomnia. Therefore, a method that can represent regularity for individual sleep
parameters over longer periods of time is essential to provide reliable feedback and
recommendations to users—this is investigated in Chapter 3. Sleep regularity is
independent of sleep duration and relates to performance during the day and the
timing of sleep [130].
(d) Discussion on Sleep Parameters
Objective methods monitor and measure individual sleep behaviour in a specific
setting, often a hospital or laboratory. In contrast, subjective sleep analysis typically
does not need the presence of experts or a specific location. However, subjective
methods are less accurate than objective ones [5]. These two methods can be difficult
to compare, as definitions are not consistent in objective and subjective feature
calculations. In Table 2.3, features and their formulas are presented. Some of the
formulas are for PSG but can still be translated to actigraphy; others are developed
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specifically for actigraphy data.
Table 2.3: Subjective and objective sleep parameters adapted from [5–12].
Sleep Parameters
Subjective
Pains in the Night Time to Fall Asleep Rise Time
Real Sleep Duration Feel Cold Awakenings
Enthusiasm to Get Things Done Bad Breath Snoring
User-Perceived Sleep Quality Feeling Hot Nightmares
Somnolence During Activities Drug Ingestion Bedtime
Awakenings for the Toilet # of Co-Sleepers
Objective
Time in Each Stage (TiES) Spindles Slow Waves
Turning Light-Off Time K-Complex Arousals
TST Turning Light-On Time
Parameters Description
Sleep Stages Wake, REM, S1-S4/N1-N3
Total Recording Time (TRT) Lights out to Lights on.
SE 100TST
TRT
= 100
len(Sleep Period)−WASO
len(Sleep Period) + SL
SOL Lights out to first sleep stage.
REM Latency Sleep onset to first epoch of REM.
WASO WASO = TRT - SOL - TST
Arousal (AR) Wake period <10s
Awakening (AW) Wake period >10s
Arousal Index #AR × 60/TST
Fragmentation Index (FI) 1 min. scored sleep bouts
# Sleep bouts of any length
× 100
Movement Index (MI) Scored awake minutes
Time in bed in hours
× 100
Sleep Fragmentation Index (SFX) MI + FI
Significant Limb Movement (LM) Duration 0.5-10 sec
Periodic LM of Sleep (PLMS) ≥4 consecutive LM events
PLMS Index PLMS × 60/TST
Apnoea (A) Cessation of breathing
Hypopnoea (H) Shallow/low-frequency breathing
AHI (#A + #H) × 60 / TST
Respiratory-Effort Related Arousals
(RERAs)
Arousals from sleep do not meet the definitions
of apnoeas or hypopnoeas but do disrupt sleep.
Respiratory Disturbance Index (RDI) RERAs + As +Hs × 60/TST
Sleep Onset Time (Actigraphy) The first of 15 uninterrupted sleep min.
after reported bedtime.
Sleep Awakening Time (Actigraphy) The last of 15 sleep min. followed by 30
min. of movement.
Sleep Regularity Index (Actigraphy) −100 + 200
M(N − 1)
M∑
j=1
N−1∑
i=0
δ(si,j , si+1,j)︸ ︷︷ ︸
=1 if si,j=si+1,j
∣∣∣∣∣ s = 1 if sleepingM daily epochsN recording days
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2.3.5 Behavioural, Environmental, Genetic, and Health-
Related Influence Factors on Sleep
Over the last decade, various studies have tried to find relevant behavioural influence
factors relating to sleep; some significant insights were uncovered for specific corre-
lations. In this section, we present currently explored influence factors concerning
environmental aspects, sleep hygiene, and clinical history. Furthermore, influences
coming from personalisation and presentation are discussed.
Clinical History Influence Factors Clinical history factors have been shown to
influence sleep. Such factors include body mass index (BMI), gender, age, sleep dis-
orders, and chronic diseases. Subjective measurement techniques found several risk
factors for poor sleep quality: female gender, high number of comorbid conditions,
obesity and overweightness, short sleep duration, high alcohol consumption, depres-
sion, fatigue, and anxiety [135, 136]. Access to healthcare, good family economic
status, and rural residence were found to be associated with high sleep quality [137].
Sleep duration correlates with age, BMI, depression, and fatigue [136] whereas age
influences SOL, time spent in bed [138], overnight metabolic rate (OMR) (and,
therefore, sleep quality [126]), and the environmental effect on sleep quality [139].
Generally, females have lower-quality sleep, higher SOL, wake up more often, and
take sleeping drugs more often but take less frequent naps, whereas males often suf-
fer from daytime sleepiness [138]. Based on changes in circumstances, parameters
should be adjusted, and relevant measurements should be monitored to realise a
personalised sleep behaviour assessment framework.
Behavioural Influence Factors Objective measurement techniques are used to
investigate sleep quality and provide evidence that sleep positions affect quality
of sleep [56]. Their results indicate that the increase in time spent in the supine
position for younger individuals results in enhancement of sleep. Furthermore, pos-
itive correlations were found for younger individuals between number of position
shifts and waking episodes and activity index; in the senior group, positive correla-
tions were found between number of position shifts and total minutes scored awake,
WASO, activity index, sleep fragmentation index, and waking episodes, as well as
negative correlation for SE [56]. Comparing objective actigraphy with subjective
questionnaires in children showed that sleep onset time, bedtime, sleep period, and
sleep offset time were correlated for these methods during the week but not over
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the weekend [129]. Moreover, Valenti et al. [126] showed that time spent awake
and age plays a role in OMR and that OMR is directly related to sleep quality.
An essential aspect of night-time sleep is self-induced movements; if patients lack
these, pressure ulcers can appear [44]. If body movements increase, SE decreases;
i.e., ageing reduces SE and boosts the time awake. This implies that awake time
is tied to increased body movement and, therefore, to increased OMR [126]. From
this, we can draw the conclusion that more time in slow-wave sleep (having the
lowest OMR) results in reduced OMR which, in turn, leads to better sleep quality.
Further influence factors come from the sleep environment, such as oxygen levels,
light, sound, and humidity [20,44].
Sleep Hygiene Sleep hygiene is comprised of behavioural and environmental fac-
tors that can potentially improve sleep quality: regular sleep time; comfortable
sleep environment; regular exercise; and caffeine, alcohol, and nap avoidance [134].
Caffeine avoidance and regular bedtime affect sleep positively [134]; naps increase
WASO and sleep fragmentation and decrease SE [134].
Environmental Influence Factors The home environment plays a role in sleep
and should control temperature, humidity, CO2 levels, noise, light, or aroma [20,139];
if not ideal deep sleep can be limited [20]. Generally, bedroom air quality is divided
into two groups: thermal comfort, including temperature, airspeed, and relative hu-
midity, and air contaminants from physical, chemical, and biological agents [140].
Improvements to the sleep environment can lead to improvements in sleep qual-
ity. CO2 concentration is currently used to indicate indoor air quality, but other
contaminants also require consideration and monitoring [140].
Personalisation Research suggests that different sleep parameters hold distinct
values for individuals. These distinctions are important for a personalised sys-
tem [45]. Most notably, the distinctions between healthy individuals and those
with a medical condition must be addressed [141] (this is addressed for sleep stages
in Chapter 5). The trend in medicine is towards personalised approaches [142], but
most approaches still use generalised methods and ignore personal factors such as
age, biological factors, and lifestyle [128]. One-size-fits-all methods are not ideal
for all individuals—certain diseases are sometimes more common in certain demo-
graphic groups [142, 143]. Attempts to personalise treatment based on this kind of
subcategorisation, known as clinical phenotyping, have already proven successful for
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sleep apnoea patients [144], though not in the assessment itself. Chen et al. has
investigated approaches for personalised sleep stage detection for PSG data with
individual thresholds [145]. We propose an approach for home-based assessment in
Chapter 5.
Presentation One-solution-fits-all approaches are not flexible towards the needs
and preferences of users and doctors. Yang et al. propose an intelligent visualisation
for sleep apnoea datasets to help analyse the results. The need to display comorbidi-
ties and symptoms in a way that is both accessible for patients and comprehensive
for doctors was addressed [146]. Current designs typically present daily assessments
but lack the ability to show trends over time [45]. Misinterpretation of sleep assess-
ment factors is common [45]. This can and must be addressed by simplifying the
presentation for users. Sleep changes as ageing progresses, so appropriate thresholds
for age groups [147] must be incorporated. Overall, the preservation of privacy is
essential; users must be able to decide what information can be collected and be
shared with healthcare providers. We propose a visualisation concept which tackles
these issues in Chapter 3.
2.4 Computational Analysis Methods
The main methods for sleep behaviour analysis are data mining techniques, such as
statistical analysis and artificial intelligence. Statistical analysis is a well-developed
method, whereas the use of artificial intelligence has just recently become popular
in the medical field. Despite this, it has quickly proven to be a well-performing
method for analysing more difficult scientific problems, such as sleep behaviour and
disease detection. Various techniques are available; effectiveness varies based on
the investigated sleep problem. Prominent methods are random forests (RFs), de-
cision trees (DTs), support vector machines (SVMs), k-nearest neighbours (KNNs),
HMMs, Bayesian classifiers, neural networks (NNs), and deep learning. Methods
such as recurrent neural networks (RNNs) (e.g., LSTMs), and convolutional neural
networks (CNNs), are the most commonly employed forms of deep learning in sleep
research.
We will discuss computational sleep behaviour analysis with a focus on machine
learning approaches for the main problems: sleep stage, sleep position, and sleep
disorder detection.
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2.4.1 Characteristics of Computational Methods
The applied computational methods in sleep research must be chosen carefully, as
they influence the expected results, limitations, and discussions.
DTs extract rules to split data into subsets represented in a tree structure [148]. RFs
are a collection of multiple DTs that can overcome the issue of DTs easily overfitting
training datasets due to the law of large numbers [149]. SVMs represent data in a
higher-dimensional feature space to separate classes by hyperplanes, which makes
them slow to train on large datasets since they must solve a quadratic problem where
the number of variables is equivalent to the quantity of training data [150,151]. The
performance is sensitive to the choice of the kernel and parameters [150]. KNNs
use the k-nearest neighbours within a metric space to decide to which class new
data points belong. The model calculates the distance (commonly the Euclidean
distance) to every neighbour for each prediction step and performs slowly when
many predictions must be made [152]. HMMs are based on Markov chains, in
which the current state depends on the previous states to represent transitions and
observations [153]. Naive BCs, which assume that features are independent of one
another following Bayes’ theorem, constitute a very simple approach that requires
little training data [16,154]. NNs are based on layers of artificial neurons. Functions
are applied to the layer inputs and the outputs are sent to the next layer. The
training process is based on weighting, from which predictions can be made even
for incomplete information. NNs need long training times due to the large number
of parameters that are best determined empirically and are difficult to interpret
for humans [154]. NNs with more than three layers are considered deep learning
methods and are extensively used currently due to their reliable performance and the
advantage that, even without pre-processing, discriminant features can be generated
from raw data. However, it is not possible to see which features are important
or how the outcome is produced; additionally, since a large quantity of training
data is necessary, computational costs are quite high. Time-series data are often
collected in sleep research; therefore, specific methods are designed to incorporate
the time aspect. A prominent deep learning method in the field of time-series
data classification is an RNN known as LSTM. The method was first introduced
by Hochreiter and Schmidhuber [155] in 1997, and has been extended over time,
primarily by additions of forget gates [156], and peep-hole connections [157]. Its use
in diagnostics using multiple time-series data has already demonstrated success [158].
However, in certain cases (e.g., sleep position detection), good outcomes can still be
achieved if the time component is ignored.
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Descriptive statistics, e.g., principal component analysis (PCA) [159], draws conclu-
sions based on the data itself, whereas inferential statistics, e.g., logistic regression
(LR), draws conclusions based on samples from the population. Classic LR is often
used to analyse accelerometer data because it is easy to interpret, though it is subject
to limitations. LR is generally unsuitable for learning complex patterns from noisy
accelerometer data; therefore, higher-level features are often extracted; this requires
expertise and is potentially time-consuming. Furthermore, these methods do not
use task labels for feature construction, and, therefore, cannot learn task-specific
features [10].
2.4.2 Validation of Sleep Analysis Methods
Most technologies and approaches, such as home-based sensors and single-channel
EEG, are tested against the gold standard, PSG. Researchers must be aware that the
interscorer agreement of human-scored parameters does not have a perfect agreement
but rather, one of 82.6% [160]. This can result in a bias towards a rater’s style if
only one person scores the sleep data. It also means that discussions must take
this into account. Data from actigraph units are seldom used for validation [13].
The most common performance measures in computer science are accuracy, recall
(=sensitivity), specificity, precision, and Cohen’s kappa (κ). These measures are also
used for validation purposes in sleep behaviour analysis. Occasionally, the receiver
operating characteristic curve (ROC), area under the curve (AUC), or F1 score is
given.
Accuracy is the percentage of predictions that a classifier makes correctly. Sensitivity
describes the capability of the classifier to recognise true positives, and specificity
indicates the capability that it does not generate a false negative [62]. Specificity
is defined as the number of correctly classified negative samples (TNs) divided by
the TNs plus the number of incorrectly classified positive samples (FPs), whereas
precision is defined as the positive predictive value [97]; calculated using the number
of correctly classified positive samples (TPs) divided by the TPs plus the FPs. The
F1 score based on precision and recall can be calculated with macro- and micro-
averaging methods. The multiclass F1 score is based on weighted individual class
scores. The macro F1 score is uniformly weighted, whereas the micro F1 score is
measured by calculating the overall number of false negatives (FNs), true positives
(TPs), and FPs [97]. Accuracy and precision are not able to completely describe the
situation in multiclass classification. Additionally, for imbalanced classes, accuracy
can be misleading; therefore, precision and recall, represented by the F1 score, are
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of importance. Regardless, the drawback is that the F1 score has no sufficient
intuitive explanation [161]. Therefore, the κ statistic was introduced for imbalanced
and multiclass classifications. The κ statistic compares the classifier performance
to random guessing [161], statistically measuring the agreement between annotators
for categorical items [162]. An ROC represents a classifier’s performance at different
classification thresholds in a graph, providing a global estimation of the classification
ability [62]; it is based on the precision and FP rate (1-specificity). The larger the
AUC is, the better the classification performs [62]. For multiclass problems, multiple
graphs are required.
Note that validation is performed with (1) k-fold CV (k-CV); (2) leave-one-person-
out cross-validation (LOOCV), which is favourable; or (3) one specific data split,
from which no general conclusions can be drawn. All measurements are not always
provided; therefore, it is not always possible to directly compare the results of differ-
ent methods. Generally, user-independent validation is ideal; users who are trained
on should not be tested on—otherwise, the generalisability of the method cannot be
guaranteed. This can be realised in methods (1) and (2) but needs to be addressed
to ensure that the results are trustworthy.
2.4.3 Sleep Stage Classification
The main goals in sleep stage classification are to (1) automate the process that
is normally performed by trained technicians and (2) make home-based assessment
possible. Validation is usually performed against trained human classification, which
includes variability and is thus not optimal [163, 164]. It is especially important to
consider differences in performance between measuring healthy subjects and mea-
suring subjects with medical conditions. In the following paragraphs, approaches
using sensory monitoring at home and in the medical domain are discussed. The
different technologies, their performances, and details can be found in Table 2.4 for
home-based sensory data and in Table 2.5 for medical devices (focusing on single-
channel approaches such as EEG and ECG, as these can potentially be applied at
home). The values are recalculated from the confusion matrix or by averaging the
given outcomes.
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(a) Home-Based Sleep Stage Analysis
Wearable and non-wearable devices are investigated in terms of their sleep stage clas-
sification abilities. Sleep stages monitored at home with sensor technology provide a
less-biased data source, as the subjects are in their natural sleep environment. If the
number of body-worn sensors is held to a minimum, sleep behaviour is influenced
less than it is during PSG [37].
Five-Stage Classification An ideal approach would be able to distinguish be-
tween the six or five sleep stages, depending on the chosen guideline. Currently,
research is mainly focused on the five AASM stages. In Reimer et al. [43], MSR ac-
celerometer data from the wrist and ankle, and Zephyr BioHarness 32 data from the
chest were collected from 26 individuals in a sleep lab to investigate sleep stages and
compare results to those obtained using PSG. The data were analysed using RF and
deep learning. Deep learning was used for unsupervised feature learning, followed
by a deep belief network (DBN) built from stacked restricted Boltzmann machines
(RBM). The DBN approach achieved an average 10-fold CV accuracy of 77.6% for
accelerometer data only. The RF method, which fused the data sources of the chest
strap and accelerometers, classified 80.7% correctly. A commercial Microsoft Band
I sensor was used in Zhang et al. [92] to collect heart rate and actigraphy recordings
from 39 healthy subjects. They proposed a method using multilevel feature learning
and an RNN. LOOCV resulted in a precision of 64.5%, recall of 65%, and F1 score
of 60.5% in the comprehensive group, in which resting and non-resting sleep were
included. The performance of the RNN approach is affected by the dataset size,
which, at just 37,000 epochs, is likely too small.
Using sensors at home, which interferes less with sleep habits, is showing solid results
for using accelerometer data and a chest strap with an RF method. The limitations
in five-stage classification are that (1) only healthy participants are considered and
(2) the validation datasets are relatively small, especially for deep learning. Overall,
reliable outcomes across all classes can be seen when comparing κ.
Four-Stage Classification Because it is difficult to distinguish between N1 and
N2, the two stages are occasionally fused together as light sleep and compared to
N3 (deep sleep) [166]. This results in fours stages: wake, REM, light sleep, and
deep sleep. In Aggarwal et al. [166], continuous positive air pressure (CPAP) flow
signals from 400 subjects were analysed to detect sleep stages. High-level features
40
2.4. COMPUTATIONAL ANALYSIS METHODS
were extracted with CNN and RNN, which were further used in a conditional ran-
dom field (CRF). An accuracy of 74.1% was reached, but with a weak κ of only
0.57. We can conclude that the dataset is highly imbalanced and cannot sufficiently
detect minority classes based on only one split for training and testing. Similarly,
radio waves can be analysed by combining CNN and RNN [119]. This approach
reached a moderate κ of 0.70 with up to 79.8% accuracy for the 25 healthy subjects
that participated, but investigated only one data split. Ultimately, the advantages
of both main deep learning methods were incorporated. Specifically, the CNN was
able to separate wake and REM stages, whereas RNN could separate deep and light
sleep [119]. Accelerometer data were collected in Yeo et al. [100] from the non-
dominant hand for 36 individuals. They analysed different classifiers and performed
feature selection, concluding that Random Committee performs the best. The re-
sults showed an accuracy of 80% for light sleep and 90% for wake, REM, and deep
sleep for 10-CV. The subjects’ health status was not discussed, but the study is most
likely based on healthy participants. In contrast to machine learning approaches,
equation threshold-based approaches are also investigated. In Fujimoto et al. [165],
this is done by recording data for 100 participants from a wrist-worn device featur-
ing a 3-axis accelerometer and a reflective photoelectric volume pulse sensor. The
system reached an accuracy of approximately 68.5%, which is fairly low relative to
other accelerometer approaches; however, it is validated on a larger database. The
commercial ResMed S+ device bearing an ultra-low-power radio-frequency sensor
was analysed in Zaffaroni et al. [107]. Respiration and body-movement signals are
gathered. The validation was performed with three technicians using majority vot-
ing for an overall score. 38 adults were assessed with an accuracy of 70% compared
to the 82% arrived at by the standard scoring system. In contrast, the Early Sense
sensor, which uses piezoelectric sensors, reached only 64.5% accuracy with a weak
κ of 0.54 [106] but included 63 subjects with medical conditions.
An RC approach for accelerometers appears to be promising for four-stage classi-
fication with an average accuracy of 87.5% [100]; while a non-wearable device and
deep learning method such as those used in Zhao et al. [119] comes with certain
advantages, but their accuracy is also significantly lower at just 80%.
Three-Stage Classification Researchers have occasionally further narrowed
down the problem to wake, REM and NREM stages. In Chung et al. [116], a sound
sensor and a Doppler radar sensor were combined to detect sleep-wake episodes
prior to an NREM-REM classification. Different features for each problem were
used, reaching an accuracy of 64.4% using RF for 24 patients with sleep disorders.
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Each step included a personal-adjustment structure based on a threshold derived
from the likelihood ratios from the RF classification. In Eliran et al. [117], audio
signals from microphones were analysed for 250 participants with a one-layer NN;
the process reached 87.3% accuracy. Moreover, Smart Eye Masks were applied to
determine REM and NREM sleep in seven healthy subjects using photo reflectors
and accelerometers [14]. The researchers used a RF and obtained 80% accuracy for
10-CV. In contrast, Renevey et al. [102] utilised optical wrist-worn devices by apply-
ing a trained DT and reached an overall accuracy of 81.35%. This study considered
PPG and a 3-axis accelerometer data from 15 participants.
Although it is difficult to compare different data sources, it appears that with only
three stages considered, audio signals combined with NN perform quite well even
with subjects with a medical condition. However, this is based on the outcomes of
only one training-testing case.
Two-Stage Classification Wake-sleep classification is often the first step towards
fine-grained sleep stage classification. This classification can be performed with
PPG [46], accelerometers [47], actigraph units [48], and Shimmer sensors on the
bed [13]. In Uçar et al. [46], sleep-wake stages for ten patients with sleep apnoea
were classified by KNN and SVM using PPG, from which heart rate variability
(HRV) and PPG features were extracted. The KNN approach achieved an accuracy
of 77.35% for 10-CV for HRV, PPG, and feature selection with a small dataset of
8.000, which included participants with sleep disorders. Twenty-two elderly indi-
viduals participated in a study aimed at collecting accelerometer data. These data
were analysed using a CNN approach, which was compared to a standard sleep-wake
classification approach called ESS [168], which is based on the estimation of station-
ary sleep-segments; it increased the specificity from 54% to 68% and decreased the
sensitivity from 82% to 80% [47]. In McDowell et al. [13], five Shimmer sensors were
applied on the bed of three individuals and validated against a Philips Actiwatch.
Undersampling and oversampling were used to prepare the data for RF methods.
In this way, the overfitting issue was addressed and the researchers achieved results
with a sensitivity of 93% and specificity of 86%. Alternatively, a rule-based approach
using an actigraph unit was proposed by Kuo et al. [48]; it reached an accuracy of
92.16%, specificity of 71.3%, and sensitivity of 95.02%. They tested the system with
81 subjects split by poor and good SE. Four different rules were introduced from
movement density and density thresholds. A descriptive analysis was performed
by Liao and Yang [167]. For this purpose, camera recordings were analysed and
validated against actigraphy and PSG. Frame difference and motion history were
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used to classify body motion, which is an indicator of wake episodes. Data from ten
subjects reached 92.13% accuracy for the video-based system compared to 91.24%
for Actiwatch with 91.24% accuracy.
Threshold-based sleep-wake classification using actigraph units is a powerful method.
This suggests that it is necessary to distinguish between subjects with poor and good
SE [48].
(b) Sleep Stage Analysis in the Medical Domain
In this section, the focus lies in the automation of home-based sleep stage classifi-
cation with single-channel EEG data. The pre-processing of highly sensitive data
is important as artefacts (e.g., from movement) are present and a large amount of
information is available.
Six-Stage Classification One attempt to automate sleep stage scoring was made
in 1996 [163] when an NN model with an uncertainty index was presented that
was able to classify six sleep stages using EEG, EMG, and EOG. There were 60
subjects participating—20 suffered from depression, 20 suffered from insomnia, and
20 were healthy. The results showed accuracies of 81.5% for subjects with depression,
81% for subjects with insomnia, and 84.5% for healthy subjects. These approaches
are limited in that they collect data with numerous sensors, meaning that they
are mainly useful in a hospital environment. Single-channel EEG approaches, in
contrast, could be easier used at home in the future. Researchers working with single-
channel EEG data often use the Physionet Sleep EDF database with eight subjects
for validation. In this way, an accuracy of 88.62% for empirical mode decomposition
with adaptive boosting (AdaBoost) and DT [169] can be reached; iterative filtering
with RF can reach 90.02% [170]; complex-valued non-linear features and complex-
valued neural networks (CVANN) can reach 91.57% [95]; and tunable Q-wavelet
transformations with Bagging (DTs) can reach 92.43% [162].
In this setting, NN [95] performs with almost perfect agreement considering κ. We
can conclude that pre-processing appears to be essential to successful single-channel
EEG approaches. Its limitations lie in the size of the data sample with 15.000
epochs from only eight subjects—four healthy subjects and four who have not been
diagnosed with sleep disorders but have mild difficulty falling asleep.
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Five-Stage Classification Five-stage classification typically follows the AASM
guidelines and is commonly performed in the medical domain. For single-channel
EEG coming from the Sleep-EDF data, either (1) 8 subjects with 15,000 epochs
or (2) 20 subjects with 42,000 epochs are investigated. Approach (1) can reach
87.2% accuracy with Elman-RNN (using only 6,000 epochs) [171], 90.11% with
DT [169], 91.13% with iterative filtering and RF [170], 93.69% with tunable Q-
wavelet transformations and Bagging (DTs) [162], and 93.84% with CVANN [95].
Approach (2) performs for 20-CV with an accuracy of 82% using CNN-LSTM [172]
and 83.5% with CNN on a smartphone [173]. The data sample of 20 subjects contains
only healthy individuals. Evidently, it is necessary to further investigate patients
suffering from sleep disorders. In Shahin et al. [96], 41 healthy participants and 42
participants with insomnia were investigated, reaching an overall accuracy of 77%
by applying deep neural network (DNN)-HMM. Twenty-eight subjects with sleep
apnoea were considered by Koley and Dey [174], which reached 95.88% accuracy
for SVM. A total of 5,728 patients from the Sleep Heart Health Study (SHHS) were
investigated in Sors et al. [97], which applied a CNN and reached an accuracy of 87%
but did not perform CV. Malafeev et al. [141] could reach a similar accuracy with
a CNN-LSTM including 18 healthy patients, 23 patients with narcolepsy and five
patients with hypersomnia. Sors et al. [97] reported that they reach better results for
the smaller Sleep-EDF dataset (no exact results reported); this is potentially caused
by the small number of technicians that participated. A lower number of technicians
make the system learn a specific rater’s style, which causes generalisation problems.
For single-channel usage, SVM (16,000 epochs, 28 participants) [174] and CNN
(5,384,401 epochs, 5,728 participants) [97] tested on a dataset with a larger num-
ber of participants with sleep disorders, both of which presented promising results.
CVANN (15,000 epochs, 8 participants) [95] performed well on a dataset with a
small number of participants.
Overall, the N1 stage is often difficult to distinguish [172]. This leads to models that
focus on this issue, such as the one in Aboalayon et al. [175]. Filtered single-channel
EEG signals from 13 participants of the Sleep-EDF database were investigated with
SVM; this led to an accuracy of 92.5% in distinguishing N1 from wake stages. Many
approaches for sleep stage classification rely on features and pre-processed data
while others use raw data, such as Malafeev et al. [141]. If no CV is performed, the
results must be considered with caution, such as for Sors et al. [97] and Hassan and
Bhuiyan [169].
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Four-Stage Classification To simplify the problem, researchers fuse stages to
wake, REM, light (N1, N2), and deep sleep (N3). Approaches with single-lead
ECG and CNN have achieved 75.4% accuracy when including 16 subjects with sleep
issues, 65.6% for 994 subjects with sleep disorders, and 65.9% for 5,793 subjects
with breathing issues [15]. The investigations by Li et al. [15] have low κ values
and reasonably high accuracy. This result is likely caused by an imbalance in the
investigated datasets for different sleep stages. With imbalanced datasets accuracy is
potentially overestimated, whereas κ represents the performance above the baseline
of random guessing and, therefore, is more suitable for imbalanced data; for details,
see Section 2.4.2.
In contrast, single-channel EEG from the Sleep-EDF database results in 91.2% ac-
curacy with DT [169], 91.5% with tunable Q-wavelet transformations and Bagging
(DTs) [162], and 92.29% with iterative filtering and RF [170]. Overall, RF [170]
performs the best but has the limitation of involving only eight participants.
Three-Stage Classification Further simplification leads to three stages: wake,
REM, and NREM (N1, N2, and N3). In this case, a one-channel EEG investigation
from Sleep-EDF reached an accuracy of 93.55% with DT [169], 93.9% with tun-
able Q-wavelet transformations and Bagging (DTs) [162], and 94.6% with RF [170].
Including participants with medical conditions, those using NNs reached 89.9% ac-
curacy [93]. Extending the system with EEG, EOG, and flow allowed for 89.6%
accuracy for healthy individuals and those with RLS and sleep apnoea [93]. In con-
trast, ECG data with a CNN reached an accuracy of 75.3% for SHHS and 81.6% for
16 subjects with sleep issues [15].
Figure 2.4 summarises the performance on specific datasets that used comparable
CV. We can see an overall trend for deep learning approaches performing worse
on smaller datasets, such as RNN in Sleep-EDF with eight participants. Six sleep
stages with a higher number of participants are not explored. Hence, two aims are
targeted: how well can the guideline-based sleep stages (5 or 6 stages) be detected
and which stages can be merged (reducing sleep stages). Investigating fewer sleep
stages results in higher accuracy. Newer methods, such as deep learning, are gener-
ally used more often for larger datasets. Trends indicate that more data typically
results in worse performance, some exceptions being simpler models, such as SVM
and NN (compared to deep learning approaches).
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Figure 2.4: Performance comparison for sleep stage approaches that perform CV in
the medical domain.
(c) Discussion and Suggestions on Sleep Stage Analysis
There are two main areas in sleep stage recognition that target either home-based
analysis or sleep stage analysis in the medical domain. Both approaches have indi-
vidual issues that must be addressed in future research.
Most methods for home-based assessment have several issues: (1) training on im-
balanced data; (2) inability to correctly classify complex stages; (3) exclusion of
unhealthy participants in most datasets and a limited number of participants (non-
diverse datasets); and (4) low generalisability, caused by non-standardised user-
independent validation. It is clear that accelerometers are effective at classify-
ing sleep from wake data, as movement is the main measurement used to distin-
guish sleep from wake stages. More complex sleep stages typically require ad-
ditional information, which can be addressed by combining multiple sensors with
accelerometers—this is currently tested only on healthy subjects. When reducing
the number of sensors, audio sensors can distinguish between three stages, even
for participants with sleep disorders. Wearable devices are promising for healthy
subjects and are most commonly applied, whereas non-wearables are promising for
subjects with medical conditions. Overall trends indicate that larger datasets and
more diverse datasets worsen performance, which could be a result of (1) differences
in sleep stage detection for people suffering from a medical condition and (2) in-
consistency in movement or other elements throughout the night among different
healthy individuals. The advantage of deep learning methods in larger datasets is in
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line with the known necessity for more extensive training sets, as shown in Figure 2.4
and Table 2.5. Patterns are more easily distinguishable for sleep disorder partici-
pants when datasets are larger. This follows, e.g., from the performance of NNs
shown in Figure 2.4, where the performance is compared for different dataset sizes
for which the number of sleep disorder patients can be found in Table 2.5 (see [93]).
The validation method, if mentioned at all, is rarely CV, and, is resultantly not ob-
jective in terms of user-independent validation and representation of influences from
the training data. Overall, movement data have limitations when higher-granularity
sleep stages are involved. Simple models are currently more promising than com-
plex deep learning approaches. Comparative studies are rarely performed, which
makes it difficult to determine the ideal sensor for home assessment or the ideal ma-
chine learning approach. Generally, one-model-fits-all approaches are investigated,
so no personal or other influence factors are considered. Mainly, testing against one
technician’s scoring is performed but is restricted, as technicians have an individual
component. As a result, agreement is not always present [141]. Applied machine
learning algorithms enhance the automated practices but have then the restriction
to learn one technician’s style. Typically, one data source is accessed for informa-
tion and a fusion of multiple sources is not considered. We address these issues in
Chapter 5, where we present a fine-grained sleep stage detection approach.
For sleep stage analysis in the medical domain, challenges remain for (1) the general-
isation of the model to people affected by diseases and (2) dealing with imbalanced
classes. These challenges are evident in the fact that methods perform worse on
larger and more diverse datasets. This effect is also influenced by the imbalance of
the Sleep-EDF dataset containing eight participants with a majority class of wake,
which introduces a model bias, and, therefore, positively influences performance.
Overall, it appears that single-channel EEG is sufficient to obtain sleep stages—
however, home use is still a future step. The low number of features and signal
sources required for single-channel EEG could make it possible to easily extract
in-depth information at home. Despite this potential, the gold standard remains
PSG, which is not feasible in a home setting. In general, online detection is desir-
able because it can be useful for boosting slow-wave sleep, transcranial stimulation,
and acoustic stimulation [164]. In Figure 2.4, deep learning approaches perform
worse with larger datasets, but comparative studies of simple models with the same
datasets are lacking. The trend of using deep learning methods on larger datasets is
in line with the known influence of small datasets on the methods—see RNN, which
uses only 6,000 epochs. Therefore, the performance advantages and disadvantages
of deep learning cannot be observed and discussed in detail. For smaller datasets,
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deep learning approaches perform worse, most likely influenced by the need for more
training data compared to approaches like RF and bagging. Six sleep stages are in-
vestigated only with smaller datasets, likely because of the newer guidelines that
allow for the consideration of fewer (five) stages [3]. It is easier to classify fewer
sleep stages, as the ones that are difficult to differentiate between are simply com-
bined. Overall, CV and LOOCV are the most commonly used validation methods,
which guarantees objective performance in the medical domain. When the only
performance metric in an imbalanced dataset is accuracy, the outcomes must be
interpreted with caution, as the imbalance, which is often present in these studies,
influences the accuracy.
2.4.4 Sleep Position Recognition
Sleep position recognition generally detects the four basic sleep positions: supine,
prone, left lateral, and right lateral. Higher-granularity positions are increasingly
being investigated as well. For some approaches (e.g., image-based), the number of
detected positions must be reduced due to methodological limitations. This normally
involves excluding the prone position or combining it with the supine position [39,53,
60, 61, 65, 181–184]. Other approaches detect more complex positions on top of the
four basic ones, including right fetus [53,118], right yearner [53], right log [118], left
fetus [53, 118], left yearner [53], and left log [118]. Varying arm positions [39, 179],
leg positions (see Chapter 4), and angles [57, 60], are considered higher-granularity
positions. These positions can be associated with certain issues, such as back pain
[55]. Furthermore, the basic set of positions can be extended with an unknown state,
normally the sitting/standing position [65,178,180], explaining, e.g., bed exits.
In this section, outcomes are distinguished by wearable and non-wearable devices,
as sensors in the medical field are rarely used (only in [176, 177]). A summary can
be found in Table 2.6, where different methodologies and their results are listed.
(a) Sleep Position Analysis Using Wearables
Wearables are often investigated because they are easily applied and provide high
accuracy for position detection. Some systems have almost perfect performance
for detecting sleep positions, though they normally have issues, such as the limited
number of participants investigated and the lack of user-independent validation.
In general, single sensors can effectively detect basic sleep positions. Shinar et
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al. [176] used an ECG device and achieved a specificity of 93% and a sensitivity of
79% with a k-means iterative algorithm. In Liu et al. [177], respiration impedance
signals are measured among 16 individuals; the researchers achieved 99.7% accuracy
for 10-CV.
Extending approaches with additional wearable devices reached an accuracy of
88.5% with RF [178] and 92.2% with KNN for ten subjects [179]. Barsocchi [57]
studied the feasibility of using a transmitter and receivers in the sleep environment
to distinguish four main positions and lateral incline of 30%. They were able to
reach 100% accuracy with just two sensors and KNN.
The best matching rates, however, were achieved by Barsocchi [57], which was lim-
ited by a small sample of just two participants. Higher-granularity positions includ-
ing variations in hand movement were considered by Kwasnicki et al. [179].
The next step is the real-world application, which has rarely been considered. Smart-
watches can be applied, e.g., as they were by Sun et al. [17], where RF performed the
best with a TP rate of 91.8% for 16 participants and objective LOOCV. The most
promising models, however, involve an accelerometer placed on the chest and reach
99.5% accuracy with linear discriminant analysis (LDA) for seven subjects [99]; even
rule-based approaches can reach 99.2% accuracy for 13 subjects [180] including an
unknown state.
Overall, many reviewed approaches had a low number of participants and, moreover,
often failed to state the used validation method.
(b) Sleep Position Analysis Using Non-Wearables
Non-wearables usually require more complex analysis methods because they often
produce images that need to be classified.
The use of three sleep position classifications is very common, as distinguishing
between prone and supine is quite difficult for most sensors. Consequently, Hsia
et al. [61] used pressure sensors at the upper part of the bed to investigate three
positions by focusing on the influences coming from hand positioning and laying
angle with a Bayesian classifier (BC). The results showed a low accuracy of 78.7% for
two individuals and were disproportionately influenced by the laying angle. Pressure
mats are commonly applied for position detection; they have reached up to 98.4%
accuracy with the Gaussian Mixture Model (GMM)-KNN for nine individuals [60] as
well as with RF for two subjects and no CV [184]. Other investigations have reached
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94.1% accuracy with PCA-SVM [183], 89.9% with NN-Bayesian Network (BN) for
one person [182], and 82.7% with RBM-DNN for 13 individuals [181]. Evidently,
simple data analysis models already appear promising. More complex approaches,
such as hydraulic bed transducers, were placed under a mattress to distinguish
between the four basic sleep positions among 58 participants with an NN [185]. This
led to an accuracy of 72%—that is fairly low compared to the 90.2% achieved by the
approach with pressure distribution and LR, which only included three participants
and no CV [59]. Yousefi et al. [53] utilised a pressure mat to detect five different
positions, including supine, left/right yearner, and left/right fetus, from six subjects.
The position detection was based on a three-step algorithm using normalisation,
eigenspace projection, and a KNN classifier. The average accuracy of this detection
reached 97.7%. Liu et al. [118] investigated a mobile, easy applicable solution. In
this case, a pressure-sensitive bedsheet was used to monitor six sleep positions,
including supine, prone, log, and fetus, by sparse classifiers with minimum class
residual (MCR); the process reached an accuracy of 83% for 14 subjects [118]. To
obtain a more detailed picture, cameras capable of 3D measurements have been used
and have reached 92.5% accuracy using SVM for three individuals [120]. Pressure
mats can be used to detect higher-granularity positions—Pouyan et al. [39], e.g.,
classified eight different positions in the bed, excluding prone, using pressure mats.
Their algorithm creates a pressure image that is processed using size- and shift-
invariant image processing. Positions were classified by computing the Hamming
distance between the signature images and the presented sample. Results showed
an accuracy of 97.1% for 20 subjects. Multiple angles of three positions were detected
by Ostadabbas et al. [60]; they detected 13 sleep positions from nine individuals with
a GMM-based clustering approach and reached an accuracy of 91.6%.
Studies with whole nights of data from the real-world are rarely conducted. However,
some that have been conducted have involved Kinect devices [58], 3D-Asus Xtion
cameras [65], and pressure bedsheets [118]. Kinect sensor data were collected to
distinguish five sleep positions among 20 students [58]—no blankets were used. In
one study, a single-depth camera was able to distinguish supine, left lateral, right
lateral, and the unknown position (sitting/standing). The researchers included 78
patients and reached 94.9% accuracy with a CNN [65]. Liu et al. detected six
positions by using pressure-sensitive data from a bedsheet. Three nights from three
people were investigated using a MCR-HMM, resulting in 86.5% precision and 84.7%
recall [118].
To obtain a fast and easy visualisation of the current state of sleep position in-
vestigations, we incorporated Figure 2.5, which compares all CV investigations.
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Figure 2.5: Performance comparison for sleep position approaches using CV.
Three-position investigations primarily use non-wearable devices, whereas the basic
four-position and higher-granularity-position investigations typically use wearables.
Overall, simple models with no temporal component, such as KNN and SVM, ap-
pear to be appropriate for positions investigations. Little research has been done
under real-world conditions.
(c) Discussion and Suggestions on Sleep Position Analysis
Sleep position analysis can be performed with wearable and non-wearable devices in
simulated or real-world settings. Wearable accelerometers, particularly when placed
on the chest, can reach high accuracy with simple machine learning models. Alter-
natively, respiration monitoring is also a promising approach. While research has
evaluated various data sources and technologies, a computing-efficient and robust
solution that is adaptable to individual needs and can accurately detect higher-
granularity positions is still lacking. Wearable devices are commonly used when
tracking sleep positions, but as these are worn on the body, discomfort can be a
problematic factor. Therefore, improving usability and comfort is of high interest.
Non-wearable devices, however, are also good options. Pressure mats are commonly
used and allow for high accuracy. Recent investigations have attempted to produce
3D images, however, this methods are limited because of privacy concerns. Figure 2.5
shows that non-wearable devices cannot accurately distinguish the prone from the
supine position (partially overcome by Liu et al. [118] and Barsocchi et al. [59])
as shown by the NN approach, which reaches 72% accuracy. Therefore, three-
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position approaches are investigated. By contrast, wearables perform better for
more complex positions.
Overall, applications in the real world are rarely reported but are nonetheless im-
portant. Simple models, rather than more complex approaches, appear to be ap-
propriate for sleep position investigations. These complex approaches use NN or
deep learning and are more notably influenced by the quantity of training data. A
small number of participants is usually investigated, which comes with a drawback
in that consistency in sleep positions between individuals cannot be assumed. Many
research studies fail to report the validation method used, which makes comparison
difficult. Furthermore, many studies report performance from one split of the data,
which is not an objective representation of the investigated population, as mentioned
previously.
Research needs to target real-world applications to provide reproducible results that
are able to enhance recognition rates for higher-granularity positions. Furthermore,
user-independent validation needs to become a standard to guarantee generalisabil-
ity. In the future, other sensor sources will become available and could lead to more
advanced investigations.
2.4.5 Investigation of Sleep Disorders and Diseases
Abnormal sleep behaviour was originally classified by sleep experts and further used
to diagnose individuals with sleep disorders. Recently, however, behaviour has been
investigated in automated decision-making for (1) sleep disorders, such as sleep
apnoea [18,62,186,187] and insomnia [18], and (2) certain chronic diseases, such as
diabetes, hypertension [18], Alzheimer’s disease [77], and Parkinson’s disease [78].
Established sleep parameters can be used to investigate disorders and abnormal
sleep behaviour. The potential for the field of computational behaviour analysis to
help in diagnostics has not yet been sufficiently explored.
(a) Sleep Apnoea Investigation
Sleep Apnoea Detection Javaid et al. [187] investigated the use of a non-
wearable Impulse Radio Ultra-Wide Band Radar panel under the mattress to detect
sleep apnoea events. The analysed dataset consists of 25 hours of data from 4 sub-
jects with apnoea. The overall match against PSG reached an accuracy of 70% for
5-CV with an LDA on extracted statistical features. In Aggarwal et al. [18], sleep
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apnoea diagnostics was investigated using actigraphy. The researchers investigated
the Hispanic Community Health Study (HCHS) [188] with 1887 individuals; the
results for two classes (affected and unaffected by sleep apnoea) showed an accu-
racy of 68% with a CNN [18]. An alternative for sleep apnoea-hypopnoea syndrome
diagnosis, a home-based oximetry sensor, was investigated by Gutiérrez-Tobal et
al. [189]. A dataset of 320 subjects (one night each) was analysed using different
machine learning algorithms, such as LDA, LR, Bayesian multilayer perceptron, and
AdaBoost. A split of 60% was used for training while a split with the remaining
40% was used for testing. AdaBoost with LDA performed the best depending on
the AHI: for 5, 92.9%; 10, 87.4%; and 30, 78.7%. Chung et al. [190] reached the
diagnostic ability closest to the machine learning approach by applying statistical
methods; they achieved a better accuracy of 93.7% for an AHI of 30, but the sample
was made up of only surgical patients (475 patients, one night each). Khandoker et
al. [62] analysed two sleep apnoea types among 83 patients by applying SVM to 125
sets of ECG records and extracting 24 features. This approach reached an accuracy
of 92.85% for LOOCV. An optimisation problem on kernels led to the conclusion
that the polynomial kernel with a degree of three provides the best results. The
research was limited to patients with no history of cardiovascular disease or central
sleep apnoea. The model could prove useful for determining the CPAP therapy by
analysing the change in probabilities in the outcome [62].
It is difficult to compare the approaches because the data sources used and classes
investigated are different. Nevertheless, while non-wearable devices can recognise
sleep apnoea events with an accuracy of 70%, they are outperformed by wearable
sensors such as ECG, oximetry, and actigraphy sensors.
Sleep Apnoea Treatment CPAP devices are utilised to treat patients suffering
from sleep apnoea by providing pressure to help them through apnoea episodes.
Araujo et al. [186] used CPAP and electronic health records of 3.588 patients to
investigate an approach meant to detect patients who were likely to discontinue
the therapy. The researchers performed feature selection and used oversampling to
counteract the dataset’s imbalanced distribution. Different techniques were applied,
such as linear regression, LR, DT, and SVM—RF and extreme gradient boosting,
were the only ones to significantly improve the results. Deep learning for time series
classification did not perform well, largely due to the lack of data. The results
showed that extreme gradient boosting produced the best F1 score including health
records with an accuracy of 85% for 10-CV, which is an improvement relative to the
current state of the art.
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(b) Chronic Disease Investigation
As discussed in Section 2.2.3, chronic diseases affect not only a person’s health, but
also introduce sleep behaviour changes. These changes are investigated to obtain
reliable indicators for early and advanced stages of diseases.
Aggarwal et al. [18] investigated sleep behaviour changes by considering actigraphy
data from a broad population to detect sleep apnoea, insomnia, diabetes, and hy-
pertension. A CNN was applied to the HCHS dataset, introducing a method for
embedding activities. However, the study has one major limitation: An imbalanced
dataset is used to train a supervised machine learning approach, where the majority
of subjects are not suffering from the disorders. Consequently, its models and base-
lines are highly biased towards predicting the majority class [18]. The accuracy or
related F1 (micro), when including individuals with seven nights of data, was 69%
for hypertension, 44% for diabetes, 68% for apnoea, and 41% for insomnia.
Early disease detection is especially important for the diagnoses of both Alzheimer’s
and Parkinson’s disease, which relate to sleep [77, 78]. Early stages of Alzheimer’s
disease already affect sleep behaviour based on the relationship between β-amyloid
(Aβ) and sleep quantity and quality, as measured through actigraphy [77]. Sleep
behaviour also shows relationships for patients with Parkinson’s disease. Data from
actigraph units have been explored to investigate these correlations [78]. These
newly elucidated relationships could seriously enhance early disease detection.
(c) Suggestions for Disorder and Disease Investigations
In general, it is necessary to use the existing knowledge about the relationships
between sleep and certain diseases to enhance and promote self-management and
early detection. Automating sleep disorder diagnoses (such as sleep apnoea with
daily technologies) could enable easy and inexpensive assessments.
With the increasing prominence of deep learning technology capable of processing
large amounts of data, chronic diseases could be more effectively investigated using
sleep data. Based on current sensor accuracy and accessibility, investigations on
disease diagnostics is certainly a promising prospect with the potential to make
early diagnoses at home.
In the investigations presented here, a large number of individuals are usually in-
volved. When the validation method is stated, it is CV, which guarantees an objec-
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tive process. We decided to present the accuracy metric in this section for consis-
tency, as most failed to present other measurements.
2.4.6 Sleep Behaviour Assessment Frameworks
From the three primary assessment methods (PSG, sleep questionnaires, and actig-
raphy), various sleep parameters can be extracted and used to classify sleep disor-
ders; e.g., insomnia patients are diagnosed through SOL and sleep time [6]. These
subjective and objective methods each have individual characteristics that affect
the validity and precision of the extracted information [6]; details are provided in
Section 2.3.
A home-based approach enables the objective assessment of sleep through long-term
data collection in a natural environment. This objective assessment intrigued sleep
experts [45] and led to the initiation of IoT-based approaches. Consequently, self-
management is increasingly receiving attention in sleep assessment, as daily IoT
devices become more accessible through smartphones and watches (providing in-
sight into sleep behaviour) [45]. IoT-enabled self-management tools for sleep reduce
burdens, are more efficient than self-reports [103], and allow experts to more easily
detect problems with sleep behaviour [45]. However, commercially available devices
often focus on sleep parameters that cannot be independently changed, such as sleep
stages. Users tend to misinterpret these parameters and what they mean for sleep
quality [45]. To provide appropriate feedback, connections and correlations must be
measured and adequately presented to users [43].
Current research on IoT-based assessment investigates various data analysis methods
and new sensors to try to close the performance gap with PSG. These approaches
normally concentrate on improving one specific aspect of sleep with sensors, be they
wearable or non-wearable (compare Section 2.3.2). Nevertheless, multiple factors
influence and define sleep behaviour; hence, multiple aspects should be integrated
into assessment methods. Nam et al. [127] proposed a sleep quality monitoring
flow with two sensors: an accelerometer and a pressure sensor. Sleep measurements
(activity, heart rate, and respiration) are used to extract various sleep parameters:
sleep positions, sleep stages, sleep time, and apnoea events. These sleep parameters
describe sleep quality through a proposed equation [127]. Contrarily, Doppler radar
signals gauge respiratory rate, movement, and bed exits using SleepSense, a cost-
effective, unobtrusive, and privacy-preserving system [94]. Multiple sleep parameters
can also be analysed by two accelerometers, including heartbeat, respiratory motion,
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sleep position, and movement [159].
Research suggests that every parameter has a different value to different individuals
(e.g., sleep duration). Current approaches fail to incorporate individuality despite it
being an essential aspect of any personalised system [45]. Other important aspects
are missing as well: regularity, circadian rhythm [130], flexibility, influence factors
from clinical history, and environmental factors. Some attempts have been made to
incorporate environmental factors, such as light, humidity, temperature, sound, and
air quality [20]. Deen [20] proposed a smart sleep environment for elderly people
that allows for customisation, feedback, and recommendations. Other proposals
focus on smartphones to monitor important factors of sleep: noise, location, light
intensity, and movement. Doryab et al. [66] found that less mobility and phone
usage relate to better sleep, and more social interaction increased sleep quality.
While there is some evidence to back these relationships, generalisability is still
lacking. Numerous ready-to-use smartphone and smartwatch applications exist on
the market, but most have accuracy issues [6,19,105], or provide limited information
compared to PSG and actigraphy [105] (for details, see Section 2.3.2). Sleep experts
are not fully convinced by smart devices, as performance among them differ widely.
They do, however, see the benefit of these trackers in combination with feedback on
regularity, sleep hygiene, and environmental factors [45].
2.5 Critical Analysis
In this section, we highlight the uniqueness of our approach in comparison with
relevant work from literature and the remaining open issues.
2.5.1 Uniqueness of our Approach
The uniqueness of our approach lies in the combination of different relevant sleep
behaviour aspects to establish a reliable sleep behaviour assessment framework which
accounts for influence factors, personalisation, regularity, accurate visualisation, and
the potential from the environment (for details, see Chapter 3). We propose a higher-
granularity sleep position approach which extracts representative patterns from eight
individual positions including leg positioning in Chapter 4. A comparative study
is performed for guided and real-world settings. The proposed fine-grained sleep
stage detection handles multi-source data and incorporates influence factors from
health status, gender, and race. It supersedes current one-model-fits-all approaches,
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Table 2.7: Summary of the uniqueness of our research compared to the most similar
approaches in literature.
Lit. Purpose Research Elements Comparison to our Approach
Sleep Framework
[127]
Extract sleep qual-
ity from collected ac-
celerometer and pres-
sure sensor data
Sleep positions, sleep
stages, sleep time, and
apnoea events, 3 par-
ticipants
We incorporate currently miss-
ing aspects: regularity, circadian
rhythm, influence factors, envi-
ronmental factors, sleep hygiene,
and personalisation of the as-
sessment. We use an adaptable
approach which can deal with
different sensor data and com-
bine multiple elements. Vali-
dation on a diverse and large
dataset is performed.
[94]
Noncontact and cost-
effective sleep moni-
toring with Doppler
radar signals
Respiratory rate,
movement, and bed
exits, 3 participants, 1
in a real-world setting
[159]
Monitoring sleep be-
haviour with two ac-
celerometers
Heartbeat, respiratory
motion, sleep positions,
and movement
Sleep Positions
[179]
Detect 8 positions
with arm postures
Wearables; guided set-
ting; 3 accelerometers
Higher-granular positions with
different leg postures are not ex-
tensively investigated with wear-
ables. In [179] arm positions
where investigated with KNN,
we propose LVQ with the advan-
tage of easy feature selection and
perform a comparative study be-
tween guided and real-world set-
tings including the prone posi-
tion.
[39]
Detect 8 position
with limb postures,
excluding prone
Non-Wearables; guided
setting; pressure mat
[60]
Detect 13 positions
with limb postures,
excluding prone
Non-Wearables; guided
setting; pressure mat
[118]
Detect 6 positions in-
cluding leg postures
Non-Wearables; real-
world setting; pressure
bedsheet
Sleep Stages
[46]
Sleep-Wake stage de-
tection
PPG and HRV from 10
participants
We designed a fine-grained sleep
stage detection approach which
can handle multi-source data
and incorporates influence fac-
tors from health status, gen-
der, and race for diseased and
healthy individuals.
[47]
Sleep-Wake stage de-
tection
Accelerometer data
from 22 participants
[167]
Sleep-Wake stage de-
tection
Video recordings from
10 participants
[48]
Sleep-Wake stage de-
tection
Accelerometer data
from 81 participants
Chronic Disease Detection
[18]
Classify existing
chronic diseases
Actigraphy data from
individuals affected by
apnoea, diabetes, hy-
pertension are analysed
with CNNs
We designed LSTMs to deal
with temporal aspects while fus-
ing clinical history and actigra-
phy data to detect apnoea, di-
abetes, hypertension, and CKD
at early and later stages.
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and is tested on a large and diverse dataset (compare Chapter 5). Chronic disease
detection is performed from sleep-wake behaviour by introducing a LSTM to deal
with the temporal data and multi-dimensional features coming from clinical history
and sensor data (for details, see Chapter 7). In-depth understanding on sleep and
chronic disease relations was established in our study (compare Chapter 6) on the
perception from doctors and effected individuals. A summary of the uniqueness of
our approach in relation to relevant literature is provided in Table 2.7.
2.5.2 Open Issues
In recent decades, sleep behaviour analysis has advanced considerably through the
introduction of new devices and computational methods; nevertheless, there are
still limitations and challenges that must be addressed by the research community.
Common challenges that must be met include (1) incorporating sleep behaviour
differences from both healthy and unhealthy populations into methodologies; (2)
including medical knowledge in terms of sleep structure, relationships, and influence
factors; (3) improving current technologies for home-usage; (4) validating on larger
and more diverse datasets; (5) addressing imbalanced datasets and their issues; (6)
providing adequate comparative outcomes and standards; and (7) establishing a
framework to present different aspects of sleep at home using sensor technology.
There is a strong need in sleep behaviour analysis to distinguish between healthy
subjects and subjects with medical conditions. Currently, research mainly targets
healthy individuals for sleep analysis. When subjects with medical conditions are
included, overall performance is typically lower, but this can be addressed by either
training models separately for different groups to establish personalised approaches;
or by including new features in the training process that would either include knowl-
edge of users’ health or represent behavioural differences more accurately. We ad-
dress this aspect, in chapters 3 and 5, by investigating personalised approaches and
include new features to increase performance and, in turn, reliability.
Medical researchers established knowledge of the structure, i.e., the time aspect of
sleep changes, and relations of, e.g., sleep and health factors, over the last several
decades. This knowledge can be an advantage when conducting a computational
sleep behaviour analysis. In Chapter 4, we establish an approach to investigate
sleep position changes throughout the night that advances the currently used sub-
jective questionnaires. Including temporal aspects while assessing sleep can likely
improve performance but has not yet been investigated extensively. We include
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the time aspect of sleep in our chronic disease detection approach in Chapter 7.
Current research mainly concentrates on automating human scoring tasks on well-
known problems such as sleep stage classification. A drawback of this computational
scoring is the usage of inconsistent human labelling with an inter-scorer agreement
of only 82.6% [141, 160]. One way to bring new insight into sleep behaviour anal-
ysis that is not based on human labelling is pattern recognition and unsupervised
approaches to describe sleep differently. Emerging approaches for sleep assessment
are investigating new features, such as the sleep regularity index [7]. The regular-
ity of sleep [7] represents trends over consecutive nights, which is a step towards
long-term visualisation and helps to draw more specific conclusions. In Chapter 3,
we develop an algorithm that represents the sleep regularity. This sleep regularity
provides more insight than the regularity index by representing the regularity of
individual sleep parameters. Furthermore, the automatic detection of shorter un-
derlying structures using machine learning techniques is rapidly emerging, such as
for K-complexes [191] and sleep spindle detection [191, 192]. Eventually, research
will extract this information from sensor sources other than EEG to make it easier
to gather at home.
Improving technologies for home use entails addressing potential discomfort and
integrating them into existing smart devices. Advances will likely move in the direc-
tion of wearable sensors that can be integrated into clothing and single-channel EEG
devices that are easily applicable. Advances could also be made in non-wearables,
which could be seamlessly integrated into the environment; existing methodologies
could be further explored, as non-wearables are currently less accurate. In certain
areas, such as sleep stage detection, research must be conducted to develop technol-
ogy that can accurately detect higher levels of sleep stages within a natural home
environment. In Chapter 5, we targeted this issue by bringing context to the current
differences in sleep-wake detection performance for different groups of people.
In the future, the issue of small datasets could be overcome through user contribu-
tions (i.e., by crowdsourcing sleep data to contribute to sleep research). Consumer
wearables will progressively adapt to facilitate the sharing of sleep tracking data
with researchers and could be contextualised by users’ personal information, such
as gender, age, and health status—studies could possibly be large enough to over-
come any inherent noise or inconsistencies. More diverse datasets including these
factors would enable researchers to address differences in healthy and diseased in-
dividuals. Still, a balance needs to be persevered between diverse aspects of the
dataset during training to counteract inconsistency, i.e., the bias towards the ma-
jority class. It is not yet standard for current research to provide the validation
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method used, but repeated CV and user-independent validation are critical for re-
liability. A generalised approach is usually targeted, so users who are trained on
cannot be tested—otherwise the performance ability of the method is unreliable.
No standardised performance measure exists but overall accuracy is fairly common.
In the case of imbalanced data, however, further measurements, such as recall and
precision, are necessary. Therefore, we recommend that the performance metrics
used in sleep behaviour analysis be standardised to easily allow for comparative
studies. Comparative studies are needed to investigate different methods used on
the same datasets to benchmark available approaches and assess the most promising
methods. Throughout this thesis, we address balance issues in datasets and provide
comparative results by using publicly available data and repetitive CV to assure
reproducibility.
It is well known that there are many correlations between sleep and certain chronic
diseases, and while some researchers work on them, these correlations do not receive
sufficient attention. The research being conducted is typically aimed at exploring
features that might provide hints about specific diseases. These features can be
measured continuously with sensor technology at home. Combining this data with
known relationships could increase the potential for early-stage diagnosis of some
diseases. In Chapter 7, we were driven by the current knowledge on relationships
between sleep and chronic diseases (see Chapter 6) to investigate a computational
approach for chronic disease detection through wake-sleep behaviour. People often
learn about medical issues too late for preventive treatment. Computational analysis
could enable us to uncover the patterns in sleep data that are unobtainable using
current methods. Consequently, with these patterns users could be shown their sleep
habits [45] and learn about medical issues earlier.
There is currently no framework able to combine all of the individual investigated
sleep aspects. A framework offers several benefits: (1) integration of different facets
on which researchers can build upon, (2) efficiency, (3) scalability towards user’s fo-
cus, and (4) robustness. Thus, a framework acts as a guideline for future researchers
and the first step towards a reliable system. Overall, many aspects of sleep are very
subjective [45]; therefore, individuality should be addressed and considered in this
framework. This would allow for the fusion of different sleep aspects from objec-
tive, subjective, and environmental [20] perspectives into an automatic approach
for sleep assessment and self-management. This can be extended by known rela-
tionships, e.g., between physical activity and sleep, which could actually improve
outcomes, such as in [10]. Consideration of routines and behaviours, including en-
vironmental aspects, sleep hygiene, regularity, and circadian rhythm [45, 132, 134],
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would serve to enhance sleep behaviour assessment frameworks. Models could also
benefit from including specifications that vary based on moon phase, season, day
of the week, and periodic personal sleep behaviour changes. We develop a sleep
behaviour assessment framework with the following aspects in mind: (1) a person-
alised solution to allow for self-management, (2) flexibility towards doctors’ and
users’ needs, preferences, and recommendations, (3) adaptability to available data
sources, (4) inclusion of regularity and circadian rhythm, (5) integration of the po-
tential effects of environmental factors, (6) validation on larger datasets to extract
more reliable relationships, (7) sensor considerations to improve sleep disorder di-
agnoses, and (8) personalised recommendations for users. On top of a framework
providing this overall picture, researchers should determine the best combination of
sensors and the effect of the output on the next day’s activities. An overall frame-
work would lead to new investigation areas that could provide new findings and
potentially solve the mystery around sleep. Investigating information provided to
users (see Chapter 3) and validating individual parameters will improve the current
sleep assessment process.
2.6 Summary
This chapter provided a systematic, comprehensive review on the state of the art
in computational sleep behaviour analysis. We specifically focused on the latest
developments in sleep monitoring, modelling, and computational analysis meth-
ods for sleep assessments using sensor technologies, which have recently been made
available—as well as easier, quicker, and inexpensive—to the general public at home.
This is a rapidly growing and dynamically changing research area. While previous
research has mainly sought to exploit and automate human expert knowledge, one
apparent trend has been to apply data-driven techniques to investigate data from
various perspectives, rather than through human labelling alone, to discover new
insights. In this context, we identified challenges and issues faced in sleep behaviour
assessment, some of which we will continue to address in the following chapters.
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Chapter 3
Sleep Behaviour Assessment Framework
3.1 Introduction
Sleep impacts health and well-being [20]. Thus, by assessing sleep behaviour, one
can gain insight into general health. The assessment of sleep has a long history
and has proven useful in diagnosing diseases and offering lifestyle indications [6].
In recent years, self-assessment has received growing attention as being revealing
not only for users but also for doctors, as they are able to extract additional and
important factors from a natural sleep environment. The modern healthcare system
as a whole is troubled in that many of its individual systems are unable to commu-
nicate with one another and, thus, fail to provide optimal care [193]. Current sleep
behaviour assessment is restricted to controlled hospital environments limited by
(1) the duration of monitoring (usually two days) and (2) medical sleep parameters
to diagnose diseases. As health care shifts from reactive to preventive care through
digital health and IoT technologies, the demand for home-based sleep assessment
continues to grow.
Current research largely concentrates on one specific aspect of sleep. In contrast,
we aim to bring various aspects together to form an overall framework for sleep
behaviour assessment. We believe that integrating key behavioural sleep aspects
can enhance current assessment if we incorporate existing medical and computa-
tional knowledge. This means that, within computational reason, the perception
from sleep experts on important aspects and thresholds should be integrated. We
address the following lacks that were presented in Chapter 2: (1) an overall frame-
work; (2) personalised solutions; (3) flexibility towards doctors’ and users’ needs,
preferences, and recommendations; (4) flexibility to available data sources; (5) in-
clusion of sleep regularity and circadian rhythm; (6) integration of the potential to
improve sleep quality; and (7) incorporation of sleep disorder diagnosis. To gain
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more insight into people’s sleep behaviour at home and subsequently address ob-
jective 1, we propose a sleep behaviour assessment framework that considers sleep
quality, regularity, circadian rhythm, environmental conditions, and sleep hygiene.
This framework considers personal preferences, influence factors, doctors’ recom-
mendations, and clinical history to allow for personalised medical and behavioural
assessment. To address objective 2, we develop a sleep regularity algorithm which is
embedded in the design of the framework. The visualisation of the sleep behaviour
assessment is key, therefore, to address objective 3, we design a visualisation concept
to adequately present the sleep parameters to users. Additionally, the framework fol-
lows a modular, service-oriented design that adapts to personal needs and available
technologies. We propose this with the knowledge that frameworks can integrate
different facets, are scalable, can be used efficiently, and are robust; they can act as
guidelines for future research and can be adapted. With this framework, we hope
to provide an objective, trustworthy assessment that minimises subjectivity. The
framework’s structure will be followed throughout this thesis. In the following chap-
ters, we discuss how we integrated various methodologies for specific sleep aspects
to provide general sleep assessment for users to monitor, analyse, fuse, and present
information. Our personalised, home-based framework can adapt to users’ and doc-
tors’ needs, represent regularity, and present information in a way that does not
contribute to misinterpretation.
The structure, components, and characteristics of our framework are presented in
Section 3.2; this section also details the technologies, devices, parameters, and in-
fluence factors used in our assessment process. Section 3.3 provides an overview of
the challenges facing integration into existing smart homes. The analysis on specific
sleep framework aspects is explained in Section 3.4. In Section 3.5, we explain the
outcomes and discuss limitations. A summary is provided in Section 3.6 alongside
future research directions.
3.2 The Sleep Behaviour Assessment Framework
Introducing basic structure in sleep assessment would provide focus and support by
combining different facets and perspectives; thus increases accessibility. Our gener-
ally applicable framework for sleep behaviour assessment provides this structure by
addressing the current gaps. To build this sleep behaviour assessment framework,
we consolidated various sources of medical knowledge and technological possibilities.
Our framework combines these perspectives to support a full picture of assessment
66
3.2. THE SLEEP BEHAVIOUR ASSESSMENT FRAMEWORK
inside a person’s home and remain flexible. The home-based framework enables
users to self-assess their sleep behaviour with IoT devices in the long term; the same
information can be provided to doctors so that they can diagnose problems faster
and more effectively. The assessment is divided into two main parts: biological—
circadian rhythm, regularity, and sleep quality—and potential—environmental as-
pects and sleep hygiene.
We present the framework as follows: (1) the layered-structure of the framework,
(2) the sleep assessment components, and (3) the modular-design and flexibility
characteristics. The design and elements of the framework can be seen in Figure 3.1,
which is the basis for the following descriptions.
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3.2.1 The Layered Structure
The framework is built on layers: data, assessment, extraction, emphasis, personali-
sation, potential, decision, and presentation. These are connected and interact with
each other. These layers serve as building blocks for a standardised sleep assess-
ment process. Some of them—emphasis, personalisation, and potential—can even
be removed if necessary for particular circumstances; this will be discussed more in
Section 3.2.3.
(a) Data Layer
The data layer gathers information from wearable and non-wearable devices, which
is then analysed using the appropriate methodologies. Specific IoT sensors must
be chosen based on accuracy trade-off (balance between accuracy and other factors,
such as user comfort and monitoring period) and parameters of interest. Further-
more, a full clinical history assessment is included to incorporate individual influence
factors on sleep, such as BMI, age, gender, diagnosed sleep disorders, and chronic
diseases. Environmental data include temperature, air quality, light levels, and
noise levels. Sleep hygiene usually relies on self-reporting, which should ideally be
gathered through a digital diary.
(b) Assessment and Extraction Layers
The assessment and extraction layers are strongly connected; the assessment layer
covers pre-processing (i.e., preparing the data for information extraction) while the
extraction layer deals with the extraction of relevant elements for specific compo-
nents. The information extraction can be realised through a combination of machine
learning, equation-based extraction, and statistical methods. The method used is
based on the parameters of interest (e.g., machine learning for sleep stages and
equation-based extraction for SOL), which are obtained in the extraction layer; de-
tails are provided in Section 3.2.2.
(c) Potential Layer
The potential layer provides information on aspects that can be interpreted and ac-
tively changed by users. Based on individual environmental and behavioural (sleep
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hygiene) aspects, users can aim for lifestyle changes and doctors can provide recom-
mendations. Component details are outlined in Section 3.2.2.
(d) Emphasis Layer
As discussed in Chapter 2, various factors affect sleep and should be integrated into
a sleep behaviour assessment framework, such as clinical history and the current day
(weekend/weekday). The emphasis layer highlights parameters that are particularly
important to certain cohorts. Specific cohorts, such as individuals affected by sleep
disorders or chronic diseases, need a framework that can adapt to their needs. For
example, sleep apnoea worsens when lying on the back [19] and BMI groups vary
significantly for specific parameters, such as SOL and SE (see Section 3.5). This layer
allows for insights that can help doctors judge sleep parameters based on medical
knowledge and provide outcomes that account for influence factors. We propose to
incorporate information about gender, BMI, age, chronic diseases, sleep disorders,
and the current day.
(e) Personalisation Layer
The personalisation layer considers the different extracted and emphasised param-
eters and the potential to improve sleep. These parameters are fused with doc-
tors’ recommendations and personal influence factors to present personalised feed-
back [45]. This layer visualises trends over long periods while considering the
individual-specific impacts that sleep parameters can have.
(f) Decision Layer
This decision-making support mechanism transports information based on individual
needs and preferences, and encourages active interaction between users and doctors.
Here, presentation decisions are made based on users’ communication choices (e.g.,
the restriction on sharing information with doctors) and doctors’ recommendations
(geared towards personalised self-management and parameters challenging to in-
terpret). The preferences and recommendations are then fused with the extracted
personalised parameters.
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(g) Presentation Layer
The presentation layer presents sleep behaviour parameters to the users. For the
standard user, an interpreted and simplified presentation is suggested. Certain pa-
rameters, such as sleep stages, positions, and duration, will only be monitored by
their doctors, as they are difficult to interpret. Doctors should be able to access
raw measurements and interpreted parameters to provide new recommendations for
presentation and personalisation. The user can overrule any of these presentation
recommendations by restricting the information that is shared.
3.2.2 Sleep Assessment Components
The framework focuses on four sleep assessment components: circadian rhythm,
regularity, sleep quality, and potential from the environment and sleep hygiene. IoT
sensors enable continuous home-based monitoring, meaning influence factors can be
measured and set into context with sleep behaviour. Hence, it is essential to include
specific elements for each sleep assessment component; these elements are described
in the following paragraphs.
(a) Sleep Quality
The main purpose of assessing sleep quality is to help patients self-manage their
sleep and, in turn, their health. To provide adequate feedback, connections and cor-
relations must be measured [43]. Sleep quality elements concentrate on the timing
of sleep, fragmentation, and movement, among other parameters, which are moni-
tored using various devices, including actigraph units, pressure sensors, and video
cameras [6,19]. Other parameters considered include SE, WASO, SOL, arousal, and
number of awakenings [5, 49, 105] (see Table 2.3), as well as more complex param-
eters like sleep stages [43] and sleep positions [179]. These elements are relevant
in determining a patient’s sleep status, and each parameter can be integral to the
diagnosis of a certain disease [6].
Data on sleep stages are mainly relevant for doctors to help detect anomalies and
diagnose diseases; for users, the data are difficult to interpret and largely irrelevant
[45]. Sleep stage assessment at home is generally based on HRV [46] or actigraphy
data [19], but these both continue to lack in comparison to the gold standard of PSG.
Therefore, we present a fine-grained sleep-wake detection approach in Chapter 5.
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Sleep positions affect sleep quality [56] and are associated with sleep apnoea [19] and
pressure ulcers [39]. Additionally, as sleep positions have been found to be unrelated
to sleep stages [52]; new and distinct insight can be obtained from measuring them.
Basic sleep positions are monitored by sleep trackers; in Chapter 4, however, we
propose a standardised means of considering common, higher-granularity positions.
The combination of all of these elements is likely to result in a more reliable system
that can provide personalised insight into a person’s sleep behaviour.
(b) Circadian Rhythm
Our proposed framework considers three main circadian rhythm measures: relative
amplitude, intra-stability, and intra-variability. For details, see Section 2.3.4.
(c) The Potential for Improvement
Users need a possibility to act on low assessment values, which the potential for im-
provement facilitates. This potential includes both environmental and sleep hygiene
potential.
As stated in Chapter 2, environmental factors affect sleep; therefore, altering the
sleep environment has the potential to improve sleep quality. Smart devices are able
to monitor temperature, noise levels, light levels, and air quality. As individuals
are unique in their responses to environmental factors, our framework considers this
individuality.
Sleep hygiene factors should be assessed using a digital diary. We propose keeping
subjective factors to a minimum and only using them when necessary due to the
many drawbacks of subjective measurements. We decided on the most important
factors: naps, substance use (primarily caffeine and alcohol), and exercise.
(d) Sleep Regularity
The regularity of sleep includes individual regularity measures, such as standard
rise times and bedtimes, and overall regularity. Overall regularity is assessed using
the sleep regularity index [130]; individual regularity measures must be assessed
individually.
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We recommend considering the regularity of sleep parameters and sleep timing, such
as fragmentation, duration, SE, SOL, bedtime, and rise time. Regularity measures
are extracted by summarising the changes between days over long periods of time
(and can be adapted based on the available amount of data). To represent the
regularity of specific sleep parameters, we propose the following sleep regularity
algorithm applied to each sleep parameter. It involves the subtraction of each value
x per day from a set of parameter values m (see Equation (3.1)). After subtracting,
the norm is applied (|| : R → R+), which results in (n2 − n)/2 values represented
as a vector s. The standard deviation (SD) is applied to the vector s, which results
in the sleep regularity r (see Equation (3.2)). We propose that this approach be
applied to each sleep parameter.
m = (x1, x2, . . . , xn)
sk = |mi −mj| i = (0, n], j = (0, i] (3.1)
k = (0, n
2 − n
2 ]
s = (s1, . . . , sn2−n
2
)
r = σ|s| =
√∑n
k=0(sk − s)2
n− 1 (3.2)
The lower the resultant values, the more regular the sleep parameters. We include
an option to incorporate weekend and weekday differences, as weekends usually
include sleep compensation for the weekdays. Therefore, the values in m which
refer to weekends can be excluded, if deemed necessary. The regularity assessment
is flexible to the number of days available, as shown later.
(e) Personalisation
Influence factors include BMI, gender, age, medical conditions, and days of the week
(weekday/weekend). A personalised approach fosters an appropriate integration of
these factors; our framework’s emphasis layer targets the integration of medical
status and assessment schedule (weekday/weekend).
It is essential to emphasise specific parameters based on individual characteristics,
as they significantly differ (see Section 3.5). In the emphasis layer, we incorporate
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Table 3.1: µ-function: Thresholds for age groups.
Category Age SOL(min)
0–15 16–30 31–45 46–60 61+
Teens 14–17
Young Adults 18–25
Adults 26–64
Older Adults ≥ 65
WASO (min)
≤ 10 11–20 21–30 31–40 41–50 51–60 60+
Teens 14–17
Young Adults 18–25
Adults 26–64
Older Adults ≥ 65
SE (%) Sleep Duration (h)
≥ 95 85–94 75-84 65–74 ≤ 64
Teens 14–17 <7 7 8–10 11 >11
Young Adults 18–25 <6 6 7–9 10–11 >11
Adults 26–64 <6 6 7–9 10 >10
Older Adults ≥ 65 <5 5–6 7–8 9 >9
this aspect. Listed characteristics of a user should be controlled and kept up to
date, as a person could develop a medical condition. We investigate this aspect in
Chapter 7, where we develop a deep-learning approach that continuously monitors
the current status of the user—if a significant change is detected, a doctor’s visit is
recommended and the personalised parameters can be adjusted accordingly. People
tend to catch up the lost sleep time during the week. Therefore, weekdays and
weekends should consciously be separated, as they cannot be considered equal. The
focus lies on weekdays, as a regular sleep habit should be preserved.
Influence factors affect recommendations on important things to monitor for. For
an asthma patient, sleep position on one’s back are likely more relevant, than time
spent in bed; for insomnia patients the opposite would likely be true. Medical recom-
mendations will result in changes to how information is presented to the user. These
personalised recommendations can come directly from doctors or from the system
itself, which will be prepared with basic recommendations for several scenarios.
(f) Presentation
We suggest that presentation vary based on the target group: individuals or their
doctors. We propose a visualisation concept providing simplified and interpreted
presentation for users and an in-depth presentation for doctors.
User’s Presentation This visualisation consists of three modules: sleep qual-
ity, sleep regularity, and circadian rhythm. The visualisation is designed in three
layers, which each provide a different level of information (see Figure 3.3). The
unprocessed parameters are personalised through doctors’ recommendations, indi-
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vidual characteristics, and users’ preferences. The visualisation of the parameters
follows a rating matrix in a five-level colour-based structure. For age groups different
thresholds were determined by Ohayon et al. [147] and Hirshkowitz et al. [194] (see
Table 3.1), and applied to the sleep parameters (see Equation (3.3)). The matrix
is coloured from green to red and correspondingly reaches from appropriate levels
to inappropriate levels (refer to Figure 3.2). For sleep regularity, no thresholds are
available; therefore, we suggest extracting thresholds empirically on a 5-level basis
dependent on the data investigated, and applying them similarly to Equation (3.3)
(see Equations (3.4) and (3.5)). The individual ratings are combined using the pro-
posed Equation (3.6), to step up one layer of visualisation (i.e., to present a more
abstract visualisation); inappropriate values are weighted higher (function f) while
weekends are weighted lower (function m).
visx1 = µ(rx) rx ∈ {Sleep Quality Elements} (3.3)
visy1 = ν(ry) ry ∈ {Circadian Rhythm Measures} (3.4)
visz1 = λ(rz) rz ∈ {Sleep Regularity Measures} (3.5)
visk =
1
n
∑
i∈[1,n]
m(f(visik−1)) k = 2, 3 (3.6)
f(x) =
 x if x ∈ [0, 3]2 x if x ∈ (3, 5] (3.7)
m(x) =
 x if day is weekday3
5 x if day is weekend
(3.8)
Figure 3.2: Colour scale based on threshold levels.
Doctor’s Presentation The visualisation concept for doctors focuses on the as-
pects relevant for individual patients (see Figure 3.4). Parameters that are impor-
tant for diagnoses and interpretations are presented most clearly to doctors. For
example, if someone suffers from sleep apnoea, sleep positions are relevant, so the
presentation will be altered to reflect that, i.e., the presented circles in Figure 3.4
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will be bigger. The information displayed to doctors is often that which would lead
to misinterpretation among users, such as sleep duration and sleep stages. Further-
more, the raw parameter values can be accessed directly, though availability depends
on user privacy settings.
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75
CHAPTER 3. SLEEP BEHAVIOUR ASSESSMENT FRAMEWORK
3.2.3 Modular Design and Flexibility Characteristics
Our framework has unique characteristics and a design that encourages self-
assessment and flexibility.
Self-Assessment Self-assessment can lead to the misinterpretation of certain pa-
rameters [45]. To change this, doctors offer recommendations on what the users
should pay attention to. The focus on long-term monitoring provides users with
insight into changes and regularity instead of isolated daily measurements.
Flexibility to Available Sensors The framework is fully adaptable to varying
availability of sensors, whether it is restricted by the user or by accuracy consider-
ations (certain sensors are more accurate for specific parameters [6, 19]). Different
sensors can be used in the data layer, as long as the data structure is compatible,
the information can be fused and used in the other layers.
Flexibility Towards Customers Doctors and self-managing users have different
needs. Doctors need a comprehensive picture of the available information to arrive
at conclusions, interpretations, and potential diagnoses. Users need pre-interpreted
outcomes to avoid misinterpretation and promote effective self-management, e.g.,
by providing information on behaviour which can be changed actively.
Modular Design, Preferences, and Recommendations The fusion of users’
preferences and professional knowledge makes our system reliable and understand-
able. Knowledge is integrated by advising users on what information should be
important to them. Doctors’ recommendations help emphasise the parameters that
are relevant to the users and their goals, as defined by their established preferences.
Personalisation is a key factor here, as sleep parameters affect individuals differently.
The framework has a modular design, i.e., variable layers that adapt to individu-
als. The potential, emphasis, and personalisation layers can be excluded entirely, if
necessary (e.g., if no influence factors are present or a general population approach
is preferred). The potential layer is automatically dismantled if no environmental
devices or digital diary entries are present. The exclusion of these layers has no
negative impact on the functioning of the overall framework. The benefit of a mod-
ular design is that (1) computational solutions can be developed independently from
the framework and later incorporated; (2) the framework is customisable; (3) the
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existing blocks can be used by researchers which leads to greater efficiency as they
do not need to invent knew structures; and (4) consistency is assured.
3.3 Sleep Assessment Experiments in Smart
Homes
Due to advances in technology, homes are getting smarter and sensors are becoming
better at monitor sleep behaviour in a natural environment. However, integrat-
ing these new technologies and data sources into existing environments remains a
challenge.
Combining ambient, wearable, and binary sensors for multi-purpose analyses is of
significant interest. Such a combination can improve a home’s ability to facilitate
independent living for individuals purposes, e.g., self-management of a medical con-
dition. This can improve a system in private households providing independent
living for individual purposes, e.g., self-management of a medical condition. To be
adaptable to new rapidly growing technologies [195], technological infrastructure in
users’ homes must be highly flexible to various devices and applicable to all types of
homes. We performed a study presented in the next sections to investigate current
challenges.
3.3.1 Sleep Assessment Environment Design
To provide an effective infrastructure for multi-purpose analysis seeking to, for ex-
ample, monitor sleep, fluid intake, and daily activities, two sources of data need to be
fused: (1) embedded sensors in the existing environment and (2) ambient and wear-
able sensors. This kind of arrangement is shown in figures 3.5 and 3.6. This example
was actually an experiment conducted for two weeks by researchers in a real-world
smart home. The environment at Great Northern Haven has an infrastructure of
16 smart homes equipped with ambient sensors and actuators. Older adults have
permanently occupied fifteen of the apartments since 2010; the remaining apartment
continues to be used for research and demonstration purposes [196].
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Figure 3.5: Floor plan of DKIT smart environment: permanent (semi-filled, framed)
and additional (filled) smart sensors.
Emotiv EEG
Garmin vivoactive HR
Shimmer Sensors
Samsung Galaxy S7 (edge)
H2OPal Smart Cup
Figure 3.6: Used wearable devices and their body location.
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(a) Use Cases of Interest
The challenges in activity monitoring in smart homes by fusing additional sensors
into the environment are explored for some use cases of interest. Sensor data are
collected for different user scenarios, incluing monitoring sleep and daily activities
which affect sleep.
Table 3.2: Use case: Sleep assessment.
Description The use case describes sleep quality monitoring in a smart environment
using environmental and wearable sensors.
Actors: Adults [healthy (HEA), depressed suffering from insomnia (DEP), and
affected by CKD], Smart home
Conditions: Sleep behaviour:
HEA normal
DEP problem related to sleep deprivation: falling asleep (onset), stay-
ing asleep (maintenance), and waking up early
CKD problem related to sleep disturbances: wake-ups, nocturia caused
by medication and fluid consumption.
Action sequence:
1. Adjust required sensors for sleep:
HEA,DEP Withings Aura, smartphone, camera
HEA,CKD Shimmer3 sensors, smartwatch, Withings Aura,
smartphone
2. HEA falls asleep
DEP,CKD has difficulty falling asleep
3. DEP wakes up during the night and has difficulty falling
asleep again
CKD wakes up to go to the bathroom
Table 3.3: Use case: Napping.
Description The use case is related to napping during the day.
Actors Adult, Smart Home
Conditions: Adult feels tired during the day
Action sequence:
1. Adult adjusts sensors including smartwatch, Shimmer3 sensors,
Withings Aura, smartphone
2. Adult naps in bedroom
As sleep quality is an important factor of overall well-being [20], it is considered in
our use cases for night-time (Table 3.2) and daytime (Table 3.3) sleep monitoring.
Daytime sleep periods are somewhat controversial in the literature [134]; generally,
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Table 3.4: Use case: Fluid consumption.
Description The use case illustrates the fluid consumption with a Smart Cup.
Actors Adult, Smart Home
Condition: Person is thirsty
Action sequence:
1. The person feels thirsty
2. The person goes to kitchen to fill the Smart Cup
3. The person drinks
4. Sensors in the Smart Cup measure quantity of fluid drunk
Table 3.5: Use case: Physical activity.
Description The use case is related to the physical activity of an adult.
Actors Adult, Smart Home
Conditions: Adult is inactive
Action sequence:
1. The person adjusts wearable device (smartwatch)
2. Physical activity inside the house is captured by the smart home
environment and a smartwatch, while outside the house it is cap-
tured only by the smartwatch
Table 3.6: Use case: Bed time and morning routine.
Description The use case describes bedtime and morning routine of an adult using
environmental and wearable sensors.
Actors Adult, Smart Home
Conditions: Adult wants to go to bed or get up
Action sequence:
1. The person adjusts required sensors on the body during bathroom
routine (smartwatch, Shimmer3 sensors)
2. The environment measures presence in the bathroom: use of the
sink, toilet, shower, and the hand acceleration from Shimmer3
sensors
3. Person starts the bathroom routine: comb hair, wash face, wash
hands, brush teeth, use the toilet, and shower, if necessary
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however, it’s recommended to get no more than 30 minutes [197]. Relevant con-
ditions are simulated: healthy adults without problems, depressed patients with
insomnia, and patients with CKD (see Table 3.2). Furthermore, influences on sleep
in relation to sleep hygiene and physical activity are considered.
Sleep hygiene is used as a treatment for insomnia [197,198]; this includes:
light exposure measured via light sensors in the house and time spent outside
exercise measured with environmental sensors and smartwatch (Table 3.5)
fluid consumption (Smart Cup) including caffeine consumption (Ta-
ble 3.4)
environment noise level, humidity, and temperature inside the room
nap duration (Table 3.3)
routine bedtime procedure measured with environmental and wearable
sensors (Table 3.6)
(b) Sensor Deployment and Data Collection
The smart home at Great Northern Haven consists of various wired environmen-
tal sensors, including window, door, consumption (energy, water, heating), passive
infrared sensor (PIR), Lux (illuminance), and temperature sensors (see Table 3.7).
Table 3.7: Existing smart environment sensors at Great Northern Haven.
Sensor type Count Location Detection
Door 7 doors open/close
Window 5 windows open/close
Electricity, water, & heating usage 1 boiler usage
PIR 3 ceiling movement
Lux 6 ceiling light
Temperature 6 walls temperature
The smart home’s utility was extended with wearable and environmental devices:
door, movement, flood sensors, Shimmer3 sensors, and Withings Aura (see Ta-
ble 3.8).
Two setups were designed for sleep assessment; the first involves a Withings Aura
and a smartphone under the pillow, while the second expands upon the first with
smartwatch and Shimmer3 sensors applied to the chest and extremities. The first
setting collects data throughout the night, while the second setting expands upon
the first by gathering additional data during 30–45 minute-long naps during the day.
81
CHAPTER 3. SLEEP BEHAVIOUR ASSESSMENT FRAMEWORK
Table 3.8: Additional sensors for the smart environment. R1, R2 stand for resident
bedrooms, K for kitchen, and B for bathroom.
Sensor type Count Location Collected for
Shimmer3 Sensors 5 extremities, chest daily activities, sleep
Camera 2 bedroom (R1,R2) annotation
Smartwatch 1 wrist (R1) sleep, active
Withings Aura 2 bedroom (R1,R2) sleep
Samsung Galaxy 2 bed (R1,R2) sleep
iPhone 2 smart home annotation
H2OPal Smart Cup 2 smart home fluid intake
EEG Emotiv 1 head (R1) daily activities
Securifi Door large 3 cupboard (K),
wardrobe (R1,R2)
open/close
Securifi Door small 4 fridge (K), cupboard
(K), toilet (B), tab (B)
open/close
Samsung Smart
Things Door Sensors
4 tab (K), cupboard (K),
wardrobe (R1)
open/close
MultiSensor6 3 bedrooms (R1,R2),
bathroom
movement,
temperature, light,
humidity, vibration
Flood Sensor 1 bathroom water
The Shimmer3 sensors collect accelerometer, gyroscope, magnetometer, pressure,
and temperature data. The Garmin vivoactive HR smartwatch gathers data about
sleep stages, heart rate, and movement. The Withings Aura uses an air pillow
under the mattress to calculate sleep stages, heart rate, temperature, luminosity, and
noise. The integrated smartphone sensors collect data at 0.1- to 1-second intervals.
Fluid consumption is measured with the H2O Pal Smart Cup as millilitres drunk
throughout each day. Additionally, binary sensors in the flat continuously record
various daily activities (refer to Section 3.3.1(a)).
3.3.2 Experiment Design Considerations and Lessons
Here we present challenges that must be faced when devices are added and discuss
how they are addressed throughout the process.
Hardware Setup We established an ideal setting that integrated binary and wear-
able sensors. At the start of the experiment, we encountered difficulty applying and
pairing some of the additional movement and door sensors, so they had to be ex-
cluded in further investigations. Some sensors were not easy to install, as we sought
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to use them for purposes they were not designed for. For example, door sensors were
used as tap sensors to gather data about temperature and water flow; these were
difficult to apply in the bathroom and kitchen.
Connection Difficulties We faced failures of Bluetooth connection and synchro-
nisation between wearable devices and smartphones throughout the study. Other
difficulties included internet connection problems with some devices, including the
Aura Withings and the SmartCam, which was used to collect the ground truth.
Malfunctioning Device software issues presented another challenge; some devices
stopped recording data prematurely or failed to connect properly. These difficulties
led to a lack of data during the experiment, which have to be met by an algorithmic
methodology that can handle incomplete and noisy datasets.
Data Extraction Data collection was occasionally interrupted by problems with
data transmission and raw data extraction from third-party device providers. Some
providers did not provide access to the raw data from their devices. The output
from some other devices is provided in a convoluted manner that has to be studied
in detail to understand.
Data Cleaning Data pre-processing includes data cleaning to remove erroneous
and unwanted values, data interpolation to deal with potential missing values, and
data transformation to correctly format the data.
As the collected data are from various types of sensors in a natural environment, it is
possible for noisy and redundant information to be generated (e.g., by dead batteries,
failures in sensor readings, losses in wireless transmission, and other unforeseen
events that occur in real homes). To perform data cleaning, specific filters must
be applied based on sensor characteristics and the number of people present. For
example, Bayes and particle filters clean data from binary sensors in scenarios with
multiple residents; median filters remove noise and avoid abnormal measurements.
The noisy data collected by Shimmer3 devices can be reduced by signal processing;
for the accelerometer, low-pass filters remove the gravity component from the values
and high-pass filters reveal the real acceleration.
Data Processing Data from different devices are fused and related to activities
within the smart environment using timestamps from sensors and annotations from
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cameras and the smartphone. The smartphone contains a customised application
that allows for the annotation of daily activities and their duration. Camera data are
used to obtain a ground truth for sleep movement. Smartphone annotation is mainly
used for daily activities in the bathroom and bedroom (refer to Section 3.3.1(a)).
Feature selection is performed for Shimmer3 sensors to extract relevant features for
sleep positions (see Chapter 4). Collection frequency among sensors varies. For
instance, Shimmer3 sensors on the extremities collect data at a frequency of 50Hz
while on the chest they do so at one of 520Hz; smartphone sensors gather data at a
frequency of 1–10Hz. Therefore, we suggest to either downsample or process them
independently and fuse the outcomes. For example, a high frequency is necessary
when a Shimmer3 chest sensor is used for respiration detection; when used for sleep
position detection, however, the lowest frequency suffices.
For sleep assessment, different sensors must be used and combined. Physical exercise
affects sleep positively [134]; this can be monitored by a smartwatch counting steps
and heart rate both outside and inside the home; the activeness is calculated based
on the movement. Fluid intake can be analysed using Smart Cup data. Subsequent
changes in sleep behaviour can be considered through the correlation of outputs
from these single-data sensors. We face some difficulty in matching timestamps and
data sourced from devices at different frequencies. The annotated information must
be considered carefully, as the annotation time of some activities (ground truth)
start earlier than the corresponding data collection time. The formatting of the
various extracted datasets from providers must be adjusted to enable integration
and comparability.
Occupancy The occupancy of the smart home in terms of the number of persons
varied throughout the study. The main challenge during data processing is the
extraction of behaviour patterns considering the number of inhabitants living in
the smart home. Additionally, visits to the smart home from guests and external
researchers took place on numerous occasions, and these visits must be considered
during data processing because occupancy dramatically affects data collection from
environmental devices.
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3.4 Sleep Behaviour Analysis on Specific Frame-
work Aspects
In this section, we present the datasets and investigation settings used for our anal-
yses to investigate (1) the necessity and importance of specific layers and elements
of the framework structure, (2) the focus on objective measurements, and (3) the
reliability of the developed sleep regularity algorithm.
3.4.1 Dataset
To validate the individual aspects, a real-world dataset was explored. The NSRR
provided us with the HCHS [199, 200] and multi-ethnic study of atherosclerosis
(MESA) datasets [201], which contain data collected at home on PSG, actigraphy,
individual characteristics, and sleep questionnaire information. The participants
were instructed to wear a wrist-worn actigraph unit, the Philips Respironics Ac-
tiwatch Spectrum, for a week. The data were collected in an unsupervised set-
ting [201]. Records were scored by a trained technician at the Boston Sleep Reading
Center [202] using current guidelines and specific algorithms to derive elements like
wake/sleep patterns and activity levels. Actigraphy data are available in 30-second
intervals. The datasets provide features that are necessary for our investigation,
such as ethnic background, gender, and health status.
Additionally, we simulate data to show the functionality of the regularity approach.
HCHS The HCHS [188] is a multi-centre epidemiologic study investigating accul-
turation in disease development and risk factors. Actigraphy data were collected
from 2.252 participants between 2010 and 2013. From those, data from 1,887 are
publicly available. Individuals suffering from various diseases, including hyperten-
sion, apnoea, diabetes, and CKD, participated in the study. Provided clinical history
includes individual medical information, such as BMI and family history.
MESA The initial objective of the MESA study was to examine disparity of sleep
disorders and behaviour across ethnic groups and genders as well as determine the
association between sleep and sub-clinical atherosclerosis [201,203]. 2,237 individu-
als participated between 2010 and 2013; data are available from 2,159 individuals.
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This dataset is quite diverse, as it includes data from individuals of different races,
genders, age groups, and degrees of health [201].
3.4.2 Sleep Behaviour Analysis Protocols
It is essential to provide evidence of the emphasis layer’s importance and the need
to exclude certain sleep parameters in user-specific presentation. The investigation
is based on two elements: (1) one-way ANOVA to extract significant differences
(α = 0.05) between sleep parameters among groups of people distinguished by ge-
netic information and health status considering weekend and weekday influences;
(2) pairwise Pearson correlation between sleep parameters in order to either include
or exclude them from the assessment, where we consider a correlation of 0.80 the
threshold for exclusion. Validation is performed using the HCHS dataset; data ful-
filled the assumptions for both tests. Investigation (1) establishes the understanding
of what influence factors are relevant for the individual sleep parameters incorpo-
rating the weekday information. Based on this, the need for the emphasis layer will
become clearer, and influence factors can be revealed that should be considered to
achieve personalised parameters. Investigation (2) facilitates which parameters can
be excluded to guarantee a resource-efficient assessment. We use the actigraphy data
from HCHS to extract the following sleep parameters and circadian rhythm mea-
sures: sleep fragmentation, SE, rise time, bedtime, relative amplitude, intradaily
variability, and interdaily stability.
As already stated, the motivation for this framework is to objectively represent sleep
behaviour. To justify this choice, we investigated the relationships between sleep
parameters from objective measurements and subjective ratings, which are provided
in the HCHS dataset [199,200]. We tested two machine learning models, an LSTM
and a GMLVQ, for the prediction of subjective sleep quality and used the sleep
parameters mentioned in the preceding paragraph as features. These features are
calculated from the available days for each individual, with highly correlated features
excluded. The dataset contains five sleep quality classes which are provided by a
subjective question-based assessment.
The proposed sleep regularity algorithm presented in Section 3.2.2(d) is designed
to provide a regularity measure for each sleep parameter individually. To show the
impact of our regularity algorithm, we investigate a simulated data scenario. In this
simulated scenario, the functioning of the algorithm is investigated in a four-day and
seven-day assessment, to show the influences of weekend inclusion and exclusion.
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Table 3.9: ANOVA tests: Significant sleep parameter differences among groups (e.g.,
apnoea groups differ based on fragmentation).
labels all WD* WE* all WD WE all WD WE
Gender Apnoea CKD
SF* X X X X X X
SE* X X X X X X
SOL* X X X X X X
TS* X X X X X
RA* X X X X X X X X
VAR* X X X X X X X X
ST* X X X X X X X X
BMI Insomnia Hypertension
SF X X X
SE X X X X
SOL X X X X X X
TU* X X X X
TS X X X
RA X X X X X X
VAR X X X X
ST X X X X X X X
Age Diabetes
TU X X X X X
TS X X X X X
VAR X X X
*WD-weekday; WE-weekend; RA-relative amplitude; SF-Fragmentation; SE-Efficiency;
SOL-Sleep Onset Latency; TU-Rise time; TS-Bedime; VAR-
Intradaily Variability; ST-Interdaily Stability
3.5 Results and Discussion
In this section, we present the results of the analysis and discuss the individual
elements of the framework including the visualisation concept. Furthermore, the
gaps, integration aspects, and limitations are provided.
3.5.1 Emphasising
Results indicate that it is reasonable to include an emphasis layer, as significant
differences can be found between groups. The groups are divided into multiple cate-
gories for gender (female, male), apnoea (no apnoea, mild, moderate-severe apnoea),
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CKD (no CKD, stage 1, stage 2), BMI (<25, <30, >30), insomnia (no clinically sig-
nificant insomnia, subthreshold insomnia, moderate severity, severe), hypertension
(no hypertension, hypertension), age (18–24, 25–34, 35–44, 45–54, 55–64), and di-
abetes (no diabetes, prediabetes, diabetes). As can be seen in Table 3.9, certain
parameters are correlated while others are not. For example, SOL is significantly
different for BMI groups on weekdays but not during weekends. These relations are
integrated into the emphasis layer. The results provide preliminary evidence of the
importance of emphasis as a means of representing individual influence factors.
The pairwise correlation shows that sleep fragmentation and SE are highly negatively
correlated (-0.81). This suggests that only one of these values needs to be assessed
and presented. One way to determine which one should be included is to use doctors’
recommendations or users’ preferences. Furthermore, all of the sleep parameters are
significantly different with p-values smaller than 0.05 for age and genders. This is the
case for combined data, weekend, and weekdays. Other parameters show differences
depending on the day (e.g., BMI groups are affected by the weekday for SE, SOL,
relative amplitude, and variability).
3.5.2 Sleep Parameters from Objective Measurements
The multi-class problem, even with optimisation techniques, like standardisation,
did not show promising results. The GMLVQ results in an averaged 10-fold cross-
validated accuracy of 35% for weekdays, 39% for weekends, and 32% overall for the
multi-class problem; LSTM results in even lower accuracies.
These negative results in our data-driven approaches suggest that the subjective
and objective parameters are not related or cannot properly represent each other.
These outcomes can be interpreted in one of two ways: (1) subjective measures do
not bring the optimal outcome and objective measures are preferable or (2) both
are independent and bring new information into a sleep assessment. In this chapter,
we followed the second interpretation, but following chapters focus on objective
measurements.
3.5.3 Sleep Quality and Personalisation
Reliable measurements are the basis for accurate home-based sleep assessment. The
importance of adaptable approaches was mentioned before, and personalised ap-
proaches can represent this flexibility. We will present the outcomes for our pro-
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posed approaches to sleep positions in Chapter 4, sleep stages in Chapter 5, and
detection of medical conditions in Chapter 7.
3.5.4 Regularity
We investigated a specific routine for sleep regularity assessment. Therefore, a be-
haviour routine is simulated: [1, 0.2, 0.3, 0.4, 0.5, 0.5, 0.2, 0.1, 0.4, 0.7], describing
the values of one sleep parameter for 10 consecutive days. We tested how regularity
changed over these days, when using a window of four or seven days of values, as
can be seen in Figure 3.7. The target could be either to include weekends or exclude
them. The x-axis describes the days used; D1–4, for example, indicates the assess-
ment of regularity for day 1, 2, 3, and 4. The plot displays our regularity approach
by showing the measured values (red dots) and their distribution (boxplot), the
subtraction values (green dots), and the regularity assessment (blue). The resultant
changes in regularity are shown in the blue curve. We can see that the individual
values of regularity are different for the four-day and seven-day assessments. With
four-day assessments, we see two drops and increases in regularity; when seven days
are considered, we lose the information of the second drop in the four days method
(D6–9).
(a) (b)
Figure 3.7: Sleep regularity for simulated data using (a) four-day assessment (b)
seven-day assessment.
These results suggest that days of the week influence sleep regularity and that, for
various situations, weekend and weekday results may need to be separately repre-
sented, which is possible with our flexible approach. However, this flexibility comes
with the drawback of sensitivity to individual values. Overall, our regularity ap-
proach can represent more information than the often-assessed regularity index,
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which fuses all information. The advantage of our approach is that we can extract
information about which parameters have strong or weak regularities. Many con-
clusions could be drawn from this information—strong regularity in high SOL, for
example, could suggest insomnia.
3.5.5 Visualisation Concept
The proposed visualisation concept would likely motivate people to monitor and self-
manage their current sleep habits and subsequently develop healthier behaviours
to prevent and detect conditions at an early stage. The concept aims to avoid
misinterpretation, which is currently a prominent issue.
The proposed concept makes users’ data accessible to them. The different layers
allow for varying levels of abstractions—data needs to be assessed more closely in
a lower layer if one of the parameters is marked as inappropriate. The concept also
enables doctors to closely monitor their patients from afar in an objective manner
by fusing individual-specific sensor data to extract the essential information. This
information-sharing process can help detect underlying conditions and prompt the
necessary treatments earlier. These treatments can then be adapted to a person-
alised plan to increase efficiency.
3.5.6 Integration Aspects
There were various sleep assessment aspects pointed out in Chapter 2 that need to be
investigated; some of them are addressed in our proposed framework. The proposed
assessment considers sleep regularity and circadian rhythm, which are important
sleep aspects that have largely been ignored by previous assessments. Our frame-
work enable behaviour change approaches, because it integrates the environmental
and sleep hygiene potential. The inclusion of IoT sensors and long-term monitor-
ing targets underdiagnosis and aims to increase the accessibility of self-management
strategies. The validation tasks described in Section 3.4.2 constitute a step towards
closing the gap left by small, single-subject-type samples and providing results that
better represent the general population. The fusing of various influence factors (age,
gender, and environmental condition) is addressed in the emphasis and personalisa-
tion layers. The assessed elements largely come from objective measurements taken
using technology; we only include subjective assessments to effectively incorporate
clinical history and sleep hygiene. The combination of objective and subjective
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methods can potentially (1) improve the accuracy of subjective tests with objective
measurements and (2) bring in additional subjective information that is sometimes
not sufficiently reflected by objective properties. Additionally, our objective sleep
assessment avoids the common limitation of experts needing to be present by in-
tegrating methods into our IoT-enabled framework that minimise this need. The
consolidation of doctors’ and users’ perspectives creates a more powerful approach,
as it can adapt to different needs and take different preferences and recommenda-
tions into account. Our framework can also adapt to advances in technology and
data analytics because it is built to be flexible regarding available data sources. The
minimum requirement in the proposed investigation is an actigraph unit, which is
inexpensive and can be used to extract sleep parameters.
3.5.7 Limitations
This study assumes that clinical history data is available or can be assessed with IoT
technology. The availability of gender is a notably strong assumption. In the real
world, however, not all clinical features are available, as they are either not shared
by users or not assessed.
Furthermore, we assume that doctors make recommendations about what should
be monitored for individual users. The potentially lack of these recommendations,
is only partly overcome by preparing the system with basic recommendations for
several scenarios.
Our use of personalisation can result in difficulty when comparing users. Our ap-
proach moves away from the one-model-fits-all approach but ends up moving towards
a subgroup-based comparison. Therefore, it may not be possible to directly compare,
for example, a male with sleep apnoea with a healthy female.
3.6 Summary and Future Directions
This chapter contributes to knowledge by developing a layered sleep behaviour as-
sessment framework that supports IoT-enabled home-based monitoring; the key
aspects considered are sleep quality, regularity, circadian rhythm, environmental
conditions, and sleep hygiene. We have described the measurements and tech-
niques used for monitoring and analysis; especially, the developed sleep regularity
algorithm and user-dependent visualisation concept contribute to knowledge signifi-
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cantly. The framework can handle data from multi-source channels and incorporate
clinical history and preferences; this enables it to provide a personalised medical and
behavioural assessment. The framework has been designed as a modular, service-
oriented paradigm that facilitates extendibility and flexibility to both doctors’ and
users’ needs. While large-scale implementation and evaluation are planned, initial
analysis have shown positive results, proving the framework’s viability. The under-
lying methods will be discussed in further detail in the subsequent chapters.
This framework can act as a straightforward guideline due to its block-based struc-
ture, ability to adapt to technological advances, and standardised process (from
monitoring to presentation) incorporating current relevant sleep behaviour aspects.
As our proposed framework is designed for home-based assessment, testing in a
natural environment is critical for all incorporated technologies. The inclusion of
doctors’ recommendations means the framework can have tangible effects on users’
lives. This makes it a useful tool, creating the baseline for future investigation and
testing. The inclusion of IoT sensors and long-term monitoring procedures may very
likely enhance sleep disorder diagnosis by increasing accessibility and allowing for
faster detection at home. The integration of various influence factors is addressed
in the emphasis and personalisation layer. This process could be further improved
by developing concrete methods for analysing and investigating relations with sleep
parameters. Our framework is, besides diagnostics and self-management, intended
to provide adequate feedback through detected connections and correlations, e.g.,
between day behaviour and sleep architecture [43]. Future research could focus on
ways to enhance feedback and assist users with improving their habits. Our work
on subjective and objective assessment suggests that both are independent. This
outcome will encourage researchers to investigate them in more detail.
In the following chapters, we concentrate on core aspects of the framework that
address sleep position recognition, sleep stage classification, and chronic disease
detection; the structure of our framework eases the integration of these technologies.
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Chapter 4
Higher-Granular Sleep Position Detection
4.1 Introduction
The previous chapter has presented a framework designed to improve sleep behaviour
assessment. The framework incorporates non-motion aspects, also known as stable
states. Predominantly, sleep positions explain these non-motion periods. Sleep
positions are a significant influence factor for sleep quality and, therefore, must be
investigated. Current research mainly investigates four sleep positions in guided
settings—for details, see Section 2.4.4—but, the variation of impacts extends to
more complex positions (see Section 2.2). Hence, higher-granularity positions need
to be considered. Current approaches face several difficulties: (1) non-wearables
are unable to distinguish the supine position from the prone position and they are
immobile as sensors need to be installed in the environment; (2) imaging techniques
lead to privacy concerns and have difficulty with detection through blankets; and (3)
wearables can cause potential discomfort. We decided to pursue wearable devices,
as they provide mobility and the ability to gather accurate data with more than one
person in the same bed. They can also be more easily integrated into existing smart
devices.
In this chapter, we target objective 4 by investigating higher-granularity positions
among the general population. In addition to the four basic positions, the proposed
approach looks at four classes that consider common leg position variation. To do
this, we target the following gaps extracted from literature (see Section 2.4.4): (1)
lack of a robust and computing-efficient approach; (2) no approach to track higher-
granularity positions; and (3) lack of comparative studies between natural environ-
ments and guided settings. To address issue (1), a robust and computing-efficient
method is applied that has low computational costs and can reliably classify the po-
sitions of interest. The literature suggests that distance-based approaches perform
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well for sleep position detection. Therefore, we decided on GMLVQ, a low-cost,
distance-based method that supports real-time assessment, because it can make a
decision based on prototypes representing each of the sleep positions. To investigate
a computing-efficient system, we conducted experiments to explore the necessity of
three sensors and the potential to reduce the number of features. To address issue
(2), we extract and investigate the most common positions among the wider popu-
lation [204]. The primary sensor is attached to the chest, as this has been shown to
be effective [57]. To further investigate the common positions, the number of sen-
sors is increased to three in order to monitor relevant lower limb movements. This
results in data on leg and torso positions, enabling insight into higher-granularity
positions. To address issue (3), we compare performance on datasets from both
guided and natural settings to assess the feasibility of comparative analysis using
mobile solutions. Employing accurate sleep position classification under computing-
efficient constraints implies a more reliable and efficient sleep assessment process
within our framework. Higher-granularity position detection is a solution that offers
more comprehensive information about sleep behaviour. This approach contributes
to the framework’s sleep quality component as well as the following layers: data,
assessment, and extraction.
This chapter is structured in the following way. In Section 4.2, we introduce our
approach for sleep position recognition with a focus on a low-computational-cost
model. We are especially interested in our approach’s performance differences in
real-world and guided settings. Section 4.3 describes how we collected data and ran
our experiment while investigating the differences between one-model-fits-all and
personalised approaches. The results and findings are provided in Section 4.4 and
discussed in Section 4.5. Finally, in Section 4.6, we offer a summary of the work, its
implications for future studies, and indicate the focus of the next chapter.
4.2 Sleep Position Classification
In this section, we describe our proposed approach for recognising complex sleep
positions.
As already stated, we opted for accelerometer-based detection and used a combi-
nation of sensors placed on the chest and legs to cover positions of interest. The
approach can be divided into three main steps. These steps are shown in Figure 4.1:
(1) the stable state (non-movement) detection, followed by (2) the feature calcula-
tion, and (3) a classification algorithm that considers the features and decides on
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the current sleep position.
Chest
L-Leg
R-Leg
accelerometer Stability  
detection Transition
Feature calculationLearning Vector Quantisation
 
Positions 
stable
non-stable
Figure 4.1: Sleep position detection for accelerometers applied on the chest, left leg
(L-Leg), and right leg (R-Leg).
Sleep positions appear in the absence of movement; therefore, movement periods,
known as transitions, must be excluded from the analysis. To distinguish between
stable and non-stable periods, the accelerometer data must be divided. The data
collected from chest and leg sensors are classified using the acceleration-moving vari-
ance method [205] as either stable or non-stable. This step follows Equation (4.1),
where α is empirically set to 0.5.
T (z) = 1
N
N∑
t=1
‖zt − z‖2 < α (4.1)
While other methodologies can detect stable states, the acceleration-moving variance
method requires no additional data, such as gyroscope and magnetometer data.
When the stable states are extracted, the features can be calculated. The informa-
tion on the stable periods is compressed by calculating the mean for each of the
three accelerometer axes over a sliding window, resulting in a nine-dimensional data
vector. The sliding-window concept is depicted in Figure 4.2. A window with size
w slides over each axis with datapoints (d1, . . . , dn). For each iteration, such as i1,
the mean is calculated over the data within this window (d1, . . . , dw). Afterwards,
the window slides further with an overlap (of, e.g., 50%) and, for the next window
(dw
2
, . . . , d 3
2
w), the mean is calculated. These steps continue until the end of the
data is reached.
The axes are further referred to as X, Y , and Z. The features are described as
XLeft,YLeft,ZLeft,XRight,YRight,ZRight,XChest,YChest,ZChest,
where Left is for the sensor applied to the left leg, Right is for the sensor on the
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Figure 4.2: Sliding window concept; calculating mean µ for each iteration over one
sliding window with an overlap.
right leg, and Chest is for the sensor attached to the chest.
The last aspect of the approach is the classification using GMLVQ.
4.2.1 Classification Algorithm
Environments with limited computational resources require a fast and appropriate
method. Therefore, we selected GMLVQ, because it is resource-efficient and has
never been applied to this specific problem before. GMLVQ is a distance-based
classifier similar to the KNN algorithm. However, it only computes the distance
between the model’s prototypes and a novel data pattern. Consequently, GMLVQ
scales better when new data is introduced, as the number of prototypes does not
increase. This makes GMLVQ a fast method which is appropriate for environments
with limited computational resources.
In this section, the GMLVQ is described in detail by summarising its original in-
troduction from Schneider et al. [206]. GMLVQ is an adaptive, distance-based
supervised-learning method. The basis of the model is the collection of prototypes
that are found during the training phase and describe typical representations for each
class. We constructed a relevance matrix (Λ) that transforms the data in a way that
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makes classes more distinguishable. The distance measure follows Equation (4.2).
dΛ(~ω, ~ξ) = (~ξ − ~ω)TΛ(~ξ − ~ω) (4.2)
A prototype ~ω and an n-dimensional feature vector ~ξ are considered; Λ describes an
n×n matrix. This matrix takes into consideration the correlations between features
and rotation of the axes. Every pair of features is weighed, which results in a more
robust performance [206, 207]. Overall, GMLVQ provides an intuitive model that
makes the data easier to understand. It enables us to directly interpret prototypes,
as they now exist in the same space. Furthermore, the diagonal values of Λ can be
interpreted as the relevance of a single feature, whereas the off-diagonal values can
be interpreted as the relevance of every combination of two features [206].
4.3 Experiment Design
The application of our proposed method is critical to provide insight into its perfor-
mance. As already stated, it is important to consider data collected in a person’s
natural environment. As the scope is rather unique, we needed to gather our own
data to investigate the problem of interest. This investigation is structured in the
form of different experiments in normal and computing-efficient settings. These
experiments explore individual and generalised models. Moreover, the effects of
reduced sampling rate and features are explored.
4.3.1 Data Collection
The main goal of this data collection is to investigate higher-granularity sleep posi-
tions than are typically considered. Information on ten different sleep positions is
considered: supine, prone, left lateral, and right lateral positions, with additional
positions being classified based on leg positioning—eight positions are distinguished
in the analysis process, as the difference between the others cannot be captured,
resulting in merging four of the positions into two. Data were gathered from three
sensors attached to chest and both ankles. The dataset includes data from real-world
and guided settings. Ethical approval was received by De Montfort University and
all participants permitted us to collect and use their data by signing a consent form.
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(a) Planning and Sampling
The research was conducted in the home environment of the individual participants
to reach the most natural circumstances.
Healthy participants from both genders and two age groups (28–33 years and 55–
58) were recruited to guarantee that the results can apply to a wide population.
However, gender differences and age-specific performance are not major factors in
this analysis. For one person from each age group and gender, real-world data were
collected.
Six individuals participated, four between 25 and 33 with three males and one female
and two between 55 and 58 with one male and one female. For the real-world setting,
two individuals were representatively selected—one per age group and gender was
selected (for a detailed overview of the sample distribution, refer to Table 4.1).
Table 4.1: Sample distribution in terms of gender and age group.
Setting Age Group Gender
Guided
28–33 4 Female 1
Male 3
55–58 2 Female 1
Male 1
Real-World 28–33 1 Male 1
55–58 1 Female 1
(b) Data Collection Method
For each participant, accelerometer data were gathered with a sampling frequency
of 52Hz. Additionally, two participants were continuously monitored in a real-world
setting over one night.
The guided scenario was performed under the most natural circumstances possible.
The participants were in a bed, with a pillow, and covered by a blanket. They were
asked to wear three Shimmer3 sensors, one on each of their ankles and one on the
chest (placement illustrated in Figure 4.3(a)). The sensors were applied in the same
orientation for all participants. The participants were instructed to assume each of
the ten most common sleep positions [52] for at least 25 seconds each; this process
was repeated for nine cycles to capture any potential variance. One cycle consisted
of ten positions, and no transition was performed twice. These cycles were designed
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by the researcher and communicated to the participant. Figure 4.3(b) illustrates
the investigated positions, described as follows:
Supine position laying on the back with straight legs (Sup); two variations were
monitored, those being right leg bent (SRLB), and left leg bent (SLLB).
Prone position laying on the stomach (P ).
Left lateral position laying on the left side with either both legs together (LLT )
or right leg bent (LRLB).
Right lateral position laying on the right side with either both legs together
(RLT ) or left leg bent (RLLB).
Arm sensors were not required because the arms are always bent in a similar way
for all of the positions shown in Figure 4.3(b). A researcher marked the start and
end time of each position on a mobile device and later annotated relative to the
available designed cycles.
Sensor placement in the real-world scenario was the same as that in the guided
scenario. The two individuals were continuously monitored for about seven hours.
Camera recordings were made to allow for later annotation of stable states.
x
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(a)
Supine Prone
Right Lateral
Left Lateral
 
S PSLLB SRLB
RLS RLB
RLT RLLB
L LS L LB
L LT L RLB
(b)
Figure 4.3: (a) Body placement of the sensors. (b) Monitored higher-granularity
positions; dotted lines indicate two positions that are merged into one, such as RLS
(legs straight) and RLB (legs bent).
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4.3.2 Pre-Processing
First, the acceleration-moving variance method was applied to all acceleration data
[205] to classify the non-movement periods as positions of interest. The cut-off
threshold for stable states was empirically determined as α < 0.5. The positions
were determined using camera recordings for the real-world setting and instruction
sheets for the guided settings. The camera recordings were destroyed following the
annotation.
Furthermore, the raw data were processed into windows with the size of the sampling
rate (52Hz) and an overlap of 50%. To obtain the feature vector for every window,
the values in each window had to be averaged. For certain experiments, we applied
downsampling to reach about 6Hz. This was done to address computing efficiency
in relation to sampling rates.
This approach is unable to distinguish straight legs from both legs bent in the lateral
positions. Consequently, the two classes are fused for right lateral and left lateral
into one class, from (R/L)LB and (R/L)LS to (R/L)LT . This merging is illustrated
in Figure 4.3(b) by the dotted boxes.
4.3.3 Experimental Settings
Primary interest with this experiment lies in the performance differences between
guided and real-world settings. Therefore, experiments are performed to investigate,
(1) personalised models, (2) general models, (3) effects of a reduced sampling rate,
(4) effects of a reduced number of sensors, and (5) effects of a reduced number of
features.
The experiments were divided into general and personalised model groups. The
personalised GMLVQ is trained using 80% of the data from one person; the other
20% is used for testing. The experiment repeated a 10-fold CV 20 times. The
general model is trained using the overall dataset with a LOOCV which is averaged
over 20 runs. This means that the system tests on one person and trains on all
other participants. The experiments were conducted to provide insight into the
potential generalisation of the approach. Moreover, we conducted experiments with
a reduced sampling rate and a lower number of sensors to illustrate computing-
efficient performance changes.
100
4.4. RESULTS
4.4 Results
In this section, we provide the outcomes from personalised and general models in
guided and real-world settings.
4.4.1 Application in a Guided Setting
In this section, we provide the results from the guided scenario and offer insight into
the overall performance and functionality of the presented approach.
(a) Personalised Models
The personalised models are trained on one person’s data with separate CVs. The
test results in 99.8% averaged accuracy over all validation runs.
(b) General Model
In Table 4.2, the averaged confusion matrix is shown for the general model using
LOOCV. This model achieves an overall accuracy of 83.62% for our scope of detect-
Table 4.2: Averaged confusion matrix for the general model.
Sup SupLLB SupRLB RLT RLLB LLT LRLB P Recall
Sup 94.3 2.04 3.64 0 0 0 0 0 91.35
SupLLB 3.94 96.06 0 0 0 0 0 0 96.24
SupRLB 1.83 0 98.17 0 0 0 0 0 98.20
RLT 0 0 0 81.8 18.2 0 0 0 83.30
RLLB 0 0 0 53.41 44.65 0 0 1.93 42.32
LLT 0 0.85 0 0 0 91.7 7.45 0 91.75
LRLB 0 0 0 0 0 30.87 67.35 1.78 67.37
P 0 0 0 0 7.86 0 0 92.14 88.75
Prec. 95.87 96.17 96.33 79.30 63.04 88.71 71.13 96.75 83.62
ing eight different sleep positions. However, the model has difficulty distinguishing
between lateral positions. Furthermore, the results include some misclassifications,
e.g., between the lateral and prone position. Based on these outcomes, we trimmed
the number of potential positions to six and reran the experiment to find the source
of the issue. By fusing the lateral sub-classes into the more straightforward right
lateral and left lateral, the results indicate an increase in performance With only six
positions, results show an accuracy of 98.31%.
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(c) Mechanisms to Improve Computing Efficiency
The effects of computing-efficient design on performance are explored to gain insight
into what setting is appropriate in terms of (1) sampling rate, (2) number of sensors,
and (3) number of features.
Sampling Rate We downsampled the original data to a sampling rate of 6Hz for
each participant and reran the experiments. Results indicated that the reduction
from 52Hz to 6Hz did not affect the performance of the different models.
Number of Sensors We excluded the chest sensor, as the ankles are relevant for
most of the positions, leaving us with just the two ankle sensors. For the general
model, this results in an accuracy of 79.71% for eight positions and 96.08% for six
positions. In contrast, the personalised models reach an accuracy of around 99.8%,
meaning the sensor reduction seemingly had no impact.
Feature Selection One of the advantages of the GMLVQ model is the high
availability of the relevance matrix Λ, from which important features can be ex-
tracted. The feature rankings based on the averaged relevant values are shown
in Figure 4.4(a) alongside their SD; the three most relevant features—XChest, ZLeft,
and ZRight—are shown in Figure 4.4(b). For each personalised model and the general
model, the order of relevance is unique (see Table 4.3). When applying the reduced
data, including the combination of the three most relevant features, an approximate
accuracy of 78% can be reached for the general model.
Table 4.3: Feature ranking for the personalised and general models.
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Figure 4.4: (a) Averaged relevance matrix diagonal and SD for each feature. (b)
Percentage a feature was in the top 3 relevant features across 20 10-fold CVs.
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4.4.2 Real-World Application
In this section, the general model is applied to data from two participants that were
continuously monitored over one night.
In a real world setting, scope sometimes changes. Only six positions could be mon-
itored; as we cannot control the sleep positions a person takes, only these six are
considered. The positions for both participants are:
S, SLLB, SRLB, RLT , RLLB, LLT
For participant one, applying the general model reaches an averaged accuracy of
98%. However, when we use only the three most relevant features, the accuracy de-
creases to 89.5%. In contrast, the personalised model reaches an averaged accuracy
of only 58.39%.
When applying the general model to participant two, an averaged accuracy of 97.48%
is reached. This decreases to 95.53% when only the three most relevant features are
used. The personalised model fails in this experiment.
4.5 Discussion
In this section, we discuss the findings we obtained by applying the sleep position
approach in guided and real world settings.
4.5.1 Application in a Guided Setting
Personalised Model Applying the personalised model to our collected data
reaches nearly perfect performance. This suggests that the individuals are consis-
tent in their positioning during the guided experiment. The lack of a perfect score
is likely due to the inclusion of some small parts of transitions in the training set.
Personal models come with a privacy advantage; no personal information needs to
be shared or used in a more widespread model. However, the personalised approach
comes with a limitation, as the model has to be retrained for every individual. This
retraining requires an annotated dataset, which is time-consuming and a challenge
to collect. One potential solution to this issue is an unsupervised machine learning
approach, which could handle unlabelled data.
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General Model The general model has an advantage over the personalised model
in that it can be provided to any individual with no need for additional personal
data to be provided or annotated; an off-the-shelf prototype capable of reasonable
outcomes can be provided.
Misclassification generally results from the absence of orientation changes between
positions, such as between the lateral positions (R/L)LT and (R/L)(L/R)LB. An
accelerometer can capture the orientation of the sensor, but not the relative position
in space.
The general model also has certain restrictions, as it represents only general informa-
tion on positions. Consequently, individual components of the positions cannot be
represented, which leads to misclassification. However, there are ways to potentially
improve the model. First, the classification task could be reduced to six positions
resulting in orientation-based distinction. Second, small, personal datasets could be
collected and annotated to retrain the model, and, therefore, incorporate individual
components. Thirdly, a different method of analysis could improve detection per-
formance between lateral and prone positions. For example, a rule-based approach
to distinguish between the basic positions can be combined with individual-trained
models to accurately detect sub-classes. This individual-trained models target to
differentiate between higher-granularity positions, e.g., LT and LRLB.
This experiment goes beyond most research on the topic by expanding upon the
current list of commonly investigated positions (see Table 2.6). Following the com-
pletion of our research, other researchers investigated sleep positions with a focus
on arm positions using KNN and three devices on the torso and arms [179]. While
it is not possible to directly compare these approaches, our use of GMLVQ comes
with an advantage over that of KNN: easy interpretation through the provision of
prototypes.
4.5.2 Mechanisms to Improve Computing Efficiency
Feature selection The general model can differentiate between positions even
when fewer features are considered. It’s important to note that this comes with a
decrease in accuracy but requires less computational power. Our main finding is the
individuality of different positions for each personalised model, which is displayed in
Table 4.3. As personal information from individuals is essential when training and
testing this model, the possibility exists to differentiate people on their personalised
models. Comparing the feature ranking from the general model to that from the
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personalised models suggests that the general model is less accurate for those that
do not share the same feature ranking; for them, the personalised models offer the
optimal results.
Reduced Sampling Rate When the sampling rate is reduced, a more computing-
efficient setting is achieved. Despite the fairly large reduction, from 52Hz to 6Hz,
performance remains similar. This suggests that no information is lost in the stable
state data to distinguish between the positions. We conclude that a computing-
efficient solution can be both viable and successful in sleep behaviour analysis, e.g.,
with a dynamic sampling rates monitoring stable states with a low frequency and
movement periods with a high frequency.
Reduced Number of Sensors We investigated performance with a reduced num-
ber of sensors because of the potential discomfort and high cost that can result from
the use of multiple sensors. While the use of only leg sensors with the general model
resulted in a worse performance, results stayed largely the same with the person-
alised model. This is because each individual likely adopted positions consistently
during the guided setting.
4.5.3 Real-World Application
The general model performs accurately in a real-world setting. Even though the
model is not trained on real-world data, positions can be effectively detected. In
contrast, the personalised model fails. We conclude that the guided-setting data does
not accurately represent the real-world scenario for personalised models. A general
model based on guided-setting data is still feasible, however, because it is trained on
a subgroup of individuals; as a result, it captures position variability and, therefore,
can provide more effective position detection. A more computing-efficient approach
with only the three most relevant features reaches similar outcomes, resulting in an
approach with only three 1-axis accelerometers.
Relative to current research, we can detect more different positions in the real-world
application, because we consider limb movements (refer to Table 2.6). However, this
does introduce some potential discomfort through the application of three sensors
to the body.
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4.5.4 Limitations
The findings of this study must be seen in light of some limitations within our scope.
First, only a few people were included in our data collection process, which, of course,
limits the potential generalisation of the outcomes. We counteract this effect to some
degree by including age and gender factors in our analysis. Second, only eight of the
ten most common positions can be detected by our approach. Third, annotation
is likely not 100% accurate. Automatic detection, along with research notes and
recordings, was used to keep label annotation as reliable as possible.
4.6 Summary and Future Directions
This chapter contributes to knowledge by successfully implementing an approach
to detect higher-granularity sleep positions with wearable devices. This is an im-
provement upon current sleep position detection, as eight of the most common po-
sitions were considered using acceleration data gathered by Shimmer3 devices. Our
approach works well with low sampling rates and in a real-world setting. Even
three one-axis accelerometers are sufficient and reducing the number of sensors only
slightly weakens performance. We provided a comparative study that enhanced
current analysis in real-world applications and could accurately determine higher-
granularity positions in guided settings. Overall, we conclude that the general model
is the most appropriate option for a real-world application, as it more effectively
captures the variability of positions. Compared to related work (depicted in Fig-
ure 2.5), our general model can reliably detect more positions (six instead of four)
in the real-world; additionally, we improve the performance on eight positions in
guided settings.
Monitoring these positions provides additional insight into a person’s sleep be-
haviour. This can be a good starting point for medical assessments and behavioural
interventions, such as position treatment for sleep apnoea patients [208,209]. Sleep-
related medical assessments are usually based on subjective questionnaires, which
often do not accurately depict the positions taken while falling asleep. Our approach
makes it possible to recognise, e.g., positions that prompt someone to fall asleep or
wake up. Hence, it could inspire research and discussion on this topic to investigate
the real correspondence of subjective position reporting and objective recognition.
The sleep position recognition approach should be integrated into more broad sleep
quality representations (as we are doing with our sleep behaviour assessment frame-
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work). The insight provided through more complex sleep positions alongside profes-
sional medical advice can help in better sleep self-management. Bed exit detection
could also be targeted with this approach with a few small modifications to the
trainings data. In this study, participants were instructed to wear three Shimmer3
devices and did not report discomfort, however, the potential for discomfort and
usability issues must still be considered by future studies. Clothing-based sensors
are one way to avoid the possibility of discomfort [210]; certain integration solutions
are already available on the market, such as Enflux [211] and Xsens MVN [212].
Another approach is the application of compact sensors directly on the skin [213].
Wearable technologies are becoming more practical every day, meaning the study
of even more complex positions will be possible in time. Future studies could look
at, for example, the now-difficult fused positions. As already stated, these are quite
hard to distinguish with only orientation information. The positioning of the feet
could soon be included, which could help detect positions that are not differentiated
by orientation alone. With a higher sampling rate, the accelerometer data can be
integrated twice, theoretically resulting in the true positioning. Currently, however,
this comes with a limitation that numerical integration increases small errors dras-
tically. Therefore, integration should be conducted over a short time, which could
be realised as the transition periods in real life are measured to be around three
seconds.
Sleep positions describe non-movement periods. To comprehensively describe sleep
behaviour, however, movements must be considered as well. Movement during sleep
is heavily related to sleep stages, which are further explored in the context of health,
gender, and race in the next chapter.
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Fine-Grained Sleep Stage Detection
5.1 Introduction
In the previous chapter, we explored the non-movement periods during sleep through
higher-granularity sleep positions. Additionally, we discussed the insights they offer
into sleep behaviour. Sleep stages constitute another important element of sleep
behaviour; in contrast to sleep positions, these are extracted from movement (see
Section 2.3). Current technologies used to assess sleep and wake stages have various
performance limitations; we try to overcome these by fusing and learning from mul-
tiple data sources. Sleep parameters, which indicate how well a person sleeps, are
usually calculated using wake and sleep stages. Sleep parameters extracted from au-
tomatically detected sleep-wake stages still lack in comparison to the gold standard,
in which stages are annotated manually by experts. Therefore, we develop an adap-
tive sleep parameter extraction process that is capable of interpreting sleep-wake
stages.
Traditionally, human experts classify sleep stages using PSG measurements, which
is a time-consuming task. Advancements in IoT technology have enabled common
devices to assess sleep behaviour at home; this ability could potentially eliminate
expensive in-hospital monitoring. We target several limitations described in the liter-
ature (discussed in Section 2.4.3). Commonly, one-model-fits-all approaches are em-
ployed despite evidence showing that individual sleep behaviour varies due to many
factors, including biological traits, age, medication, health, and lifestyle [128, 214].
We address these limitations by presenting an adaptive learning approach that uses
multiple data sources in order to achieve objective 5. This provides us with a fine-
grained sleep-wake recognition process capable of capturing and characterising the
factors that influence sleep stage recognition at different levels of granularity. We
go beyond the commonly used physiological data and develop a diverse dataset
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by integrating clinical history (health status) and genetic information (gender and
race). We employ a multilayer perceptron (MLP) model that is trained and tested
on this diverse dataset. Diversity plays an important role in training machine learn-
ing methods [141]; especially crucial is the inclusion of both healthy and diseased
individuals. We avoid the common mistake of testing against just one technician’s
scoring by using a dataset scored by multiple technicians. The problem with one
technician is, that they have individual styles and machine learning algorithms learn
them. This issue can be reduced by including scoring by multiple technicians and,
therefore, potentially reduce variation in the trained models. A direct method would
be to train one model per technician and combine the answers of the different mod-
els. However, the dataset provides an averaged scoring and, therefore, indirectly
deals with the issue. Generally, only one data source (e.g., actigraphy) is used; re-
search has yet to employ a combination of different data sources. Actigraphy has
proven successful in home-based classification; HRV features have emerged fairly
recently. For this reason, we explore these sources and their combination, as the
sensors capable of extracting this information could help to achieve a more accurate
classification. We emphasise the importance of balanced datasets, as imbalanced
data can lead to unreliable classification with a bias towards the majority class. To
ensure comparability with other approaches, we use a publicly available dataset.
Measuring sleep parameters at home with actigraphy is usually done by interpret-
ing wake-sleep episodes using static thresholds without regard for various individual
influence factors, such as age [125]. To improve upon standard sleep parameter
extraction from sleep-wake behaviour, we develop a process that adapts to users’
needs and subsequently addresses objective 6.
The ability to accurately detect sleep stages and extract sleep parameters provides
us with the following advantages in terms of the framework introduced in Chapter 3.
First, this information can help experts diagnose diseases and detect abnormalities
in natural-environment sleep behaviour. Second, it constitutes a better basis for
measuring sleep parameters, which allows for a more accurate and objective assess-
ment of sleep quality. This approach contributes to our framework’s assessment
and extraction layers as well as its sleep quality, regularity, and circadian rhythm
components.
The rest of this chapter is organised as follows: In Section 5.2, we detail our sleep
stage recognition approach and describe how we extract sleep parameters through
our sleep-wake recognition process. In Section 5.3, we explore the influence factors
of sleep stage recognition and perform tests to validate our approach. The outcomes
are provided in Section 5.4 and discussed further in Section 5.5. A summary of the
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work and future research directions are provided in Section 5.6.
5.2 Sleep Stage Recognition and Application
In this section, we describe the application of multi-source data learning, feature
extraction, and pre-processing for sleep stage recognition. We also discuss how we
combine our recognition approach with a personalised sleep parameter extraction
process.
5.2.1 Multi-Source Data Learning Approach for Sleep-Wake
Recognition
We propose a multi-source data learning approach with a fine-grained structure to
detect sleep and wake stages. Our aim is to move away from a one-model-fits-all
approach towards a personalised approach. We consider a two-stage classification
problem following the gold-standard of 30-second scoring intervals; these intervals
are scored as sleep or wake stage.
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Figure 5.1: Multi-source data learning approach for sleep-wake detection.
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A visual representation of our multi-source data learning approach is presented in
Figure 5.1. We incorporate two types of data: personal data, including gender,
health status, and race; and physiological data, including actigraphy, HRV, or a
combination of the two. The physiological information is fused with clinical his-
tory and genetic information (influence factors). Depending on the specifics of the
personal data, a portion of this fused information is selected and a final dataset is
assembled. The selected training datasets are pre-processed and features are ex-
tracted (extraction explained in more detail in Section 5.2.3). The features are used
to train MLPs with one hidden layer that has the same size as the list of features.
The structure is depicted in Figure 5.2, which shows the number of input features
(F1, F2, ..., Fn) and nodes in the hidden layer (N1, N2, ..., Nn). The overall model
consists of three layers: input layer, hidden layer, and output layer. The output
layer describes the classification targets, which are wake (W) and sleep (S) stages.
The number of nodes is adjusted to the accessible sensory data input features, either
being 18 for HRV, 7 for actigraphy, or 25 for both (details in Section 5.2.3).
We decided on the MLP empirically based on initial experiments comparing methods
considered appropriate in the literature. These methods show similar outcomes with
respect to accuracy; the best outcomes across several experiments are presented here:
GMLVQ, 78.2%; KNN, 79.0%; MLP, 79.1%; AdaBoost, 79.2%; and RF, 80%. A
model with a simple structure that is still able to learn from the data can counteract
the possibility of overfitting. MLP contains three layers and still performs well; the
tested AdaBoost and RF have a more complex structure—AdaBoost is tested on 100
estimators and RF is tested with 50 estimators and a depth of 30. The results from
AdaBoost and MLP are not significantly different (t-test on two related samples).
Furthermore, the SD over the repeated experiments was lower for MLP compared
to AdaBoost, therefore, was chosen, as it suggests a more stable performance. We
investigated the mean squared error (MSE) for the training and test sets and found
that RF was overfitting (MSE was high for testing and low for training). MLP did
not show overfitting, as a consequence was chosen as being an appropriate model
for further investigations.
For testing on unseen individuals, a model is selected based on subject’s personal
information. Features from the physiological data are then calculated and given to
the selected model to assess sleep and wake stages.
We illustrate the idea of a fine-grained adaptive structure against the traditional
general approach in Figure 5.3. The information used to reach a granular adap-
tive model details gender, race, and clinical history. In our tests, we include
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Figure 5.2: Multilayer perceptron design.
four races—White, Asian-American, African-American, and Hispanic—and three
diseases—RLS, insomnia, and sleep apnoea. The standard data for general sleep-
wake approaches are used to generate specific models. This data typically includes
physiological data from a single data source (e.g., actigraphy or HRV). We expand
upon this with multiple data sources by fusing actigraphy and HRV. Figure 5.3
shows the steps to achieve fine-grained models. First, gender information deter-
mines gender-specific models. Second, the health status of an individual—included
if available—determines a health-status-specific classification. Third, race identifi-
cation, if available, determines a race-specific model. This information can also be
combined to select a model with two or all three influence factors. Each of these
steps is flexible; if at least one is included, a fine-grained sleep-wake recognition ap-
proach is reached. The advantage of a fine-grained approach is that influence factors
can be incorporated into individual models.
The proposed approach is designed to be adaptable to (1) available personal in-
formation and (2) available sensory data. First, the availability of gender, health
status, and race is not guaranteed. Therefore, only one is necessary to reach a some-
what personalised approach. Second, the approach can incorporate multiple data
sources by combining calculated features through a 30-second raw data structure.
This is feasible by adapting the size and overlap of the windows when calculating
individual features. Generally, this approach can be applied to any data source that
provides information on sleep in a similar structure. The design of our approach
allows for varying levels of granularity, ranging from gender-specific to race-health-
gender-specific.
5.2.2 Personal Sleep Parameter Extraction
Sleep parameters can be extracted from sleep-wake stages assessed by accelerome-
ters, but this approach still does not achieve comparable performance to the gold
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Gender data
available?
Health status
 data available?
Race data
available?
-
-
-
Figure 5.3: Illustration of the steps from a general to a fine-grained approach.
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standard (PSG). Therefore, we developed a personalised sleep parameter extrac-
tion process that incorporates our fine-grained sleep-wake detection approach (Sec-
tion 5.2).
The wake-sleep episodes are the basis for sleep parameter extraction. This means,
e.g., for sleep duration that the extracted sleep episodes are summarised with the
knowledge of sleep onset and sleep offset. Currently, static thresholds are used to
define sleep parameters such as SOL [124]. These approaches are not personalised
for individual groups despite it being well known that group factors influences accu-
racy such as age [125]. Therefore, we incorporate dynamic thresholds that change
depending on personal factors. We propose to personalise the thresholds for sleep
parameters based on subgroups (i.e., health status, race, and gender). In this inves-
tigation, we follow an empirical threshold determination (details in Section 5.3.2).
5.2.3 Feature Extraction and Pre-Processing
Feature extraction and pre-processing are essential, especially since we want to val-
idate an approach adaptable to different data sources. Since the used data sources
provide different sampling rates, we adopt a common 30-second interval structure
(the standard used in PSG). Furthermore, we consider a balanced training and test
set. We do not use the raw actigraphy and HRV data directly; we extract specific
features.
For actigraph data, the provided data include activity counts and light data in
30-second intervals. Furthermore, we calculate the mean and SD features over 5-
minute overlapping windows. Activity counts summarise the intensity of activeness
at a time. While light gives information about the ambient light divided into white-,
red-, green- and blue-light. These light features can help to judge the day-night-
rhythm. Light exposure at night has shown effects on sleep, blue light increased
alertness and red light increased cortisol levels [215]. Furthermore, blue light is
emitted by smartphones and can help to judge a by movement unrelated wakefulness
with the blue light level. Both can cause awakenings or difficulties falling asleep,
therefore, they are important aspects to assess sleep and wake stages. When using
light as features patterns can be learned by the MLP which reflect the influences
and help better judge sleep and wake stages. Overall seven features are extracted:
activity counts, mean, SD and four light features.
To extract the HRV features, an analysis based on ECG is performed by the
NSRR [202] to extract QRS complexes and, therefore, R-points. The QRS com-
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plex describes three of the graphic deflections in a typical ECG (see Figure 5.4).
From these R-points, normal-to-normal intervals (NNIs) and cardiac inter-beat in-
tervals (RRs)—the intervals between adjacent QRS complexes—are determined (for
details compare [216]). Certain intervals are excluded based on the exclusion criteria
presented in [217] to remove artifacts: Excluding individuals (1) with sleep stages
of <2 hours, (2) with normal-to-normal-intervals (NN) <1.000, (3) NN < 0.35 sec
or > 2.5 sec, (4) <180 NN within 5-minute windows.
Q
R
S
QRS
 Complex
Figure 5.4: QRS complex for ECG.
To receive the HRV features the information is fused into features getting values for
30-seconds each coming from 256Hz sampling rate. The idea is based on the amount
of extracted beats within epochs of 30 seconds. In Table 5.1, the extracted features
are provided, divided into time- and frequency-domain features.
The included time-domain features were: (1) NNI averages; (2) ratio of successive
NNI beats to RR intervals (cardiac inter-beat intervals); (3) instantaneous heart
rate average; (4) NNI SD; (5) 5-minute-interval-based SD of NNI averages; (6) 5-
minute-interval-based average of NNI SDs; (7) percentage of disparity of contiguous
NNIs bigger than 10, 20, 30, 40, and 50 ms; and (8) square root extraction from the
mean of squared difference between contiguous NNIs [217]. The frequency-domain
measurements we used are based on the spectral power of the NNIs: (1) up to 0.4 Hz;
(2) between 0 and 0.003 Hz (ultra-low-frequency power); (3) between 0.003 and 0.04
Hz (very low-frequency power); (4) between 0.04 and 0.15 Hz (low-frequency power);
(5) between 0.15 and 0.4 Hz (high-frequency power); (6) low-frequency power to
high-frequency power ratio; (7) normalised high-frequency power; and (8) normalised
low-frequency power [217]. The HRV measurements are calculated either over the
whole sleeping period or over 5-minute intervals according to the NSRR formulation
in [217]. Whole night values are treated as a constant feature for data from a
specific subject. As traditional resampling can cause a reduction in high-frequency
components and the Fast Fourier transformation needs balanced distributed samples,
Lomb periodograms are used for frequency-domain spectra calculation of irregular
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Table 5.1: HRV features which are calculated and excluded (x) based on their pre-
assessed pairwise correlation.
Feature Description x Feature x
Time-Domain
30-sec Intervals Whole Sleep Period
NN_RR ratio of consecutive NNs* over all
RRs*
x Tot_NN_RR x
AVNN average of all NNs* Tot_AVNN
IHR average instantaneous heart rate Tot_IHR
SDNN standard deviation of all NNs* x Tot_SDNN
rMSSD square root of the mean of the squares
of difference between adjacent NNs*
Tot_rMSSD
percentage of differences between ad-
jacent NNs* that are
pNN10 >10 ms Tot_pNN10 x
pNN20 >20 ms Tot_pNN20 x
pNN30 >30 ms x Tot_pNN30 x
pNN40 >40 ms x Tot_pNN40
pNN50 >50 ms x Tot_pNN50
5-min Intervals
SDANN standard deviation of the averages of
NNs*
SDANNINDX mean of the standard deviations of
NNs*
Frequency-Domain
5-min Intervals Whole Sleep Period
TOTPWR total NNs* spectral power up to 0.4 Hz x Tot_TOTPWR x
ULF ultra-low FP*: [0, 0.003 Hz] Tot_ULF
VLF very low FP*: [0.003, 0.04 Hz] Tot_VLF x
LF low FP*: [0.04, 0.15 Hz] x Tot_LF
HF high FP*: [0.15, 0.4 Hz] Tot_HF x
LFn normalized LF x Tot_LFn x
HFn normalized HF x Tot_HFn x
LF-HF-ratio the ratio of low to high FP* x Tot_LFHF
*NNs-normal sinus beat intervals; RRs-cardiac inter-beat intervals; FP-frequency power
data samples [200,217]. Furthermore, correlated features are excluded from the HRV
measurements, reducing the number of features from 38 to 18.
In order to train and test in a balanced manner, we apply downsampling and ensure
balance on gender (equal number of male and females) and sleep stages (equal
number of wake and sleep events). As the MLPs classify per event and do not look
at the time series, we can delete different values from the majority class randomly
per repeat of CV. Moreover, the data is standardized per feature with the z-score:
zi = (xi − x)/σ, where xi is the observed value, x is the mean of the sample, and
σ is the standard deviation. For the case of non-gender-specific training, we keep
a ratio of 1/1 for male/female and sleep-wake stages, creating a gender- and sleep
stage-balanced dataset. Furthermore, we reject all individuals with less than 400
examples of sleep-wake stages.
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5.3 Evaluation of the Proposed Approach
The following scenarios are investigated to validate our approach and test the useful-
ness of the personalised models fused with granular-adaptive data analysis. In this
section, we present the considered experimental data and the experimental settings
to investigate the performance and influence factors of our approach.
5.3.1 Dataset
We use the MESA dataset described in Section 3.4.1 with the exclusion criteria
detailed in Section 5.2.3 to obtain a diverse dataset. The diversity comes from the
inclusion of participants (1) from different ethnic backgrounds, including African-
American, White, Hispanic, and Asian-American; (2) of both genders; (3) aged
between 45 and 84; and (4) with different health statuses, either healthy or diagnosed
with a sleep disorder (sleep aponea, insomnia, or RLS) [201]. The segmentation of
the dataset, corresponding to the data presented in Table 5.2, shows the number of
people and average age with SD per data source as well as the considered diversity
factors. The diversity factors include race, health status, and gender. We can clearly
see an unequal distribution, which should be taken into account. For the case of
females and males together, we provide the number of available data used in the two
different test settings (i.e., gender-balanced and gender-imbalanced cases; details in
Section 5.3.2).
In this investigation, we use the first night of actigraphy, which was collected simul-
taneously with PSG [200,201,203] to validate our fine-grained approach. The scoring
of the recordings from actigraphy has a 76.71% match with the PSG scores while
downsampling and averaging show only 73.45% coherence, suggesting a majority
class bias (see Section 5.4). This shows the necessity of improving current recogni-
tion rates and establishing a fine-grained approach. The ground truth of PSG for
sleep stages is given by the R-K, which we translated to wake and sleep stages. This
means wake is considered normally but S1, S2, S3, S4, and REM are fused into one
stage called sleep. We employed sensors that could be easily applied at home. These
sensors are actigraphy and ECG measuring HRV. To use the dataset, we need to
extract features and pre-process in line with the process described in Section 5.2.3.
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5.3.2 Sleep-Wake Analysis Scenarios
The validation of our proposed personalised sleep-wake recognition approach is per-
formed in various scenarios that are described in detail in this section. As already
stated, we conducted health-status-specific and race-specific experiments. Health
status categories include: all health statuses (shown as All-HS); healthy (He); di-
agnosed with apnoea (Apn); diagnosed with insomnia (Ins); and diagnosed with
RLS (RLS). Race categories include: all races (All-Races); African-American (B);
White (W); Hispanic (H); and Asian-American (A). All investigations are validated
with six times 10-fold CV to ensure representative outcomes and we report averaged
accuracies with SD in Section 5.4. Accuracy is considered sufficient, as data are al-
ways balanced for sleep stages. Based on changes of SD across different repeats of
CV, we find the influences that the used training data has; if the SD is higher, the
approach works better for certain training-/testing-splits than for others (a low SD
is preferable). The scenarios are investigated for different accessible data sources:
actigraphy, HRV, and the two fused together (fusion is done on the feature level).
The structures of the sleep-wake analysis scenarios include the following steps:
First, we compare our fine-grained approach on actigraphy data with the original
sleep-wake classification, which is part of the used dataset [202]. The original sleep-
wake classification is denoted as ‘Original Sample’ and is based on the imbalanced
dataset with respect to sleep-wake stages. In the original approach, activity counts
are analysed by comparing the activity levels within ± two minutes time period (<
40 is sleep, >=40 is wake), details can be found in [218]. Additionally, we explore
the performance in the downsampled case, referred to as the ‘Under-sampled’. This
scenario is further referred to as scenario (1).
Second, we analyse data for females (Female) and males (Male); all data from the
specific gender groups are used in the model. The average of these outcomes is also
given (Avg. Gender) in order to be comparable to the overall performance when
personalisation is not integrated. Furthermore, the race-specific and health status-
specific analyses are performed. We will refer to ‘Avg. Races’ as the average of all
individual race-specific trained models and ‘Avg. Health Status’ as the averaged
performance of all health status-specific models. Combinations of, e.g., gender and
race information in a model are referred to ase’. These scenarios are further referred
to as scenarios (2).
Third, we compare the outcomes with the case in which the data from both genders
are taken together to train a more general model. This general approach is explored
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with a 1/1 ratio for female/male and sleep-wake stages per individual (All; (3a))
or imbalanced towards gender using all data from all individuals (All-biased; (3b)).
These scenarios are further referred to as scenarios (3a) and (3b).
Fourth, we consider gender as an extra feature in the data, either balanced sleep
stages and gender (Incl. Gender; (4a)) or imbalanced towards gender (Incl. Gender-
Biased; (4b)). These scenarios are further referred to as scenarios (4a) and (4b).
Fifth, we determine the best approach in terms of training data. Models are trained
on individuals with a medical condition and tested on both healthy individuals and
individuals with a medical condition. Additionally, models are trained on healthy
individuals and tested on both healthy individuals and individuals with a medical
condition. In the results section, we refer to this analysis as ‘Train Disease - Test
Healthy’ (i.e., train model on diseased individuals and test on healthy individuals).
Lastly, we investigate the performance of the variable-threshold-based parameter
extraction process built upon our wake-sleep assessment approach. We use the
lights-off time from PSG provided in the MESA dataset to make a direct comparison
with the actigraphy. This means that both data sources are used from the lights-off
time onwards. The scope of the functionality investigation lies in SOL, because SOL
is important to show abnormalities of sleep behaviour and to indicate insomnia.
5.4 Results
In this section, the results of the investigated scenarios are presented for both actig-
raphy and HRV data.
5.4.1 Comparison of Approaches
In Figure 5.5, the outcomes of the original sleep-wake classification [202] are com-
pared with the outcomes of our fine-grained approach for actigraphy data. The
‘Original Sample’ case reached an accuracy of around 76%. For the ‘Under-Sampled’
case, the repeated-averaged accuracy decreases by around 3%. For example, for ‘All-
HS’, a decrease from 76.71% to 73.45% can be observed.
Furthermore, the results are given for: ‘All’ (compare to Section 5.3.2, 3a), ‘Gender’
(4a), ‘Avg. Gender’, ‘Avg. Races’, ‘Avg. Gender and Race’, and ‘Avg. Health
Status’.
121
CHAPTER 5. FINE-GRAINED SLEEP STAGE DETECTION
In Figure 5.5, actigraphy-based recognition rates are improved by around 5% when
using MLPs, compared to the downsampled recognition methodology that is cur-
rently used. For example, ‘All-HS’ reached 78.98% for ‘Avg. Gender’ compared to
the downsampled 73.45%.
The ‘Avg. Health Status’ models reach an accuracy of 77.88%, while gender-specific
personalised models on top of the health-specific classification can achieve an aver-
aged accuracy of 78.47% (79.16, 79.38, 78.06, 77.29) and even 78.75% (78.87, 78.93,
79.05, 78.15) if race is also specified. Overall, the gender-specific approach reaches
the best outcome, with 78.98% in the ‘All-HS’ case.
The effect of including race- and gender-specific data is especially prominent in the
diseased cases (e.g., 79.05% accuracy for insomnia ‘Avg. Gender and Race’ compared
to 78.06% for ‘Avg. Gender’). The results show that a fine-grained model is superior
to standard one-model-fits-all approaches, especially for diseased individuals (e.g.,
79.05% for ‘Avg. Gender and Race’ compared to 77.01% for ‘All’).
Furthermore, it is evident that including gender (Incl. Gender) as a feature during
training does not mentionably change the recognition rate towards ‘All’. This can
be seen, e.g., in ‘Ins’ which reaches an accuracy of 77.01% for ‘All’, which is very
similar to 77.05% for ‘Incl. Gender’.
5.4.2 The Impact of Personal and Physiological Data
In figures 5.7, 5.8, and 5.9, the results from (2)–(4) are presented for ‘Male’, ‘Female’,
‘Avg. Gender’ (see Section 5.3.2 2), ‘All’ (3a), and ‘Incl. Gender’ (4a).
The SD is not given in ‘All’ and ‘Incl. Gender’ to allow for visual clarity; overall,
however, the SDs for ‘All’ and ‘Incl. Gender’ are similar and 1–5% higher than in
the individual-trained models. For example, ‘White, RLS, All’ has an SD of 7.8%
and ‘White, RLS, Incl. Gender’ has one of 7.6% while the gender-specific ‘Avg.
Gender’ SD is only 0.95%.
Furthermore, it should be noted that the SD is lower in scenarios (3b) and (4b),
gender-imbalanced analysis, relative to scenarios (3a) and (4a), balanced case (see
Figure 5.6). Put more concretely, for (3b) ‘All-Races, Apn, All’ the SD is 0.5%; for
(4b) ‘All-Races, Apn, Incl. Gender’ SD is 0.4%; for (3a) SD is 3.4%; and for (4a) SD
is 3.7%. There is an accuracy difference between (3a) and (3b) as well as between
(4a) and (4b) for HRV; this difference is not as obviously present for actigraphy.
For example, with HRV, (3a) ‘A, He, All’ reaches an accuracy of 79.1% while (3b)
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Figure 5.5: Performance overview of original sleep-wake classification and the pro-
posed approach.
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Figure 5.6: Gender-balanced and gender-imbalanced HRV training results.
reaches an accuracy of 71.6%.
In Figure 5.7, accuracy is generally higher for male participants compared to females.
For example, ‘All-HS’ in the ‘All-Races’ case can reach 80.04% accuracy for males
and 77.92% for females. In contrast, for HRV in Figure 5.8, the outcomes are more
similar; the individual female models perform better overall with an 80.60% averaged
accuracy compared to one of 79.64% for the male models. In the combined case in
Figure 5.9, however, the males (85.77%) outperform the female models (84.65%)
again.
The effect of fewer individuals is represented in higher SDs (see Table 5.2). For
example, ‘HRV, Female, A, Apn’ with six individuals has an SD of 1.6% while
‘HRV, Female, W, He’ with 601 individuals has an SD of 0.2%. It should be noted
that the ‘Male, Asian, Apnoea’ case contains just one participant, meaning it is
unrepresentative. It is excluded from the presented results, as no conclusions can
be drawn from it.
For ‘He’ (‘White, He, Male’ with SD of 0.2%) and ‘All-HS’ data (SD of 0.2%), the
SD is usually lower than in the disease models (‘Apn’: SD of 1.1%, ‘Ins’: SD of
0.8%, and ‘RLS’: SD of 0.8%; see Figure 5.7).
The average SD for HRV is generally higher, with 1.08% for ‘Avg. Gender’, 4.27% for
‘All’, and 0.68% for ‘All-biased’, while, for actigraphy, it is 0.79% for ‘Avg. Gender’,
3.42% for ‘All’, and 0.59% for ‘All-biased’, and, for the combined case, 0.86% for
‘Avg. Gender’, 4.09% for ‘All’, and 0.6% for ‘All-biased’.
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Overall, the accuracy for actigraphy data has less variation in races and health
statuses (ranging from 76.3% to 82.2% for ‘Avg. Gender’) compared to that for
HRV (ranging from 74.2% to 86.2%); this is evident in figures 5.7 and 5.8. However,
it is more challenging to distinguish between wake and sleep stages in the Hispanic
group with actigraphy (averaged ‘Avg. Gender’ accuracy of 76.65%), than with HRV
(81.22%).
HRV in Figure 5.8 indicates that, if we look at both diseased and healthy individuals,
our method performs better for diseased individuals than for healthy ones. For
example, ‘White’ averaged diseased results reach 82.05% accuracy; ‘White’ averaged
healthy results reach just 76.64% accuracy. This trend is also visible when the data
sources are combined (see Figure 5.9). Actigraphy shows less variable accuracy
rates in this respect (in ‘B’ averaged diseased outcomes reach 78.46%, ‘He’, 80.08%;
see Figure 5.7), though between male and female models, actigraphy shows more
variable accuracy rates.
Based on these trends, we investigate the combined cases (see Figure 5.9). The
trends are consistent with the general trend reported for the HRV case. The com-
bination of sources improved the accuracy from the HRV case by around 5% (from
74.5% to 80.6% for ‘All-Races, He’). For actigraphy, only a 1% increase is observed
for the case of the healthy individuals (from 79.21% to 80.87% for ‘All-Races, He’).
However, it also shows a 5–8% increase in the diseased individuals (from 77.29% to
85.47% for ‘All-Races, RLS’).
5.4.3 Models Trained on Healthy and Diseased Individuals
In figures 5.10, 5.11, and 5.12, the analysis outcomes from setting (5) are given
for actigraphy data, HRV data, and them both together. Results are provided for
the models trained on individuals with a medical condition and tested on healthy
individuals (‘Train Disease - Test Healthy’) and as well as for the models trained on
individuals with a medical condition and tested on individuals with a medical con-
dition (‘Trained Disease - Test Disease’). Additionally, the average of the outcomes
(‘Avg. Disease Trained’) is given. The fields are coloured in shades of red for the
models trained on individuals with a medical condition and coloured in shades of
blue for models trained on healthy individuals. Furthermore, we provide the aver-
age of the individual models trained on individuals with specific medical conditions
(‘Avg. Ind. Disease Models’) and the average of the individual models trained on
healthy and diseased individuals (‘Avg. Ind. Models’).
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Figure 5.7: Outcomes for actigraphy data: Accuracy with SD for female (Female),
male (Male), and both together (All); averaged female and male (Avg. Gender);
and both together including gender as a feature (Incl. Gender).
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Figure 5.8: Outcomes for HRV data: Accuracy with SD for female (Female), male
(Male), and both together (All); averaged female and male (Avg. Gender); and both
together including gender as a feature (Incl. Gender).
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Figure 5.9: Outcomes for the combined data of actigraphy and HRV: Accuracy with
SD for female (Female), male (Male), and both together (All); averaged female and
male (Avg. Gender); and both together including gender as a feature (Incl. Gender).
From Figure 5.10, an apparent performance difference between male and female
groups is visible in all investigations (e.g., ‘All-Races, Males’ reaches 80.4% while
‘All-Races, Females’ reaches 77.01%). Additionally, it is difficult to detect the sleep-
wake stages for Hispanic females—this problem does not exist with Hispanic men.
When comparing figures 5.11 and 5.12, we can see a similar trend for HRV and the
combined case; the trained models are most distinctive in the HRV and combined
case (Figure 5.12), meaning models trained on diseased and healthy individuals are
preferable. For example, for white males, 85.85% is reached with the fine-grained
model compared to 82.73% and 81.43% for ‘Avg. Disease Trained’ and ‘Avg. Healthy
Trained’, respectively. This trend is also present in Figure 5.10 but only when race is
considered (e.g., for Asian males: 82.28% is reached for ‘Avg. Ind. Models’, 80.17%
for ‘Avg. Healthy Trained’, and 79.87% for ‘Avg. Disease Trained’).
5.4.4 Comparison to Existing Methods
In Table 5.3, we compare our proposed model to standard sleep-wake recognition
(presented in Section 2.4.3). Note that we calculated the macro-average for recall
on a balanced dataset, meaning that recall and accuracy are the same. It is not
possible to accurately compare our outcomes with Wolz et al. [47] and McDowell et
al. [13], as their ground truth is provided by an actigraph unit while ours is based
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on PSG. Only Uçar et al. [46] provide a 10-fold CV. However, we also repeat this
analysis six times and on a bigger dataset to provide results that more accurately
represent the general population. Our model is trained on the highest number of
individuals and with the highest level of diversity of any study done before on this
topic. Overall, we can reach the highest κ of 0.69 using our fine-grained approach
on gender and health statuses by combining two data sources.
Evidence shows that camera recordings lead to the highest levels of accuracy [167].
The studies, conducted by Kuo et al. [48] and Khademi et al. [128], are very similar in
accuracy, though Khademi et al. [128] reach a recall of 38%, which is considered low.
Our accuracy is lower than that of Kuo et al. [48], but we use a balanced dataset in
terms of gender and sleep-wake stages with more participants. We also use processed
activity counts and light levels instead of raw accelerometer data. Additionally, our
approach reaches higher κ values than Parro and Valdo [219] despite us including
both males and females while they only included males.
Table 5.3: Comparison with other methods.
No HS* Sensor Feature No Acc. Rec. κ Method
[46] 10 Ap PPG 28 77.4 79.0 0.59 KNN
[167] 10 - Camera - 92.1 - - -
[48] 81 poor/good SE Actigraphy 2 89.7 92.9 0.62 -
[128] 54 diverse Actigraphy 39 87.0 38.0 - XGB*
[219] 43 male Actigraphy - 85.3 - 0.53 RQA*
Ours 1,641 diverse ECG 18 79.1 79.1 0.58 MLP
1,576 diverse Actigraphy 1+6 79.0 79.0 0.58 MLP
1,576 diverse Combined 25 84.6 84.6 0.69 MLP
* HS- Health Status; RQA - recurrence quantification analysis; XGB - extreme gradient boosting
5.4.5 Personalised Sleep Parameter Extraction
We have shown that our sleep-wake recognition approach is an improvement in
accuracy over the standard approach (‘Original Sample’). We use this approach
as the basis for our personalised sleep parameter extraction, which we investigated
here as a means to obtain SOL. We compare all investigated approaches to the gold
standard of sleep assessment, PSG.
In Table 5.4, we present an optimal threshold level for the original—a one-threshold-
fits-all approach—and our approach. Furthermore, we investigate whether person-
alising the thresholds results in improvements to the approach. The original SOL
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calculation (Org.) uses the 15-minutes rule on the original sleep-wake stages ob-
tained from actigraphy (provided by NSRR [202]). Our variable-threshold process
incorporates personalised sleep stage detection. In searching for one optimal thresh-
old for all groups of individuals, we reach improvement over the original in mean
difference with a threshold level of 25 minutes. The mean difference is lower for our
sleep-wake analysis approach with 20.16, compared to 20.74 in the original. When
we use the full possibility of our proposed approach, we explore dynamic thresholds
(variable-minute approach) that are adapted to various subgroups. The personalisa-
tion of these thresholds is relevant; therefore, we explored threshold values between
2 and 50 for categories based on gender, health status, and race. This produces
a better correlation with PSG at 17.78 mean difference, superior to 20.74 for the
original and 20.16 for our optimal static threshold. Furthermore, we investigate
the Pearson and Spearman correlation with PSG; Pearson correlation represents
linear relations and Spearman correlation depicts monotonic relations. It should be
noted that there could still be a relationship even if both are found to be zero, as
some cases are not represented (e.g., a parabola). Our investigations reach a lower
Spearman correlation, however, our approach reaches a lower mean difference, which
we consider the leading indicator. Thresholds must be adjusted alongside changes
to personal factors to reach the optimal match with PSG. A comparison between
the original 15-minute rule and our variable personalised threshold (variable-minute
approach) is depicted in Figure 5.13. For male participants (shown in green), im-
provement is visible. Overall, our approach tends to underestimate SOL while the
original tends to overestimate it.
5.5 Discussion
5.5.1 Comparison of Approaches
The difference between the original and the downsampled case indicates that sleep
states, which are downsampled, more often match with the sleep stages of the ground
truth (PSG) than it is the case with the wake stages. This demonstrates the better
fit between the majority class (sleep states) and the ground truth from PSG.
The lower outcome for ‘Avg. Health Status’ demonstrates the influence of the train-
ing data on the recognition rate and the importance of fine-grained approaches, as
we can increase the performance by personalising the model in terms of gender and
race.
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Table 5.4: SOL: Correlations and sum of differences.
Approach Threshold Correlation Mean Difference
Pearson Spearman
Original 15 0.68 0.73 20.74
Our 25 0.63 0.57 20.16
Original Male 15 0.63 0.73 26.50
Our Male 15 0.63 0.62 24.08
Personalised Thresholds
Gender-Specific
Female 25 0.60 0.50 20.29
Male 25 0.72 0.69 19.94
Mean 20.16
Health Status-Specific
Healthy 25 0.67 0.60 19.98
Apnoea 20 0.61 0.56 14.20
Insomnia 20 0.62 0.50 27.43
RLS 25 0.65 0.64 18.09
Mean 19.78
HS* Gender Mean 19.67
Race-Specific
White 25 0.60 0.54 17.84
Asian 20 0.77 0.62 17.28
African 20 0.66 0.58 22.87
Hispanic 25 0.58 0.60 23.56
Mean 20.05
Race Gender Mean 19.69
HS* Race Gender Mean 17.78
HS - Health Status
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Original 15-minute-rule
Our variable-minute approach
Figure 5.13: Comparison of SOL approaches; the original sleep-wake algorithm us-
ing a 15-minute-rule and our fine-grained model using a variable-minute approach
with PSG. Linear regression, Bland-Altman plot, and histogram of differences are
presented.
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The findings show that fine-grained models have an advantage over standard one-
model-fits-all approaches. Notably, individuals with a medical condition show an
improvement in performance (e.g., ‘Avg. Gender and Race’ (79.05%) and ‘All’
(77.01%)). This is a positive result, as diseased individuals are usually the tar-
get group for sleep behaviour analysis. This effect likely comes from the fact that
gender, race, and health status are influence factors for sleep.
Another finding is the importance of properly including the information during the
training process; we tested the inclusion of gender as a feature ‘Inc. Gender’ and
gender represented as two separate models. The gender-specific models can represent
the differences in gender better.
5.5.2 The Impact of Personal and Physiological Data
The differences in SD between the general approach and the personalised gender-
specific case show the stability and reliability of our fine-grained perspective in
sleep-wake recognition, as the SD is lower for repeated analysis.
The finding that SD for HRV data is lower in the imbalanced case than it is in the
balanced case suggests that a bias is introduced and the majority class is represented
better. Additionally, it suggests that patterns are different between individuals and
different timepoints. This can be explained by changes in HRV between differ-
ent sleep stages; therefore, HRV was generally used, in literature, to investigate
higher-granularity stages. In contrast, actigraphy is based on movement being more
consistent over time, so this effect is not as prominent.
The finding revealing that models for male participants tend to perform better
than models for female participants suggests that males and their movements are
more consistent while females vary more by individual components, meaning that
individual-trained models would have an advantage.
The number of individuals affects performance and must be considered when re-
viewing the outcomes.
The result that SD is lower for models on healthy individuals and all health statuses
together relative to disease-specific models could either be caused by the influence
of the individual numbers or the classification task at hand.
The average SD for HRV is higher than for actigraphy or the combined case. These
findings indicate that actigraphy has a positive influence on SD in the combined
case.
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Which data source is ideal varies by case and desired outcome. With actigraphy,
outcomes are more stable over all fine-grained models, while HRV shows higher vari-
ability (ranging from 74.2% to 86.2%; see Figure 5.8). However, certain subgroups
face difficulties and low reliability with actigraphy but good performance with HRV,
such as Hispanics. These findings demonstrate that the choice of data source is quite
relevant when detecting sleep and wake stages.
We found that HRV performs better when considering diseased individuals rather
than healthy individuals. This suggests that the HRV differences between sleep
and wake stages are more significant in diseased cases. Actigraphy, however, shows
more differences between male- and female-individual models while disease-specific
models perform slightly worse than those with healthy individuals.
Overall, a combination of HRV and actigraphy performs best. Presumably, actig-
raphy pushes the recognition rate in healthy cases while HRV pushes it in diseased
cases. It is likely that the actigraphy and HRV data are independent of each other
and are thus able to capture different behaviour. As a result, a combination of the
data sources features is a promising approach. This is an important finding which,
to our knowledge, has not been investigated before.
5.5.3 Models Trained on Healthy and Diseased Individuals
In our investigations, male and female groups show differences in performance for
actigraphy data. This relates to the idea mentioned earlier of males having less
variability in body movements. For specific groups, sleep and wake episodes are
more difficult to separate for females (e.g., Hispanics). This could be caused by
the smaller individual set of 157 females compared to the 181 in the male case (see
Table 5.2). More likely, however, is that the gap is caused by underlying differences
in sleep-wake patterns between males and females. This, once again, makes the
personalised fine-grained models a great solution for more reliable sleep-wake stage
recognition.
Our results demonstrate that individual-trained models on healthy and diseased
individuals are preferable. Our fine-grained sleep-wake behaviour analysis approach
is the optimal method of investigation. Furthermore, disease-trained models (‘Avg.
Ind. Disease Models’) are preferable for HRV, whereas for actigraphy, it is not so
clear; best models need to be determined based on individual use cases.
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5.5.4 Comparison to Existing Methods
Our investigation is the only one provided in Table 5.3 which considers a balanced
dataset for training (see figures 5.5 and 5.6); however, downsampling can influence
the recognition rate. We are also the researchers to investigate, in a study on this
subject, the combination of multiple data sources and the relevance of clinical history
and personal information. We incorporate the highest number of individuals and
the highest level of diversity. We use sensors that are easy to apply at home and do
not interfere much with the privacy of individuals; video recordings, used in studies
like Liao and Yang [167], continue to raise privacy concerns. Characteristics of our
validation data—fewer features and higher accuracy—make our HRV model a better
choice than other methods, such as Uçar et al. [46]. Overall, we reach the highest
κ value, 0.69, by using our fine-grained approach on gender and health statuses
and combining two data sources. Many approaches test against just one technician,
making that technician’s style too influential [141]. Our dataset is scored by multiple
technicians, so it does not encounter this issue. In addition, we investigate the
combination of actigraphy and HRV as a means to enhance model accuracy, which
was achieved.
Compared to other approaches, we simply use five features, one from actigraphy and
four from light levels, and can reach good κ results for a balanced dataset, but we
do not reach the same accuracy rates. This gives us the impression that the larger
and more diverse dataset used in our study influences the performance and, in turn,
better represents the general population. Overall, a balanced dataset represents a
realistic recognition rate but leads to a decrease in performance and higher variability
in SD, such as in the original sleep-wake recognition model (see figures 5.5 and 5.6).
However, our multi-source data learning approach for granular sleep-wake behaviour
detection adapts to these effects and provides comparable accuracy, improving when
multiple data sources are available.
5.5.5 Personalised Sleep Parameter Extraction
The personalised sleep parameter extraction shows a better mean difference and
indicates that the thresholds must be adjusted to fit better with varying personal
factors. This means, e.g., that sleep apnoea and healthy individuals require differ-
ent thresholds. Furthermore, results indicate that our multi-source data learning
approach for sleep-wake stages applied in a real-world environment can improve
sleep parameter extraction. The variable threshold technique shows advantages in
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the Bland-Altman plot with a better fit but tends to underestimate the SOL. Par-
ticularly for male participants, SOL can be improved by our method, likely due to
their more consistent sleep-wake patterns. Overall, we can see that a personalised
approach is optimal; however, further analysis is still necessary to determine the
best thresholds levels for all groups.
5.5.6 Limitations
Limitations in our analyses are (1) the necessary inclusion of clinical history and
personal information; (2) downsampling; (3) lack of comorbidity consideration; (4)
varying number of individuals; (5) HRV’s extraction from ECG. First, clinical his-
tory and personal information must be available for our granular adaptive approach.
If none of this information is provided (may not be shared by real-world users), a
fine-grained sleep stage detection cannot be provided. Additionally, our approach
does not cover for non-binary individuals; to overcome this future researchers need
to determine whether their sleep behaviour corresponds to gender identification or
sex-at-birth. Second, when downsampling is performed, not all the data from the
majority class are necessarily used, even if repeated; to reach a balance in sleep and
wake stages, the majority class is reduced. We sampled randomly for each repetition
and did not cover for already-used or not-used periods. This means potentially that
not all data are used. Third, comorbidity is not considered in our approach; it may
have an influence on the recognition rate that we are unaware of. Fourth, as men-
tioned throughout this chapter, the number of individuals varies within groups and
differences in individual counts can influence performance. Fifth, HRV features are
extracted from ECG, which has more contact points with the human body and is
considered less comfortable than PPG. Monitoring PPG with pulse rate variability
is a promising alternative to HRV extraction from ECG with good coherence [220].
Another potential limitation could come from the way data has been collected, as
PSG and actigraphy have been gathered simultaneously. Therefore, PSG could
potentially influence the natural sleep habit negatively. This issue is difficult to
overcome, because a ground truth is necessary.
5.6 Summary and Future Directions
This chapter contributes to knowledge in two folds. First, we proposed a fine-grained
sleep-wake behaviour analysis approach that is adaptable to gender, race, and health
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status as well as accessible physiological data sources. Second, a variable thresh-
old technique for sleep parameter extraction was developed which incorporated the
sleep-wake detection approach. The validated sources include HRV and actigra-
phy data. Analysis using our fine-grained approach revealed the influence factors
on performance for sleep-wake recognition. These proved useful when categorising
for variable threshold extraction. The investigations produced results comparable
to those found in the sleep-wake detection literature; our use of variable thresh-
olds in sleep parameter extraction constituted an improvement over the currently
available ground truth. Our findings are as follows. First, gender-separated models
provide higher accuracy, indicating that gender is an influence factor on how wake
and sleep periods are differentiated. Second, disease-dependent classification is rel-
evant, as it shows clearly better results compared to the healthy cases for HRV and
the combined case. Third, the inclusion of multiple data sources (the combination
of HRV and actigraphy) improves the recognition rate considerably and makes our
approach more closely matching with the gold standard, PSG. Fourth, the findings
demonstrate the potential for variable thresholds for sleep parameters extraction.
The basis for sleep behaviour investigation is a reliable sleep-wake recognition ap-
proach. We have shown that (1) personalised models, considering clinical history
and genetic information and (2) models trained of multiple data sources, can improve
the performance of such approaches. These outcomes serve as a basis for reliable
sleep parameter extraction through variable threshold adaptation for our sleep be-
haviour assessment framework. Incorporation of the knowledge brought about by
our investigations could lead future researchers to new insights. Perhaps our per-
sonalised approach could eventually find similar success even when sleep is divided
by the guideline-specific stages: N1, N2, N3, and REM. We propose an investi-
gation of multiple two-class classification problems that would ultimately be fused
together into an overall model. One would distinguish between REM from NREM
sleep, one would distinguish between light (N1, N2) and deep sleep (N3); and one
would distinguish between N1 and N2. This method includes multiple personalised
models for pairs of sleep stages, each optimised for an individual problem. Fur-
thermore, the incorporation of multiple data sources suggests a promising direction
for boosting recognition rates. Future research could look at new combinations of
already-investigated data and potentially open up new avenues of investigation for
sleep-wake classification. The variable-threshold process allows for the possibility of
personalised, home-based sleep health monitoring, which is reliable.
Sleep stage behaviour analysis is currently used to detect anomalies and diagnose
diseases in a laboratory. Home-based analysis makes a proper investigation of the
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relationship between sleep and chronic disease possible. To show the necessity of
such an investigation, we assessed the perspectives from individuals affected by
medical conditions and doctors in related fields. We targeted specific chronic diseases
to investigate how chronic diseases can induce sleep changes.
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Chapter 6
Understanding of Sleep and Chronic
Disease Relations
6.1 Introduction
In previous chapters, we developed methods to improve sleep behaviour analysis for
home-based assessment. Past research and our investigations have demonstrated
relations between sleep architecture changes and medical conditions. To effectively
implement home-based assessments, the use of daily technology is key—individuals
should feel comfortable with it. We performed semi-structured interviews to gather
perspectives from individuals and doctors on sleep issues, technology usage, and
their daily lives.
This chapter addresses elements that are missing from the literature, including (1)
semi-structured interviews to assess influence factors, symptoms, and used sleep
assessment methods; (2) investigations into sleep perspectives of doctors and indi-
viduals affected by a medical condition; and (3) discussions on differences in those
perspectives. We interviewed individuals suffering from a chronic disease about (1)
their sleep issues; (2) the effects of sleep quality on their daily life; (3) the influence
factors for their sleep issues; and (4) their usage of technology. From doctors, we
were interested in their views on: (1) sleep issues; (2) prominence of sleep issues
in their specific field of medicine; (3) influence factors for sleep problems; and (4)
technology usage at home. Subsequently, we address objective 7, as an in-depth un-
derstanding of sleep and chronic disease relations is developed. We use a qualitative
approach to obtain the perspective of reported sleep issues in the Chinese popu-
lation. We looked at the Chinese population because they are under-represented
in current studies. Throughout this chapter, we refer to individuals living with a
chronic disease as affected individuals.
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Structurally, this chapter is divided into four sections. First, our research methods
are presented in Section 6.2. Second, the results from our interviews are provided
in Section 6.3. Third, we discuss the findings on sleep and perspective differences,
as well as the limitations of this study, in Section 6.4. Lastly, Section 6.5 includes a
summary, implications for future studies, and the focus of the following chapter.
6.2 Methods
For this study, we conducted explorative qualitative analysis with semi-structured
interviews. In this section, we explain the methods used for planning, sampling,
data collection, and data analysis.
6.2.1 Design and Settings
The interview process was planned to take place in China at the Affiliated Zhongshan
Hospital of Dalian University over one week in October 2017. This hospital has
2,200 beds, 2,887 employees, and can accommodate 5,000–7,000 people per day.
At our request, the hospital director contacted doctors with experience in chronic
diseases. All doctors interviewed were knowledgeable about chronic diseases and
sleep problems. Participants living with a chronic disease were contacted by their
doctors. Dalian University provided a translator to support our interviews with
translations and to take notes. Additionally notes are taken by the researcher during
the interviews. The combined notes were made into transcripts and subsequently
summarised following the interviews.
We gathered a diverse sample from various departments to gather opinions from
individuals with various chronic disease backgrounds. The goal was to include at
least one expert’s opinion and that of two or three affected individuals per chronic
disease. Family members could be present during the interview and offer clarifica-
tions if necessary. We followed the inclusion and exclusion criteria, described in the
next section, for the process of recruiting interviewees.
(a) Inclusion and Exclusion Criteria
Participants were included in the study if they fulfilled the inclusion criteria. The
interviewed participants are either affected individuals or doctors in relevant fields.
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Table 6.1: Inclusion and exclusion criteria.
Inclusion Exclusion
General Adult Individual under 18 years
Provide consent Don’t provide consent
Volunteer
Individuals with
a chronic disease
Suffering from chronic disease Healthy individuals
Able to communicate Unable to communicate
Doctors Knowledgeable about sleep is-
sues
Doctors from unrelated fields
Specialist in a specific chronic
disease
Has contact with affected indi-
viduals
Has no personal contact with
patients
Medical education
All participants were adults and gave consent to be interviewed and to have their
data collected and analysed.
In this study, we recruited doctors from various departments who worked with in-
dividuals suffering from a chronic disease, such as insomnia, cancer, stroke, and
arthritis. The doctors needed to have a medical degree, be a specialist for a specific
chronic disease, and know about sleep issues and common sleep disorders. Further-
more, they needed to regularly be in contact with affected people.
The affected individuals needed to be able to communicate, understand the ques-
tions, give their consent, be willing to explain their sleep issues, and be conscious
of their difficulties. As participant 10 was unable to communicate effectively due to
the state of their disease, we excluded their data from the analysis.
6.2.2 Ethical Considerations
The investigation was performed with ethical approval from De Montfort University.
All individuals participated in this study voluntarily. Potential participants were
informed of the aim of the study, the questions, and the interview setting; written
informed consent was received prior to data collection. The participants have the
right to withdraw from the study at any time. All participant identities are kept
completely anonymous and their data are stored securely. Participants did not
approve the collection of audio data.
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6.2.3 Data Collection
Interviews took place in the hospital for about 5–10 minutes with a translator present
at all times. The interviews were not recorded; instead, notes were taken. Based
on the knowledge and state of the interviewees, interview questions were sometimes
adjusted or left out. Interviews with affected individuals were conducted by a re-
searcher with a translator, doctor, and occasionally a family member (or multiple)
present. Interviews with doctors were conducted face-to-face by a researcher.
Participants received the study information sheet translated into Chinese (by a
colleague at De Montfort University). Details of the study were explained in Chinese
by a translator. Participants could ask questions before giving their consent. Those
who gave consent were interviewed by a researcher about their experiences with
medical conditions. We followed two different protocols in a semi-structured style
for doctors and affected individuals. The guideline questions were divided into
‘Introduction Questions’, ‘Sleep Issues’, and ‘Self-Management’.
We started with introduction questions, such as ‘What is your profession’ and ‘What
is your background’ for doctors, and ‘How long have you been suffering from this
chronic disease’ for affected individuals.
We asked for the doctors’ perspective regarding sleep problems: ‘Are chronic dis-
ease patients affected by sleep problems’ and ‘Which problems do they usually have’.
Furthermore, we asked: ‘What method is currently used to assess sleep’ and ‘What
would you suggest to people with sleep issues’. For affected individuals, we asked
‘What kind of problems do you have during sleep’, ‘Is it affecting your daily life’,
and ‘Is it a burden’. To gather more details on the nature of their problems, we
investigated further: ‘What difficulties and challenges do you face during sleep and
during the day after a bad rest’. Furthermore, we were interested in what they think
affects their sleep: ‘Do subjective or objective elements relate to your sleep quality’.
As there is currently a trend towards home-based assessment and self-management,
we were interested to know if doctors see an advantage in self-management tools
and information they could extract from home-based devices. First, we asked if
they know about options for home-based sleep assessment and self-management:
‘Are their options to self-manage sleep issues from your point of view’. Our interest
was also to extract ‘What information would you like to get from a patient that
would help in the treatment decision process’. Generally speaking, we sought to
know ‘Do you think the data collected could help you, as a doctor, check patient’s
conditions’ and, get more information on sleep problems such as potential sources
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(e.g., environmental influences). We were also interested to ask affected individual
‘Do you self-manage something in your daily life’ and ‘Do you think technology
would be helpful’.
6.2.4 Participants
The survey was conducted in collaboration with Dalian University and the Affiliated
Hospital of Zhongshan Hospital in China. Participants included 18 people from five
different departments:
• Rehabilitation department
• Ear-Nose-Throat department
• Orthopaedic department
• Oncology department
• Neurology department
The participants were distributed as follows: 33.4% from the Rehabilitation depart-
ment; 11.1% from the Orthopaedic department; 33.4% from the Oncology depart-
ment; 16.7% from the Neurology department; and 5.6% from the Ear-Nose-Throat
department (see Table 6.2).
Rehabilitation
33.4%
Neurology
16.7%
ENT
5.6%
Oncology
33.4%
Orthopaedic
11.1%
Table 6.2: Department statistics of participants.
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We interviewed 6 females and 12 males, of which 7 are doctors and 11 are affected
individuals. The gender distribution for doctors is 57.1% males (4 individuals) and
42.9% females (3 individuals); the gender distribution for affected individuals is
18.2% females (2 individuals) and 81.8% males (9 individuals). We recruited partic-
ipants living with insomnia, cancer, stroke, and arthritis. The gender distribution
for those subgroups can be found in Table 6.3.
Table 6.3: Number of participants in terms of gender and affiliation.
Source Gender Affiliation
Affected
Individuals
Female 2 Insomnia 1
Cancer 1
Male 9
Insomnia 1
Stroke 4
Cancer 3
Arthritis 1
Doctors
Female 3 Neurology 1
Rehabilitation 2
Male 4
Oncology 2
Orthopaedic 1
ENT 1
6.2.5 Data Analysis
A qualitative content research analysis—an inductive thematic analysis—is con-
ducted. The interviews were semi-structured and followed key questions to define
the area of exploration and guide the participant through the session.
The process included the following steps (steps 5–9 are taken from [221]): (1) plan
the study; (2) collect data; (3) transcribe and summarise each participant’s interview
notes; (4) compare notes with the translator; (5) familiarise ourselves with the data;
(6) extract initial codes; (7) group the information thematically; (8) revisit the
data to review the themes; and (9) name the themes. This includes the coding of
the text, sorting of these codes, and categorising the statements of the respondents
towards themes. The extracted codes are manifested in the individuals’ answers;
personal interpretation is kept to a minimum at this stage. Inductive thematic
analysis is data-driven, which broadens the possible findings beyond the researcher’s
specific area of interest [221]. We further grouped the themes by doctors and affected
individuals to allow for a discussion about the differences between them. Finally, we
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provide an overall discussion about the themes and the relationships among them.
To provide a rigorous research, we included both genders for doctors and affected
individuals to provide a rich sample of studied perspectives. During analysis, we
revisited codes, categories, and themes to objectively extract our findings [222].
Selected interview notes are presented in our results to provide support for the
extracted themes.
6.3 Results
In this section, we present the results of our thematic analysis. The analysis revealed
six general themes: sleep problems, causes, impacts, assessments, treatments, and
technology usage. Moreover, subthemes related to the overarching theme were iden-
tified (for details, refer to Figure 6.1). For readability and anonymity, we introduce
an abbreviation—an ID—for each interviewee. The participants are categorised as
either a doctor ‘D’ or an affected individual ‘P’ and numbered to create an individual
ID. For example, D2 relates to a doctor with the ID-number 2. It should be men-
tioned that the included notes are not direct quotes but rather general sentiments.
We indent the notes and include the person’s ID, medical condition/expertise, and
gender at the end of each note.
Sleep 
Problems
Falling Asleep Staying Asleep Getting Back to Sleep 
Physical
Mental
Normalisation
Impact
No
Assessment
Talking
Sensor-Based
AssessmentCauses
Associated 
Mental Health
 Condition
Environmental
Factors
 
Associated
Physical
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Associated 
Disease
 
Treat Cause
Preventive
Self-Treatment
 Lifestyle 
Approach
Experiences
Treatment
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Treatment
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Figure 6.1: Thematic analysis for sleep perspective of doctors and affected individ-
uals.
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6.3.1 Sleep Problems
All affected individuals report that their sleep is troublesome.
... sleep is very bad (P7, Cancer, Male)
... sleep is heavily affected (P9, Cancer, Male)
... do not sleep very well (P5, Stroke, Male)
People generally report similar sleep issues concerning falling asleep, staying asleep,
and getting back to sleep. In Figure 6.2, we can see that for affected individuals
all three categories are equally common, while for doctors falling asleep issues are
reported more frequently. This can likely be attributed to the doctors treating more
patients that had a stroke, as stroke patients suffer from insomnia more often [89].
In the following subsection, we will provide examples and details for these three
sleep problem classes.
Figure 6.2: Statistics for the reported sleep problems from affected individuals (outer
circle) and doctors (inner circle).
(a) Falling Asleep
Doctors and participants agree that falling asleep is an issue. It is perceived by
many affected individuals independent from their condition:
It takes more than 30 minutes to fall asleep without medication (P1,
Insomnia, Female)
... huge problems falling asleep (P8, Cancer, Male)
... difficult to fall asleep (D1, Neurology, Female)
150
6.3. RESULTS
Interviewees use words such as “huge” and “difficult”, demonstrating the severe
impact of their medical condition on their sleep. For some, it is an persistent issue,
but appears not every day.
1–2 times per week, hindered ability to fall asleep (P11, Arthritis, Male)
(b) Staying Asleep
Sleep quality is strongly connected with sleep fragmentation, i.e., staying asleep
throughout the night is essential to provide an individual with a good rest. However,
many interviewees reported trouble staying asleep.
Wakes up every 1–2 hours (P3, Stroke, Male)
Wakes up three times each night ... has shallow sleep (P1, Insomnia,
Female)
... wakes up a lot (P7, Cancer, Male)
Individuals wake up often during the night (D3, Rehabilitation, Female)
(c) Getting Back to Sleep
When a person wakes up, it is often perceived as challenging to fall asleep again.
Doctors are aware of this often-reported issue.
It takes 2–3 hours to fall asleep again (P1, Insomnia, Female)
... cannot fall asleep again (P5, Stroke, Male)
... hard to fall asleep again (D4, Rehabilitation, Female)
6.3.2 Causes
The perspective of affected individuals is the most relevant, as they can explain
present sleep symptoms and their relation to other chronic-disease-related symp-
toms they face. Doctors are able to provide an overall view on potential causes.
Some interviewees see their sleep issues as being related to their mental health, en-
vironment, physical condition, or disease. In Figure 6.2, the main cause for sleep
issues is reported to be the disease or comorbidities affected individuals are suffering
from, followed by the physical condition and environmental influence aspects. For
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doctors the main reported cause is the physical condition, followed by associated
diseases. Mental Health and the environment can have an impact as well. Each of
the different causes are further discussed in the following subsections.
Figure 6.3: Statistics for the causes from affected individuals (outer circle) and
doctors (inner circle).
(a) Associated Mental Health Conditions
Doctors mention mental health associations.
Insomnia is often caused by mood and pressure in young adults (D1,
Neurology, Female; comment: mood refers to anxiety and depression)
Post-stroke depression can cause sleep issues (D1, Neurology, Female)
(b) Environmental Factors
Environmental factors affect sleep directly and are reported by many individuals
and doctors.
Light and noise influence sleep immensely (P7, Cancer, Male)
Waking up is caused by the environment, like when my granddaughter
is playing (P2, Insomnia, Male)
(c) Associated Physical Conditions
People also mention physical conditions as a cause of sleep issues, such as sleep
positions, nocturia, pain, and lifestyle habits, refer to Figure 6.4. The statistics show
a quite similar distribution for doctors and affected individuals the only difference is
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that positioning is mentioned by doctors as associated physical condition. Overall,
pain is the main cause for sleep issues followed by nocturia, and changes in lifestyle
habits.
Figure 6.4: Statistics for the associated physical conditions from affected individuals
(outer circle) and doctors (inner circle).
Sleep positions are mentioned by one of the doctors in relation to breathing issues.
Positioning affects breathing while asleep (D2, Ear-Nose-Throat, Male)
Furthermore, nocturia is mentioned mainly by individuals who have suffered a
stroke.
... need to go to the bathroom (D3, Rehabilitation, Female)
... need to release during the night is directly connected to sleep issues
(P4, Stroke, Male)
Pain as an influence factor is controversial among affected individuals and doctors.
Doctors relate sleep issues to specific pain levels but individuals report issues at
lower thresholds.
... exists a relationship between sleep issues and pain (P11, Arthritis,
Male)
... suffers from sleep issues (P9, Cancer, Male, Pain Level: 4)
Some doctors have a different opinion on pain in relation to sleep.
Very seldom do patients awake because of pain (D7, Arthritis, Male)
Sleep issues related to pain start at a pain level of seven (D6, Oncology,
Male)
Lifestyle habits are another cause, as well as a consequence, of sleep issues.
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...being bound to the bed is why I developed insomnia (P2, Insomnia,
Male)
Getting up and going to sleep very early decreases sleep issues (D1,
Neurology, Female)
Sleep quality improves when going to be early (P1, Insomnia, Female)
(d) Associated Diseases
Affected individuals often suffer from comorbidity, which is mentioned as one of the
leading causes of sleep issues along with chronic diseases generally.
There exists a relationship between most chronic diseases and sleep issues
(D1, Neurology, Female)
Stroke is strongly related to sleep (D3, Rehabilitation, Female)
Sleep is affected by high blood pressure (P5, Stroke, Male)
Hypertension is related to sleep issues (P6, Stroke, Male)
Some individuals mention that certain conditions do not relate to sleep issues
Cancer does not influence insomnia; no relationship between diabetes
and sleep issues (P1, Insomnia, Female)
Only 10–15% of stroke patients have sleep issues (D4, Rehabilitation,
Female)
6.3.3 Impact
In general, bad sleep affects individuals’ daily lives and their perceived health status.
(a) Influences on the Next Day
Most of the affected individuals reported influences on the next day.
Next day is considerably influenced by bad rest (P4, Stroke, Male)
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(b) Mental Condition
Sleep issues can cause mental health issues, such as hallucinations, anxiety, and
feeling annoyed, refer to Figure 6.5. In the statistics, we can see that sleep is often
reported by doctors and affected individuals to impact anxiety, while feeling annoyed
is only reported by affected individuals. Hallucinations can be caused by sleep issues
as well and are reported by doctors and affected individuals.
Figure 6.5: Statistics for the impacts on mental health from affected individuals
(outer circle) and doctors (inner circle).
Sleep issues can cause mental health disorders, such as visual hallucina-
tions and anxiety (D1, Neurology, Female)
... dreams often ... sometimes affected by anxiety (P1, Insomnia, Female)
Sensitive nerves (P7, Cancer, Male)
Individuals feel anxiety and often feel worried (D3, Rehabilitation, Fe-
male)
... feels annoyed and depressed the next day (P2, Insomnia, Male)
... feels miserable (P9, Cancer, Male)
Furthermore, people can feel hopelessness and despair.
... sickening feeling during the day (P8, Cancer, Male)
Daily life considerably affected (P4, Stroke, Male)
The situation is uncomfortable (P6, Stroke, Male)
Sleep is heavily affected (P9, Cancer, Male)
Affected individuals are concerned with their family’s perspective of their state.
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Family members would describe me as not anxious and not depressed,
while my perception is the opposite (P1, Insomnia, Female)
My family would describe me as being moody (P2, Insomnia, Male)
(c) Physical Condition
Physical condition is reported as affected the next day. The impact on the physical
condition is shown in Figure 6.6. We can see that affected individuals only report
feeling tired the next day and dizziness likely caused by blood pressure issues. Doc-
tors further report the influence on the reaction time, which is reasonable as after a
bad rest, affected individuals are often exhausted and have concentration issues [36].
Figure 6.6: Statistics for the impacts on physical conditions from affected individuals
(outer circle) and doctors (inner circle).
Feeling tired after getting up (D1, Neurology, Female)
Exhausted and no strength the next day (P3, Stroke, Male)
Difficulty getting up (P5, Stroke, Male)
Dizziness has already led to multiple falls (P1, Insomnia, Female)
Slow reaction time (D1, Neurology, Female)
(d) Normalisation
Affected individuals tend to normalise their condition [69].
P1 explains that she was a pig farmer. Therefore, she is used to being
tired. She does not care a lot about sleep and states that her life is not
affected too much. It is a phase that started to get worse in the last few
months (P1, Insomnia, Female)
156
6.3. RESULTS
Insomnia has phases (P2, Insomnia, Male)
Responses suggest that some individuals get used to insomnia. For example, P1
mentioned that her daily life is not affected, as she was used to heavy work and, as
a consequence, being tired. Doctors who are not directly involved in assessing sleep,
but who specialise in a chronic disease, often normalise the sleep condition of their
patients.
People are often sick and tired, so they most often do not have sleep
issues (D4, Rehabilitation, Female)
6.3.4 Assessment
In general, three types of assessment are conducted by doctors: no assessment,
talking, and sensor-based assessment, where no assessment is the most common, for
details, see Figure 6.7.
Figure 6.7: Statistics for the used methods for assessment from doctors.
(a) No Assessment
Most commonly reported was that no sleep problem assessments take place.
In general, no assessment is used (D3, Rehabilitation, Female)
Some doctors are also aware that current methods are not promising and a change
is necessary, others make aware of the difficulty of assessment for certain patient
groups.
No questions are asked about sleep but would be necessary (D4, Reha-
bilitation, Female)
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Difficult to communicate with patients (D3, Rehabilitation, Female)
(b) Talking
Talking with an individual can provide insight into their issues and symptoms. Doc-
tors typically talk with their patients but do not make scaled assessments.
Talking face-to-face with the patient as part of a psychological assess-
ment is the method used to assess sleep issues (D3, Rehabilitation, Fe-
male)
(c) Sensor-Based Assessment
Sensor-based assessment involves various sensors applied to the body. This usually
takes place in a laboratory under the observation of a specialist.
For patients with breathing issues, a two-part assessment is done during
a sleep-lab assessment. First, sleep quality is assessed based on sleep
stages, awakenings, and oxygen levels. Second, a trend picture over time
is created from the collected data (D2, Ear-Nose-Throat, Male)
No sensor-based assessment is done (P1, Insomnia, Female)
6.3.5 Treatment
Treatment is essential for affected individuals as their life is severely impacted by
their issues. We discuss in this section the different treatment methods shown in
Figure 6.8. Especially common for affected individuals is self-treatment, followed
by treating the cause usually with medication, and changing the lifestyle. Rarely
preventative medication is reported by affected individuals, even though, it is com-
monly reported by doctors. This could come from people not being aware of their
preventative treatment.
(a) Self-Treatment
A common method among our interviewees is self-treatment.
... uses traditional Chinese medicine; moving to another province im-
proved sleep quality (P2, Insomnia, Male)
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Figure 6.8: Statistics for applied treatment methods from affected individuals (outer
circle) and doctors (inner circle).
Going to bed early improves sleep quality (P1, Insomnia, Female)
Change in the environment would help (P6, Stroke, Male)
(b) Preventive
Preventive methods are used to treat an issue before it appears.
Preventive medicine is given to patients (D3, Rehabilitation, Female)
Patients receive medication easily to sleep better, to keep them fit for
the next day (D4, Rehabilitation, Female)
Traditional Chinese medicine is used for prevention (P1, Neurology, Fe-
male)
(c) Lifestyle Approach
Changes in sleep hygiene can improve a person’s sleep quality and is used as a
treatment.
Suggestions are given to improve health, such as exercising, listening to
music, communicating with friends, bathing feet in hot water, drinking
milk, and going to bed at the same time (D1, Neurology, Female)
Lose weight, stop smoking, and stop consuming alcohol are suggestions
to improve sleep issues (D2, Ear-Nose-Throat, Male)
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(d) Treat the Cause
The cause is usually treated when pain occurs and is seen as the reason for sleep
issues.
Pain killers are the treatment; no pain means no sleep issues (D5, On-
cology, Male)
Medications, such as sedatives, are given to patients with medical conditions.
A combination of antidepressants and sedatives are given to patients
(D1, Neurology, Female)
... receives medication (P4, Stroke, Male)
(e) Experience
Doctors point out that there is a lack of assessment and an issue with preventive
medication being too easily prescribed.
Patients are easily medicated to keep them fit for the next day of exercises
(D4, Rehabilitation, Female)
Affected individuals have positive and negative experiences with treatment. Some
see treatment as effective.
Treatment helps (P9, Cancer, Male)
Treatment and medication help (P6, Stroke, Male)
Others do not see an improvement
Sleep issues arise even when on medication (P4, Stroke, Male)
Medication does not change anything (P3, Stroke, Male)
6.3.6 Technology Usage
Most individuals have never used technology—only two have.
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(a) Diagnosis
For assessment and diagnosis, technology could be very useful. Doctors with patients
with sleep issues are keen to use technology and get insight into sleep behaviour.
As many details as possible would be helpful in the assessment process
(D1, Neurology, Female)
However, they also see disadvantages in current assessment methods and believe
there is a need for improvement. Figure 6.9 shows that doctors are in general
positive towards technology but see the need for change to make technology more
reliable almost as equally important.
Figure 6.9: Statistics for the opinion towards technology from doctors.
There are many elements in PSG. Significant education is necessary to
become a sleep expert who can analyse the data ... the automated
systems that are currently used are not reliable in detecting different
sleep stages and need to be controlled by human experts. Therefore, au-
tomation is not as accurate as human assessment (D2, Ear-Nose-Throat,
Male)
(b) Treatment
While most of the interviewees did not have experience with devices, some did report
the use of technology.
Blood sugar screening testing performed at home (P1, Insomnia, Female;
comment: P1 did not view this as using technology)
The effectiveness of certain devices and new potential use cases were pointed out.
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Technological device to stimulate the body described positively as being
useful (P5, Stroke, Male)
No real issue if the pain level is measured, controlled, and treated; Tech-
nology could help in this aspect (D5, Oncology, Male; comment: D5
refers to tools which assess pain levels as technology)
6.4 Discussion
In this section, the findings are discussed and their relation to literature is examined.
6.4.1 Sleep Problems
Poor sleep quality is an issue for people living with a chronic disease [81] and has
been reported by all of our interviewees. Our findings indicate that sleep quality
affects people living with specific chronic diseases differently. There are three major
sleep issues that are reported by affected individuals and doctors: problems falling
asleep, problems staying asleep, and issues falling asleep after waking up.
6.4.2 Causes and Impacts
We focus our scope to analyse affected individuals’ perspectives of sleep and their
condition. Note that there are still other influence factors for sleep issues.
Arthritis and joint pain are directly related to sleep issues [91]. This relation is
in line with our findings. We found that cancer-affected individuals report pain as
a cause for awakening; this is supported by literature [67, 90]. Strokes have also
been shown to influence sleep [89], which is supported by our findings (especially by
participants with nocturia).
Insomnia-affected individuals have a very subjective perspective on their sleep. They
misjudge specific objective symptoms as being more severe by, for example, over-
estimating SOL and underestimating total sleep time [68]. Nevertheless, insomnia
symptoms are often trivialised [69], which is likely a cause behind affected indi-
viduals normalising their condition. For example, P1 denied that she was affected
by insomnia but mentions symptoms including dizziness and fatigue. Interestingly,
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there is an apparent gap in perspective between family members and affected indi-
viduals. For example, P1 describes herself as having anxiety but says that family
members would describe her as neither depressed nor anxious.
In our interviews, environmental factors were often mentioned as a cause for sleep
issues. This is likely due to the fact that people are more aware of their environment
because they suffer from shallow sleep.
Our findings suggest that sleep issues are related to specific mental and physical
conditions, including hallucinations, sensitive nerves, and feeling annoyed. The feel-
ing of being annoyed is likely caused by feeling tired and weak. Doctors mentioned
hallucinations, though affected individuals mainly referred to them as dreams.
Chronic diseases clearly influence sleep behaviour; on the other side, poor sleep
affects peoples’ daily lives and increases the risk of developing a chronic disease [80,
85]. In this study, all participants with various chronic diseases had sleep issues; most
reported effects in their daily life. In conclusion, knowledge about the relationship
between sleep and chronic diseases could enable data analytics to effectively diagnose
medical conditions using sleep behaviour data (refer to Chapter 7).
There are many reasons why sleep issues are worth considering. For example, people
suffering from cancer and arthritis often claim that they wake up or have difficulty
falling asleep due to pain. Difficulty falling asleep could also be a sign of insomnia.
6.4.3 Assessment and Treatment
Treatment of sleep issues is not always adequate and medication is provided easily;
behavioural change therapy is rarely suggested [90]. The main problems here are (1)
failure to employ assessment methods and (2) preference of preventive medication.
For some doctors, especially those who specialise in stroke and rehabilitation, it
is challenging to communicate with their patients, as their diseases often make it
difficult for them to communicate effectively. Many other fields simply view sleep
assessment as unnecessary, likely because doctors receive no instruction on it. Some
doctors see the importance of changing the current approach with stroke patients.
Many affected individuals treat themselves with traditional Chinese medicine and
lifestyle changes. They try out various things to help them improve their sleep.
Doctors also suggest lifestyle changes to their patients. Our interviews suggest that
people are largely open to self-assessing and self-managing their sleep issues. This
could be realised through the assessment tools we developed in combination with a
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self-management approach, which could be developed in the future.
Affected individuals react differently to the same treatments. This suggests that it
is best to follow a personalised approach in order to consider the individuality of
each person.
6.4.4 Technology Usage
Most affected individuals in our study had a positive opinion towards technology
despite having had limited exposure to it in the past. The individuals who had
used devices for treatment reported positive effects. Doctors saw the advantage of
technology in assessment and treatment, as it provides more information to help
diagnose sleep diseases, assess pain levels, and adjust treatments. They also pointed
out the importance of improving current technologies, such as sleep stage detection,
to make them more reliable.
6.4.5 Differences in Doctors’ and Affected Individuals’ Per-
spectives
Overall, doctors and affected people mostly agreed on the discussed topics, but some
notable differences were observed.
Doctors often had perspectives of their patients’ sleep status that differed from the
affected individuals’ perspectives. Especially for participants with cancer, doctors
did not seem concerned about their sleep issues. They claimed that cancer-affected
individuals are only affected from a specific pain level threshold upwards, but affected
individuals claimed that they faced issues at lower pain levels. Most of the doctors
are generally not very concerned about sleep issues and are not instructed to assess
patients’ sleep quality. Only some doctors are aware of the current lack of assessment
and would like to see a change from the standard of liberal medicating to cause
assessment and treatment.
Technology was observed differently. Affected individuals felt positively about tech-
nology if they had experience with it; otherwise, they had no opinion. Doctors also
felt positively but were often keen to point out issues in current technology and
suggest areas for improvement.
Sleep assessment for individuals with a chronic disease is essential, as shown through
our interviews. There is clearly a connection between chronic diseases and sleep
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issues. In our research, it was commonly reported that chronic diseases change sleep
behaviour. There is a significant gap between the awareness of affected individuals
regarding their sleep issues and doctors’ responses.
6.4.6 Limitations of the Study
This study was performed in just one hospital, potentially creating a bias in terms
of race and ethnicity.
Gender was equally distributed for doctors but has a strong bias towards males for
affected individuals. We did not investigate the gender difference in the perspective
of sleep issues. However, there certainly could be differences, as women and men
often perceive symptoms differently. It was shown in [223] that biological factors
drive gender differences in sleep behaviour and disorders.
A translator was necessary for the interviews; the interviewer and interviewee did
not share a cultural or language background. No audio data were recorded, as this
was preferred by interviewees. The language barrier and lack of recordings together
constitute limitations and surely influenced our results to some degree. Verbatim
analysis from audio recordings constitute a more in-depth investigation, and with
translations a certain mode of expression can be lost. This was counteracted, how-
ever, by comparing the notes taken by the translator and interviewer after each
session, where discrepancies were addressed by consulting the translator. The sam-
ple of 18 participants is small, but our main goal was to capture general impressions
from a diverse group; for that, our sample was certainly sufficient.
6.5 Summary and Future Directions
The chapter contributes to knowledge by developing an in-depth understanding
of relevant stakeholders perspectives on sleep. Doctors’ and individuals’ opinions
strongly matched on the sleep issues we asked about. Some doctors, however, were
unaware of their patients’ sleep issues or were not equipped to assess them any fur-
ther. As expected, the reported daily life effects and sleep issues varied based on
participants’ conditions; this is in line with the literature. The environment was
often mentioned as a strong influence factor, likely due to shallow sleep. Incorpo-
rating daily technology is essential for experts in the field, but users in our study
were hardly familiar with technology, so it was not an aspect we could pursue.
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Our findings confirm the results on sleep stages from Chapter 5—health status defini-
tively plays a role. Our findings in Chapter 5 are in line with other studies on changes
in sleep architecture stemming from certain chronic diseases [77, 78]. Additionally,
we found that many current experts are not convinced regarding the reliability of
automated sleep stage detection for PSG, as it requires an experienced scorer. Our
fine-grained sleep stage recognition system aims to improve sleep stage recognition
in a natural environment to avoid these doubts over reliability. Furthermore, one of
the doctors we interviewed emphasised the importance of home-based, IoT-enabled
assessment, which supports the design of our framework in Chapter 3. Sleep po-
sitions were mentioned as an influence factor for sleep quality, which confirms the
importance of our investigation on higher-granularity sleep positions in Chapter 4.
The findings encourage investigations into technology for sleep behaviour assess-
ment and remote diagnostics. Sleep can change and affect daily behaviour as a
result of chronic diseases. These effects can be used to explore further sleep and
wake behaviour in relation to chronic disease detection, which we investigate in
Chapter 7. Importantly, the work is a starting point to investigate individual needs
and differences in perspective among doctors and affected individuals in more depth.
We found that the individuality needs to be considered to provide effective treat-
ment and assessment (which we also stressed to a certain extent in chapters 3 and
5). Additionally, our findings suggest that self-assessment could minimise improper
treatment approaches, such as preventive medication.
In the following chapter, we investigate the possibility of automating chronic disease
detection from sleep-wake behaviour. Based on our findings, we develop a home-
based approach that detects the onset of chronic diseases. This approach can be
used in our framework to provide a personalised and user-centred tool.
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Chronic Disease Detection from
Sleep-Wake Behaviour
7.1 Introduction
In sections 2.2 and 2.4.5, we reviewed research on medical conditions and sleep
that suggested a bidirectional and complex relationship between them. It has been
clinically observed that people suffering from chronic diseases, such as diabetes [21,
26], CKD [32], hypertension [79], arthritis, and stroke [26], usually have trouble
with sleep, such as difficulty falling or staying asleep and daytime sleepiness [26].
Our findings in Chapter 6 are clearly in line with the literature, as they show (1)
relations between sleep behaviour and chronic disease as well as (2) the need to
detect changes in circumstance (diseases). The relationship between chronic disease
and sleep behaviour is recognised by both doctors and affected individuals. Many
chronic diseases show evidence of correlations with sleep-wake behaviour and there
is a rising interest in making use of these correlations for early warning systems.
The diagnosis and early detection of medical conditions would lead to earlier starts
for clinical interventions [70] and, therefore, an increased likelihood of success [41].
It is not possible to monitor sleep information flow continuously through traditional
medical channels (doctor or hospital visits). Therefore, to reduce healthcare costs
and improve lives, we propose a home-based monitoring system that is optimal
for both patients and doctors. Our proposed framework is capable of continuously
monitoring sleep and adapting to users’ changing circumstances (e.g., developing
a chronic disease). To provide this functionality, changes in circumstances must
be assessed as soon as possible; the integration of a system capable of detecting
changes in circumstances is essential. Already-known relationships with sleep-wake
behaviour could be used to predict chronic diseases.
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In this chapter, we address objective 8 by developing a method for chronic disease de-
tection that entails mining sleep-wake behaviour with deep learning. Specifically, an
LSTM is designed for this investigation, as it is able to deal with temporal data and
multi-dimensional features. The differences between diseases are likely manifested
in (1) the actigraphy sleep-wake patterns of the individuals, comprising information
of the SE and sleep duration [131]; and (2) the clinical feature characteristics, such
as BMI. Therefore, with actigraphy, features are extracted from consecutive days of
monitoring and then enriched with data on patients’ clinical history. The fusion of
medical knowledge (existing correlations between clinical history and chronic disease
development) with computational technology creates a strong basis to detect early
and advanced stages of various chronic diseases. The backbone of our approach is
made up of the multi-dimensional clinical data features.
This chapter contributes to the literature in two ways. First, we apply a compu-
tational technology that makes decisions from objective measurements. We design
LSTMs specific to our investigations of interest. In contrast to previous work [18],
our use of LSTMs enables us to incorporate the temporal aspects of the actigraphy
data. Second, we fuse clinical history and actigraphy data to introduce a multi-
dimensional feature vector. By fusing these data, we make use of existing medical
knowledge. Furthermore, we perform tests on multiple chronic diseases. We anal-
yse our results in depth by exploring significant differences in clinical features for
correctly- and incorrectly classified individuals. These clinical features indicate a
relationship with different disease stages and likely contain additional information.
Through this novel approach, we address the challenges facing chronic disease de-
tection and the limitations of previous work. These limitations include the lack of
(1) fusion of medical knowledge with computational technology; (2) investigations
into early disease detection; and (3) implementation of a reliable method that can
handle temporal data. This approach contributes to the emphasis and personalisa-
tion layers of our sleep behaviour assessment framework. Furthermore, adjustments
to changing circumstances in our framework’s modular design become feasible for
chronic-disease-affected individuals with this approach.
In Section 7.2, we describe the approach for chronic disease detection, including the
initial method configuration. In Section 7.3, we explain the dataset and describe
the test settings. Section 7.4 presents the results, which are further discussed in
Section 7.5. Finally, Section 7.6 offers a summary of the work and future research
directions.
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7.2 Chronic Disease Detection Approach
In this section, we present an approach to detect chronic diseases in early and
advanced stages, considering sleep-wake behaviour and clinical history data. In
other words, medical knowledge and computational technologies are fused to enhance
current diagnostic decision-making.
Sleep-wake behaviour can be measured continuously using an actigraph unit to pro-
vide time-series data. Time-series data are data that have time dependency; in our
case, those are activity counts and white light data. Activity counts indicate the
intensity of activeness over time. White light tells us the level of light at a specific
time, helping to judge the day-night rhythm. In order to detect anomalies in sleep
patterns, longer time periods must be considered, because looking at one-day solely
cannot reflect the indicators of regularity. We decided on a deep learning method for
time-series data classification—an LSTM (as described in Section 2.4.1). An LSTM
can learn temporal dependencies in observations. It can link causes over time, as the
method allows for continuous learning by applying gates which are able to memorise
information [155, 156]. This is a key aspect that other machine learning algorithms
lack; they are unable to handle delayed or sparse indications. Time-series data
has already seen success in diagnostics [158], following an architecture described by
Graves et al. [224].
We designed a specific architecture for the LSTM method presented in Figure 7.1.
First, embedding is performed by applying a word-2-vec method for the time-series
data (activity counts and white light). Embedding can extract useful features to
reflect similarities and relationships within data. Originally, words are translated
into a vector representation [225, 226]. Activity counts and white light data are
used as inputs for the word-2-vec approach to improve the results. The technique
converts the data into a smaller set of easier-to-use features, which are then used
as inputs for the LSTM [225, 226]. Second, the extracted embedding features are
fused with another source of information: clinical history data. Clinical history
data are used as additional constant features over the entire time-series per person.
This means, at each time point, the clinical history information stays the same
per individual. Details on the features used can be found in Section 7.3.2. The
combination of actigraphy data and clinical history data is used as an input for the
LSTM. Third, the LSTM design is followed. The design is key to provide success
and avoid overfitting. Various techniques can counteract overfitting. We integrated
some of them into our design: (1) regularisation methods such as dropout and
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(2) a balance between a powerful and, therefore, larger network (more layers and
neurons) and the issue of overfitting, which is more likely when more parameters
should be learned from fewer data. Therefore, a complex problem, such as in our
case, requires multiple hidden layers. Our LSTM consists of three LSTM layers,
each using a dropout strategy for training followed by a dense layer to flatten and
fully connect. Dropout is used to ignore neurons during the training phase and
prevent overfitting [227]. The rate of dropout can be set between 0.0 to 0.9 (0.0
correlates to no dropout). For example, setting the dropout rate to 20% means that
two in ten inputs will be randomly excluded. Dense layers apply a matrix-vector
multiplication, resulting in a transformation of the data into a lower-dimensional
feature vector. The last step is a softmax activation, which normalises scores to
probabilities for classification of two or three classes. Two classes are (a) diseased
and (b) healthy, and three classes are (a) pre-disease-affected, (b) diseased, and
(c) healthy. The two-class problem sees disease detection distinguishing between
affected and healthy individuals, whereas the three-class problem sees early disease
detection distinguishing between affected, pre-disease-affected, and healthy.
 time-series data
Embedding
activity score
white light
clinical data
...
...
...
LSTM LSTM LSTM
Dense layer
 
2 classes3 classes
disease- 
affected
healthy
disease- 
affected
healthy
pre-disease- 
affected
Softmax layer
dropout dropout dropout
Figure 7.1: The LSTM architecture for disease detection.
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7.3 Evaluation of the Proposed Chronic Disease
Detection Approach
In this section, we discuss the used data and pre-processing and describe the tests
performed to evaluate the approach.
7.3.1 Datasets
For our investigation, we use the HCHS dataset described in Section 3.4.1. The
actigraphy data are available in 30-second intervals, which provides 2,880 activity
count values per day (30 seconds x 2 per minute x 60 per hour x 12 per day =
2,880). The data for six consecutive days per person are used in our analysis.
This is necessary to provide a balanced dataset for training purposes, as not all
participants have seven full days of data. Initial results show that using the same
amount of data for each individual results in better outcomes, which is in line with
previous work [18].
The proof of concept is investigated for four different chronic diseases and conditions:
(1) diabetes, (2) hypertension, (3) CKD, and (4) sleep apnoea. These are divided
into three different classes each: (a) healthy, (b) pre-disease-affected (early stage),
and (c) diseased (see Figure 7.2(a)). Healthy means they do not have the disease
investigated for the specific classification task but can be affected by another disease.
In the used dataset only two classes are available for hypertension.
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Figure 7.2: (a) The number of people per disease separated by healthy, mildly
affected, and affected. (b) Comorbidities in the dataset based on diabetes, apnoea,
CKD, and hypertension.
(1) Diabetes is characterised by hyperglycemia [228]. Pre-diabetes is defined as the
elevation of plasma glucose above the normal range but below that of clinical di-
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abetes [228]. People affected by diabetes are more likely to have trouble sleeping
due to the heightened glucose level that influences sleep. Furthermore, lethargy
and insomnia can be caused by diabetes [229]. (2) Hypertension is defined by ab-
normal blood pressure. Hypertension is classified by a systolic pressure of 140 mm
Hg or higher or a diastolic pressure of 90 mm Hg or higher [74]. Hypertension is
associated with habitual short sleep duration. Furthermore, insomnia is correlated
with increased hypertension risk [79]. (3) CKD is a severe health problem defined
as kidney damage and is divided into five stages indicated by glomerular filtration
rate [76]. In our analysis, only stages one and two are investigated. A wide range of
symptoms affects the patients leading to, e.g., fatigue, sleep disturbances, restless
legs, and increased urination during the night [32]. (4) OSAS is defined as the upper
airways becoming repeatedly blocked during sleep [64]. Classification is based on
the AHI, where the events per hour are given. In our use-case, >4% oxyhemoglobin
desaturation is used for the AHI rating. In the test case, three groups were used:
no, mild, and moderate to severe apnoea (for a full description see Section 2.2.3).
In Figure 7.2(b), the number of people in the dataset with more than one disease
and the various combinations of them are provided (e.g., apnoea and diabetes, or
diabetes and hypertension). Many comorbidities are present, though some are more
prominent than others and, therefore, can influence the classification, as the healthy
people can potentially be affected by another disease. However, this is not within
the scope—we do not consider comorbidities during our classification.
To give an overview of the data and the individual differences, circle plots are given
between affected and healthy individuals in Figure 7.3. The plots show activity
count data (green) over the intervals of being awake (grey) and asleep (red) over
seven consecutive days. Yellow stands for unavailable data due to differences in the
end times. The plots illustrate non-diabetes-affected (Figure 7.3(a)) and diabetes-
affected (Figure 7.3(b)) as well as hypertension-affected (Figure 7.3(c)) and apnoea-
affected (Figure 7.3(d)). The images depict data from affected individuals (note,
not the pre-disease-affected individuals). These images are examples of individuals
classified correctly by our approach. Note that there are personal differences between
individuals but that general conclusions can still be drawn for specific disease groups,
as the results will show in Section 7.4. The use of diseased and healthy individuals
is an approach applicable to the real world, because often not all underlying diseases
are known. It should be mentioned that this results in a group of individuals who do
not have the specific disease but can also not be classified as fully healthy (e.g., they
can be unaffected by apnoea but still have diabetes, as comorbidities are common;
refer to Figure 7.2(b)).
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(a) Unaffected by diabetes (b) Affected by diabetes
(c) Affected by hypertension (d) Affected by apnoea
Figure 7.3: Differences in individual sleep patterns affected by different diseases over
seven days; activity counts shown in green; sleep shown in red; wake periods shown
in grey; absence of available data indicated by yellow.
7.3.2 Processing
Data of interest needs to be pre-processed, including (1) actigraphy data (activity
levels and white light) and (2) clinical data, such as BMI, family history of dia-
betes, and presence of hypertension, diabetes, or asthma. Activity levels and white
light data are used for all disease-specific tasks and applied clinical history data
are adapted to each disease. For CKD, risk factors include diabetes, high blood
pressure, and obesity [230]; as a result, these factors are included as clinical history
information (diabetes, hypertension, and BMI). For sleep apnoea, comorbidities are
typically obesity, diabetes, hypertension, and sometimes asthma [231]; therefore, the
corresponding factors are included as clinical history information (BMI, diabetes,
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hypertension, and asthma). For diabetes, obesity and family history of diabetes are
important [232] (BMI and family history of diabetes). For hypertension, obesity and
diabetes are relevant [233, 234]; that is reflected in the clinical history information
(BMI and diabetes).
The data is normalised for training and testing during the classification process.
7.3.3 Chronic Disease Detection Analysis
In this chapter, an LSTM approach is followed. We are mainly interested in compar-
ing training and testing performances in different settings as well as investigating
potential features for improvements to the approach. Furthermore, we compared
our approach with existing results from Aggarwal et al. [18], which used CNNs. Our
approach differs in two ways from that of Aggarwal et al. [18]. First, we follow a
method designed for time-series data, and second, we incorporate clinical history
data to look at important relationships already established in the literature (refer
to Section 7.3.2).
As with any LSTM model, the parameters and the architecture (details in Sec-
tion 7.2) need to be adjusted empirically, which we did through initial experiments.
Therefore, multiple settings are investigated, including (1) number of neurons in the
hidden layer, (2) embedding settings, (3) dropout rate, and (4) different optimisers.
Based on initial experiments with various neuron sizes, we selected the following
layer sizes: 1st layer input size of [400+clinical history factors] and layer output
size of 200; 2nd layer input size of 200 and layer output size of 100; 3rd layer layer
input size of 100 and layer output size of 50. Furthermore, we chose a dropout rate
of 0.2 after experimenting with values between 0.0 and 0.9. To reach a batch size
that allows for training per person, the batch size for training and testing is six, as
six days are available per individual. Splitting the daily data from 2,880 sequences
into 180 (dimension per day, 180x16) or 240 (dimension per day, 240x12) implies
batch size training rates of 96 (16*6) and 72 (12*6), respectively (see Figure 7.4).
The sequence length of 2,880 (one day) was not used any further after initial tests
due to its long training time not resulting in increased accuracy. The model was
investigated with an Adam optimisation method [235], as initial experiments ruled
out Root Mean Square Propagation for our study. Embedding size was set empiri-
cally to 200, where only the activity levels and white light data are embedded. This
makes it possible to represent the data sequence in a feature vector [226] with size
200, creating an input vector for the LSTMs of size [400+clinical history factors]
consisting of 200 features for activity counts, 200 features for white light and the
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various clinical history factors for each disease (see details in Section 7.3.2). The
training process was stopped when loss did not decrease within eight intervals (with
a maximum of 50 epochs).
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Figure 7.4: Training batch size transformation for a sequence length of 180.
The first test investigates the optimal sequence length. The sequence lengths tested
were 180 and 240 for each disease-specific classification for two and three classes.
Repeatedly incorrect classification of certain participants indicates that we should
investigate the incorrectly classified participants in more detail to extract differences.
These differences can be viewed as potential sources for misclassification that can
be used as additional information for improving the classification approach. Par-
ticipants labelled as ‘incorrectly classified’ are those that were classified incorrectly
more than two times during testing. The significant differences in clinical history
factors are further investigated for incorrectly and correctly-classified diseased indi-
viduals. The clinical data were investigated using an independent two-samples t-test
for different means, variances, and sample size (Welch’s t-test). The independent
variable is diseased, correctly classified/diseased, incorrectly classified. The depen-
dent variable is one of 38 clinical factors pre-established from the available variables
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in the dataset [202, 236]. When using a significance level of 5%, different sets of
clinical factors can be extracted that have significant differences between the cor-
rectly classified and the incorrectly classified. These are provided with the p-value
of the statistical test. These parameters include, among others, BMI, family history
of diabetes, and hypertension.
The third test investigates the potential improvement that could be reached by
including the knowledge of having six days of data per person. This is done based
on (1) counts and (2) average. The data per person for a sequence length of 180 is
180x96. Method (1) counts how often a class is classified between, e.g., intervals of
length 96; the one with the highest amount, or the first one in the list if there are
two, is reassigned to the whole interval to 96 values. Method (2) takes the average
of the interval using a threshold of 0.5.
Furthermore, we compared the outcomes of the optimal scenario, based on the
sequence length test, with results from related work. In Aggarwal et al. [18], ‘task-
specific’ models are those that are trained end-to-end for the disorder task at hand;
‘multi-task learning’ models are trained jointly with all of the disorder prediction
tasks (insomnia, apnoea, diabetes, and hypertension).
To guarantee reproducibility, we repeat our experiments. The test results present
the averaged outcome for each test, which follows a leave-n-people-out approach.
The value n is 10% of the available diseased individuals for each disease-specific
classification. This means a 10-fold CV for participants is conducted (i.e., training
on 90% of the data and testing on 10%). Furthermore, each test is repeated six times,
meaning 60 validation performances are conducted. Per fold, the best ‘AUC’ and
best ‘accuracy’ of all epochs are chosen to give a 10-fold outcome that was averaged
over the six repeats (further referred to as ‘averaged best AUC’ and ‘averaged best
accuracy’). The reported outcomes are accuracy, precision, recall, F1 score, and
AUC.
The following investigations are performed: (1) disease detection based on a two-
class problem tested with different sequence lengths for apnoea, CKD, hypertension,
and diabetes; (2) early disease detection for diabetes and apnoea, detecting early
and advanced stages, resulting in a three-class classification problem tested with
different sequence lengths; (3) investigation of significant clinical history factors for
incorrectly and correctly classified diseased individuals; (4) improvement of accuracy
by including knowledge of six days of data per person; and (5) comparison of our
overall results to those from a related work.
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7.4 Results
In this section, the results of the different tests are presented for disease and early
disease detection.
7.4.1 Disease Detection
For disease detection, the LSTM approach is explored for a two-class classification.
We provide the performance and findings per disease. In Table 7.1, the performance
of each disease investigation is detailed. This includes the batch size as both 180
and 240 averaged over the best accuracy or best AUC; we also include here the
precision, recall, F1 score, AUC, and accuracy results.
Table 7.1: Results for different sequence lengths are given for the tested chronic
diseases. Each table shows the averaged CV outcomes for precision (P), recall (R),
F1 score, AUC with SD, and accuracy (acc), for ‘averaged best AUC’ and ‘averaged
best accuracy’ (refer to Section 7.3).
(a) Diabetes
Size Avg. P R F1 AUC(SD) Acc.
180 acc 0.70 0.77 0.73 0.75(±7e-3) 0.71
180 AUC 0.69 0.74 0.70 0.76(±7e-3) 0.69
240 acc 0.69 0.79 0.73 0.76(±0.02) 0.71
240 AUC 0.67 0.77 0.72 0.77(±0.02) 0.69
(b) Hypertension
Size Avg. P R F1 AUC(SD) Acc.
180 acc 0.60 0.64 0.61 0.60(±0.01) 0.60
180 AUC 0.58 0.60 0.58 0.60(±0.01) 0.58
240 acc 0.58 0.60 0.58 0.56(±2e-3) 0.58
240 AUC 0.55 0.57 0.55 0.57(±2e-3) 0.55
(c) Apnoea
Size Avg. P R F1 AUC(SD) Acc.
180 acc 0.82 0.77 0.78 0.82(±0.05) 0.79
180 AUC 0.79 0.75 0.76 0.85(±0.05) 0.77
240 acc 0.83 0.75 0.78 0.81(±0.07) 0.79
240 AUC 0.81 0.70 0.74 0.84(±0.07) 0.76
avg.- averaged over, acc.- accuracy
(d) CKD
Size Avg. P R F1 AUC(SD) Acc.
180 acc 0.80 0.71 0.73 0.72(±0.15) 0.75
180 AUC 0.75 0.63 0.66 0.78(±0.15) 0.69
240 acc 0.79 0.62 0.67 0.68(±0.07) 0.71
240 AUC 0.74 0.55 0.59 0.73(±0.07) 0.66
Diabetes Our experiments on ‘averaged best accuracy’ and ‘averages best AUC’
show that, for diabetes, similar results can be achieved with sequence lengths of 240
and 180; they result in an AUC of 0.76(±0.02) and accuracy of 0.71 for 240. A
length of 240 has a slightly higher SD than one of 180 (for ‘averaged best accuracy’;
see Table 7.1a). Therefore, the best sequence length based on accuracy and SD is
classified as the 180 sequence length case.
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Table 7.2: Significant clinical factors analysis outcome of the independent two-
sample t-test is given for each disease, based on the diseased incorrectly classified
and the diseased correctly classified individuals. ↑ indicates a higher level in the
incorrectly classified case and ↓ a lower level in the incorrectly classified.
Disease Clinical Factors(p-value)
Diabetes ↑ BMI(0.02) ↑ Fam. Hist. Diab.(2.1e-09)
↑ Pneumonia(0.018)
Hypertension ↑ BMI(1.8e-17) ↓ Total Drinks per Week(0.012)
↑ Apnoea/Hypopnoea Index(4.8e-05) ↑ Treatment of Hypert.(0.013)
↓ Alcohol Use (0.028) ↑ Physical Activity Level(0.036)
Apnoea ↑ BMI(2e-3) ↑ 4-level Hypertension(3e-3)
↑ Hypertension(1e-3) ↑ 3-level Diabetes(0.04)
↓ Diabetes Diag.(0.025) ↓ Antidiabetics(0.036)
↑ Antihypertensives(0.025) ↑ Cigarette Use(0.017)
↑ Hypertension Treatment(0.015)
CKD ↑ BMI(0.032) ↑ Antihypertensives(0.025)
↑ Hypertension(1.4e-3) ↑ Treatment of Hypert.(0.012)
↓ Airflow Limitation(0.044) ↑ Physical Activity Level(0.043)
↑ 4-level Hypert.(0.021) ↑ Stroke(0.036)
For diabetes detection, 120 diseased individuals are incorrectly classified as healthy
individuals over all tests and 205 are correctly classified as diseased. For the healthy
individuals, 107 are incorrectly classified from 325 individuals randomly selected
from all healthy individuals in the dataset (see Table 7.3).
Table 7.3: Counts for incorrectly/correctly classified individuals during testing for
diseased and healthy with a sequence length of 180; more than two times incorrect
constitutes incorrectly classified.
Disease Counts per Person
Healthy Affected
overall correct incorrect overall correct incorrect
Diabetes 325 218 107 325 205 120
Hypertension 475 349 126 475 332 143
Apnoea 85 72 13 85 62 23
CKD 60 49 11 60 43 17
In Table 7.2, three variables are significantly different in the diseased case compar-
ing correctly classified and incorrectly classified. These are BMI, family history of
diabetes, and pneumonia. The group that is incorrectly classified sees: (1) higher
average BMI (at 33.3, than the group that is correctly classified, at 31.6); (2) higher
family history of diabetes (0.9, almost double the 0.5 for the correctly classified
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group); and (3) higher pneumonia (0.22 over 0.12).
The results are improved when the knowledge of six days per person is incorporated.
This results in an accuracy increase of about 1%, to 72.5% and 72.7% for 180 and
240, respectively. This makes the combined score the best optimisation technique
for the diabetes case (see Table 7.4).
Table 7.4: Results when the knowledge of six days per person is incorporated.
Each entry shows accuracy calculated by using the highest count of labels per per-
son (counts) and the best score per person (average); details can be found in Sec-
tion 7.3.3.
Disease Size Accuracy Combined Amount Combined Score
(Counts) (Average)
Diabetes 180 0.714 0.725 0.725
240 0.712 0.726 0.727
Hypertension 180 0.603 0.615 0.620
240 0.578 0.587 0.589
Apnoea 180 0.794 0.813 0.810
240 0.791 0.808 0.800
CKD 180 0.750 0.756 0.767
240 0.709 0.728 0.722
Hypertension The performed comparison with Aggarwal et al. [18] shows that our
approach improves the precision, recall, and F1 score but can reach only similar
accuracy for sequence length 180 in the multi-task case (see Table 7.5).
Overall, hypertension performs least well for the two-class problems (see Table 7.1b).
The best outcome is achieved using 180; it results in an accuracy and AUC of 0.60
with minimal variation. Our investigation showed that there were 143 participants
incorrectly classified more than two times with sequence length 180 and 332 were
correctly classified as diseased. For the healthy individuals, 126 were incorrectly clas-
sified from a randomly selected 475 from all healthy individuals (refer to Table 7.3).
When using a significance level of 5%, six variables are significantly different be-
tween the diseased individuals who were correctly classified and those who were
incorrectly classified: BMI, alcohol use (yes/no), total drinks per week, AHI, treat-
ment of hypertension, and physical activity level (see Table 7.2). The group that
is incorrectly classified sees: (1) higher BMI (34 over 30 in the correctly classified
group); (2) lower total drinks per week (1.28 compared to 2.56); (3) higher AHI (7.5
over 3.9); (4) higher treatment of hypertension (0.62 over 0.5); (5) lower alcohol use
(2.05 compared to 2.23); and (6) higher physical activity level (2.52 over 2.4).
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Table 7.5: Comparison between task-specific and multi-task results from Aggarwal
et al. [18] and our results for apnoea, hypertension, and diabetes.
Experiment Model Precision Recall F1 Accuracy
Hypertension
Task-specific CNN 0.44 0.31 0.37 0.69
Multi-task CNN 0.48 0.41 0.44 0.61
180 LSTM 0.60 0.64 0.61 0.60
240 LSTMM 0.58 0.60 0.58 0.58
Apnoea
Task-specific CNN 0.31 0.63 0.42 0.55
Multi-task CNN 0.40 0.48 0.43 0.68
180 LSTM 0.82 0.77 0.78 0.79
240 LSTM 0.83 0.75 0.78 0.79
Diabetes
Task-spec CNN 0.40 0.51 0.45 0.41
Multi-task CNN 0.46 0.47 0.46 0.44
180 LSTM 0.44 0.58 0.50 0.47
240 LSTM 0.44 0.57 0.51 0.48
An improvement of 1–2% in accuracy can be achieved when using the combined
scores method, resulting in 0.59(240) and 0.62(180) accuracy (see Table 7.4).
Sleep Apnoea The best outcome for sleep apnoea can be reached using ‘averaged
best accuracy’, resulting in similar outcomes for sequence lengths of 180 and 240
(see Table 7.1c). An accuracy of 0.79 and an AUC of 0.82 can be reached. Our
investigation showed that there were 23 incorrectly classified as healthy and 62 cor-
rectly classified as diseased. For the healthy individuals, 13 were incorrectly classified
from 85 randomly selected participants from all healthy individuals. The incorrectly
diseased group has significant differences from the correctly diseased group in the fol-
lowing variables: BMI, 4-levels hypertension, hypertension, hypertension treatment,
3-levels diabetes, diabetes diagnosis, antidiabetics, antihypertensives, and cigarette
use (see Table 7.2). The incorrectly classified group sees: (1) higher BMI (38 over
33); (2) higher 4-level grouped hypertension (3 over 2.3); (3) higher hypertension
(0.8 over 0.4); (4) higher 3-level grouped diabetes (2.3 over 2.0); (5) lower diabetes
diagnosis (2.2 compared to 2.6); (6) lower antidiabetics (0.27 compared to 0.07); (7)
higher antihypertensives (0.47 over 0.2); (8) higher cigarette use (1.9 over 1.5); and
(9) higher hypertension treatment (0.6 over 0.3).
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An improvement to accuracy is depicted in Table 7.4 with the combined amount
technique reaching an accuracy of 0.813 and 0.808 for 180 and 240, respectively.
In comparison, the results of Aggarwal et al. [18] in Table 7.5 can be improved
considerably by using our approach, from an accuracy of 0.68 (CNN) to 0.79 (LSTM)
and precision from 0.40 (CNN) to 0.82(180) or 0.83(240) (LSTM).
CKD For CKD detection, the best model can be classified as the 180 sequence
length model with an accuracy of 0.75 and AUC of 0.72 (see Table 7.1d). ROCs
were interpreted and showed a higher SD for the individual true positive rates, which
represents the differences in epochs and folds.
An accuracy of 0.77 can be reached with the 180 sequence length model using the
combined score technique; an accuracy of 0.73 can be reached with the 240 sequence
length model using the combined amount technique (see Table 7.4).
Our investigation showed that there were 17 participants incorrectly classified and 43
participants correctly classified as diseased (for sequence length 180). Of the healthy
individuals, 11 were incorrectly classified. Eight variables are significantly different:
BMI, antihypertensives, hypertension, treatment of hypertension, airflow limitation,
physical activity level, 4-level grouped hypertension, and self-reported prevalent
stroke (see Table 7.2). The incorrectly classified group sees: (1) higher BMI (35 over
30); (2) higher 4-level grouped hypertension (2.9 over 2.3); (3) higher hypertension
(0.8 over 0.4); (4) lower airflow limitation (0 compared to 0.1); (5) higher physical
activity level (2.6 over 2.3); (6) higher prevalent stroke (0.3 over 0.03); (7) higher
antihypertensives (0.6 over 0.3); and (8) higher treatment of hypertension (0.7 over
0.3).
Overall, our disease detection approach shows good outcomes for diabetes, apnoea,
and CKD. For hypertension, the overall outcome is less promising (see tables 7.1b
and 7.5. The results of the two-class tests for hypertension and apnoea were com-
pared to the results from Aggarwal et al. [18]. Our hypertension results showed
no improvements in accuracy over Aggarwal et al. [18], though they did show im-
provements in precision, recall, and F1 score. For apnoea detection, our approach
outperformed the process from Aggarwal et al. [18] using CNN (see Table 7.5).
7.4.2 Early Disease Detection
The early detection tests show the outcomes of the three-class problems: healthy,
pre-disease-affected, and diseased. As the SD of CKD was already high for the two-
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class problem, we concentrated on diabetes and sleep apnoea. The outcomes show
potential for early detection but should be seen as preliminary. Further research
could expand upon these findings with additional features or classification models.
Diabetes In Table 7.5, the three-class problem of diabetes is compared to the related
work of Aggarwal et al. [18]; our approach reaches an improvement in accuracy of up
to 7% from 0.41 (CNN: Task-specific) and 0.44 (CNN: Multi-task) to 0.47 (LSTM:
180) and 0.48 (LSTM: 240). Additionally, recall and F1 score show improvement
overall. Precision has similar outcomes.
For early detection of diabetes, similar outcomes can be achieved for sequence lengths
of 180 and 240—averaged accuracy of 0.47 and 0.48, and averaged AUC of 0.63 and
0.61, respectively (see Table 7.6a). Accuracy can be improved to 0.48 (180) and 0.49
(240) using the count method.
Table 7.6: Sequence lengths tests for early disease detection with a multi-class ap-
proach, using one class against the others (e.g., C1 describes C1 against all other
classes); C1 is healthy, C2 is diseased, C3 is pre-disease-affected; avg. describes the
average over all classes and all repeats.
(a) Diabetes
Size Precision Recall F1 AUC(SD) Acc.
C1 C2 C3 avg. C1 C2 C3 avg. C1 C2 C3 avg. C1 C2 C3 avg.
180 0.48 0.49 0.35 0.44 0.58 0.59 0.50 0.58 0.53 0.56 0.34 0.50 0.66 0.66 0.51 0.62 0.47
240 0.48 0.50 0.35 0.44 0.58 0.60 0.51 0.57 0.53 0.58 0.35 0.51 0.65 0.67 0.53 0.62 0.48
(b) Apnoea
Size Precision Recall F1 AUC(SD) Acc.
C1 C2 C3 avg C1 C2 C3 avg C1 C2 C3 avg C1 C2 C3 avg
180 0.59 0.55 0.37 0.48 0.57 0.56 0.46 0.57 0.58 0.66 0.34 0.56 0.71 0.68 0.49 0.63 0.53
240 0.56 0.49 0.38 0.46 0.56 0.55 0.47 0.56 0.59 0.50 0.30 0.52 0.69 0.64 0.49 0.61 0.54
Sleep Apnoea For sleep apnoea, the best results can be achieved with a sequence
length of 240, which results in an averaged accuracy of 0.54 and an averaged AUC
of 0.61 (see Table 7.6b). Accuracy can be improved to 0.55 (180) and 0.56 (240)
using the count method. There were 9 participants who were repeatedly incor-
rectly classified for the pre-disease-affected case, 24 for the diseased case, and 18 for
the healthy case. Overall, 85 individuals per group are used for training. The fea-
tures that show significant differences between the incorrectly and correctly classified
groups are as follows: BMI (p-value: 0.012), antihypertensive (0.028), hypertension
(0.0018), hypertension treatment (0.029), 3-level diabetes (0.049), diabetes diagnosis
(0.019), family history of diabetes (0.038), pneumonia (0.017), and 4-level hyper-
tension (7.6e-4). The incorrectly classified group sees: (1) higher BMI (38 over 34);
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(2) higher antihypertensive (0.5 over 0.2); (3) higher hypertension (0.8 over 0.4);
(4) higher hypertension treatment (0.58 over 0.3); (5) higher 3-level diabetes (2.4
over 2.0); (6) higher family history of diabetes (0.7 over 0.4); (7) higher pneumonia
(0.3 over 0.04); and (8) higher 4-level hypertension (3.0 over 2.3). We can see that
similar features are significant in the two-class apnoea problem.
7.5 Discussion
In this section, our results are discussed and limitations are examined.
7.5.1 Disease Detection
Overall, smaller training batch sizes of 180 result in better performance. This makes
sense, as there is a trade-off between batch size and training epochs. As we set the
epochs to maximum 60, it seems that 180 reaches the optimum within these available
epochs. Our approach recognised sleep apnoea best with an accuracy of 81%. This
is reasonable, as sleep apnoea is only related to sleep/wake habits. Additionally,
diabetes and CKD demonstrate potential to be detected by sleep-wake behaviour.
However, hypertension shows low recognition rates; this is potentially related to
the high amount of comorbidity in the dataset, especially with hypertension pa-
tients (see Figure 7.2(b)). Minimal variations in the detection of hypertension with
low performance suggest that specific groups cannot be detected. This encourages
further research into the incorrectly classified participants to extract differences in
those.
In general, diseased individuals are more likely to be incorrectly classified than
healthy individuals. This can be caused by existing comorbidities that are more
strongly related to sleep behaviour changes. More information is needed, such as
from the significantly different clinical history factors between the groups. Some of
these significant different parameters might be able to improve the recognition rate in
the future; especially, as some of them have shown relations with specific diseases as
found in literature. For example, CKD patients have a higher risk for strokes [237];
this matches with the extracted clinical factors for significant differences between
the individuals that are incorrectly and correctly classified. Because of the smaller
data sample in the CKD case, a higher number of clinical factors are found to be
significantly different, as smaller variations have a higher impact.
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Integrating the knowledge from the data into the process reaches around 2% im-
provement in accuracy, which is a reasonable outcome. We consider segments with
a length of 180 timepoints and classify them as being either diseased or healthy.
We then incorporate the knowledge that 96 of these segments belong to the same
person, consequently, only one overall classification is necessary per 96 segments.
The individuals segment-based classifications could later be extended to provide a
certainty about how likely the person was classified as diseased.
Compared to Aggarwal et al. [18], our approach results in better precision, recall,
and F1 score but lower accuracy for hypertension. These results could stem from the
fact that the embedding used was not designed for activities, but for words. This
could be improved by, e.g., emulating the activity embedding proposed by Aggarwal
et al. [18].
7.5.2 Early Disease Detection
Early disease detection has proven to be a challenge. We can improve current
accuracy by up to 7% but there is still significant room for improvement and for
further research in this area.
Overall, we conclude that the pre-disease condition is harder to classify. Early
detection is complex and in need of further insight from more features or data
sources. Potential sources could be other sensor devices (e.g., pulse oximeter) or the
presented significantly different clinical factors.
Interestingly, the significant different clinical history factors for sleep apnoea are
similar to the ones in the two-class classification, the list is extended by the family
history of diabetes and pneumonia. This finding suggests that sleep apnoea classi-
fication from two and three classes have similar identifiers, which strengthens the
integration of further features within the assessment.
7.5.3 Limitations
Two limitations of this experiment are the usage of a pre-defined embedding function
and the lack of an evaluation of different loss functions. Initial experiments on pre-
defined embedding showed good results and were used for further investigations.
The word-2-vec embedding method could be improved by using a designed act-2-
vec method, as presented by Aggarwal et al. [18] for the activity count and white
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light data. Based on the literature, the categorical cross-entropy approach has been
used for classification, but others have not been tested.
The decision was made to use the same amount of data for each individual—six
days each. This decision resulted in some limitations, as (1) some individuals have
a full weekend in their dataset while others have just one day and (2) not all partici-
pants share the same consecutive days sequence, which can lead to difficulties when
training the classification algorithm. This could likely be overcome by including
weekdays as a feature; however, this was outside the scope of the study.
A detailed interpretation of why the approach of Aggarwal et al. [18] is improved
is not possible through our assessment. As we only compared our overall approach,
we introduced a limitation. The main scope was to investigate the performance of
our overall approach and the clinical features that influence that performance. We
were not interested in whether the inclusion of clinical features or the time-series
approach were behind the improvement.
The use of diseased and healthy (unaffected by investigated disease) is a real-world
approach. It needs to be mentioned, as this can result in a group that is unaffected
by a specific disease but is also unable to be classified as fully healthy.
The significant feature analysis for early disease detection could offer more insight by
grouping the individuals who were incorrectly classified into two groups, (1) healthy
and (2) pre-disease-affected; this, however, was not within the scope of this research.
7.6 Summary and Future Directions
This chapter contributes to knowledge with a chronic disease detection approach.
We have investigated the hypothesis of chronic disease detection based on the corre-
lations between sleep-wake behaviour and chronic diseases. An LSTM algorithm fus-
ing actigraphy data with clinical features was applied, leading to a multi-dimensional
feature vector for effective disease detection. We have tested and evaluated various
use case scenarios, including two-class disease detection problems (healthy versus dis-
eased) and three-class early disease detection problems (healthy, pre-disease-affected,
and diseased) for four common chronic diseases: hypertension, diabetes, sleep ap-
noea, and CKD. Our approach shows promising results, varying by use case due to
differences in chronic diseases characteristics. As assumed, there is no one-size-fits-
all approach for chronic diseases; however, using specific clinical features for each
disease can address the varying characteristics to a certain extent. Nevertheless,
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our approach significantly contributes to the literature; it is an improvement over
existing research in terms of performance and clearly demonstrates the feasibility of
predicting chronic diseases from sleep-wake behaviour. Further investigations will
be needed to enable early detection, however.
The availability of a mechanism, such as ours, that properly incorporates relations
between sleep and chronic diseases, as well as clinical history factors, is impor-
tant to diagnosis diseases. This mechanism enables our framework to automatically
adapt to changes in health status resulting in a personalised sleep behaviour assess-
ment. Our findings indicate that it is possible to detect diseases by fusing knowledge
sources. This can encourage researchers in the future to (1) conduct in-depth evalua-
tions to determine any other chronic diseases that can be detected using sleep-wake
behaviour analysis and (2) investigate the reasons for why some of them are less
accurate than others. We provided salient features for various chronic diseases and
determined which clinical data play significant roles in disease detection; these provi-
sions should be expanded upon in the future. Early disease detection is a developing
field that is highly important to the medical field. Our work lays a foundation for
future research approaches involving time-series analysis for early disease detection.
To our knowledge, our approach was one of the first to propose and investigate a
method to classify various early diseases by fusing medical knowledge from clin-
ical history data with actigraphy measurements. Further work is still necessary
to incorporate comorbidities and the presented significantly different clinical data
parameters.
The integration of a chronic disease detection mechanism makes our adaptable
framework possible.
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Chapter 8
Conclusions and Future Work
Sleep helps us to relax and recharge. Consequently, if the quality of our rest is
inconsistent or inadequate, our health is adversely affected (e.g., by a weakened
immune system and a higher risk of chronic diseases). These adverse effects often
manifest in sleep issues, such as sleep deprivation and apnoea, which are common
in the population and can have severe impacts. These issues can be classified by
abnormalities if sleep behaviour is properly monitored and assessed.
Technological advancements have enabled people to continuously monitor and inves-
tigate their sleep behaviour in their natural sleeping environments. This ability has
provided many new insights. Academics and commercial actors investigate technical
solutions to provide meaningful information and potentially prompt early interven-
tions. Modular, personalised, and adaptable approaches are vital for reliable and
effective home-based sleep assessment. These technical solutions facilitate predictive
and personalised healthcare.
We discuss the conclusion from our conducted research in Section 8.1, and the
made contributions and the relevance of our work in Section 8.2. Furthermore, we
identify open issues and opportunities for future research in Section 8.3 and provide
concluding remarks in Section 8.4.
8.1 Summary of Work
In Chapter 1, we established the research background on sleep behaviour assessment,
outlined the motivations behind our investigations, and addressed the challenges our
work intends to overcome. Moreover, we described the overall aims and objectives
of this thesis.
To meet our aims and objectives, we reviewed the literature for current open is-
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sues and challenges in the field. We presented the key challenges we identified in
Chapter 2; these included the lack of a sleep behaviour assessment framework, an
accurate method for sleep position detection, a sleep stage analysis process, a sleep
regularity algorithm, visualisation standards, and a chronic disease assessment based
on correlations with sleep issues. The subsequent chapters described the work done
to address these open issues.
The overarching aim of this thesis was the development of a home-based sleep be-
haviour assessment framework. We developed an overall framework that can support
future researchers through an integration of the most crucial sleep behaviour aspects
with the following properties: being adaptable to technology developments, appli-
cable in existing home environments (e.g., smart homes), and designed to aim at
avoiding user misinterpretation. Chapter 3 presented this framework design and
detailed its layered structure, components, and characteristics. The main benefit
of this design is its adaptability to users’ needs, doctors’ recommendations, and
available data sources. In addition, we proposed (1) a sleep regularity algorithm
to investigate the important aspects of regularity (objective 2) and (2) a visuali-
sation concept aimed at avoiding misinterpretation (objective 3). The framework
aims to represent an overall picture of sleep by assessing it and setting it in context
with related factors such as chronic diseases, environmental changes, and routines.
Furthermore, we discuss the necessity and challenged of seamlessly integrating our
approaches with existing environments. The framework serves as the backbone for
chapters 4–7. Each one targeted individual components of the framework and ad-
dressed the identified challenges from the literature review. Future work must apply
this framework in a real-world setting and test it under various conditions, e.g., in
a smart home.
Our fourth objective was to establish an approach that could detect higher-
granularity sleep positions, which are common in the population. The integration of
leg positioning with a reliable and computing-efficient algorithm facilitated a real-
time assessment of more complex sleep positions. In our approach, features are
extracted from stable state data and a GMLVQ model is applied. In sleep position
recognition, it is crucial to find a balance between the number of integrated sensors
(which potentially influence sleep behaviour) and the potential for detecting more
complex positions (which provide more information about sleep behaviour). This
approach was evaluated using wearable devices on six individuals with both personal
and general models. The comparative results showed that the approach is applicable
in both simulated and real-world settings. One limitation comes from the exclusive
use of orientation data; this could be overcome in the future by incorporating abso-
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lute or relative positions.
Our fifth objective was to investigate sleep-wake behaviour by addressing the key
issues with standard approaches: one-model-fits-all approaches, exclusion of medical
knowledge, and investigations are often limited to one data source. To close these
gaps, we adopted an adaptive learning approach. We developed a fine-grained sleep
stage detection approach to enable more reliable detection of sleep-wake stages. The
personalised sleep patterns were learned using data from multiple sources, including
personal and physiological sources. The personal datasets are a fusion of clinical
history and genetic information, such as race, gender, and health status. Further-
more, to assess sleep behaviour, sleep parameters must be reliably measured from
extracted sleep-wake patterns. Consequently, we effectively developed a personalised
sleep parameter extraction process (objective 6). To incorporate the differences be-
tween groups of individuals, we used dynamic instead of static thresholds that could
better represent these differences. The strength of this approach lies in the fusion
of computational technology with medical knowledge about factors that influence
sleep architecture. The approach was extensively investigated using a large and di-
verse dataset to improve the performance to be more in line with PSG assessment.
This investigation demonstrated the importance of personalised approaches in sleep
behaviour analysis and the positive effects that come from including influence fac-
tors. The fusion of physiological data sources brings together the advantages of
actigraphy (which performs well on healthy participants) and HRV (which performs
well on diseased individuals). The approach is adaptable to available data but is
dependent on access to personal data. Future work should consider comorbidities
and investigate the fusion of multiple physiological data sources even further.
Our objective to detect chronic diseases from sleep-wake analysis was achieved two-
fold. First, a thematic analysis was performed on sleep issues and their relationships
with chronic diseases, in addition to treatment satisfaction and technology accep-
tance. In Chapter 6, we presented the outcomes from interviews differentiating be-
tween the perspectives of doctors and individuals suffering from a medical condition.
Our findings confirm that there are relations between sleep and chronic diseases and,
therefore, that it is possible to use sleep-wake behaviour to detect chronic diseases.
Furthermore, results supported our framework design through individuals’ responses
regarding (1) the importance of home-based IoT-enabled assessment (addressed in
Chapter 3); (2) the importance of in-depth sleep position detection (addressed in
Chapter 4); (3) changes in sleep architecture (see Chapter 7); and (4) current limita-
tions of sleep-stage approaches (addressed in Chapter 5). Second, the main finding
in the relations between sleep and chronic diseases was further pursued. We pro-
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posed a method using sleep-wake information to detect chronic diseases that aimed
to distinguish between early and advanced stages. The integration of multiple data
sources bringing relevant information together made this research fairly advanced.
The benefit of our approach comes from the usage of (1) the temporal aspect of
our data in the design of the approach and (2) the multi-dimensional feature vector.
Another advantage is the in-depth analysis of features that influence performance.
The approach was evaluated using the HCHS dataset and showed promising results.
In future work, the salient features should be reassessed by being incorporated in
the approach; additionally, more medical conditions and potential influences from
comorbidities should be included.
To summarise, we designed a framework for sleep behaviour assessment. Further-
more, we investigate improvements to individual parts of this framework. This
framework has been designed to work with a variable number of data sources de-
pending on availability, and considers users’ needs, as discussed in Chapter 3. The
integrated technologies are personalised; individual aspects are incorporated to pro-
vide a solid estimate of sleep status. This was achieved by combining medical knowl-
edge with computational technologies and incorporating multiple data sources and
influence factors for sleep position detection, sleep stage recognition, and chronic
disease detection. The incorporation of a regularity assessment and a visualisa-
tion component were aimed at providing an efficient and understandable framework
structure.
8.2 Revisit of Contributions
Our research significantly advances computational sleep behaviour analysis. Specif-
ically, we have made eight significant contributions to the literature: (1) a modular
layered sleep behaviour assessment framework that incorporates developed sleep
analysis approaches; (2) a sleep regularity algorithm for individual sleep parame-
ters; (3) a user-dependent visualisation concept with varying levels of abstractions;
(4) a higher-granularity sleep position detection approach that considers leg move-
ment; (5) a fine-grained sleep stage detection approach using multiple data sources;
(6) a personalised sleep parameter extraction process with dynamic thresholds; (7)
in-depth understanding on sleep and chronic disease relations with findings con-
firming the worth in using sleep-wake behaviour for chronic disease detection; and
(8) a sleep-wake behaviour-based chronic disease detection method including multi-
dimensional features.
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The first contribution is a modular layered sleep behaviour assessment framework
that addresses the lack of a guideline for accurate and understandable sleep assess-
ment. The layered design provides a flexible structure tailored to individual needs
and facilitates the integration of new technological advances. The modular design is
essential, as individuals are influenced differently based on their clinical history and
daily routines. The framework monitors the main elements of sleep and influence
factors to enable self-management as well as personalised and predictive healthcare.
This opens up new potential areas of investigation, e.g., the investigation of cor-
relations between different elements in the framework. The personalised approach
has the potential to help predict anomalies faster, provide alerts, and offer tailored
recommendations. The framework is ideal for sleep behaviour assessment because
it is scalable, robust, and efficient. The framework can deal with data from mul-
tiple channels and incorporates clinical history and preferences, thus allowing for
personalised medical and behavioural assessment.
The second contribution is a sleep regularity algorithm that addressed the limita-
tions of the standard two-day regularity assessment. Regularity describes the state
of having a regular sleep behaviour, and when measured over longer period of time
it is of great value in sleep assessment. Sleep regularity can provide insights into
sleep disorders. To guarantee a reliable assessment, we use long-term assessments
for individual sleep parameters. This constitutes a new way of assessing sleep reg-
ularity, which has the advantage of comparing behaviour over multiple days. This
offers new opportunities to determine differences and anomalies in sleep rhythm by
incorporating various factors, such as day of the week, season, or moon phase.
The third contribution is a personalised visualisation concept, which is adaptable
to the needs of users and doctors. Currently, information about sleep is presented
without context, and often lead to incorrect conclusions. Appropriate visualisation
benefits users by allowing for self-management and doctors by enabling them to
provide accurate recommendations, diagnosis, and treatments. To avoid misinter-
pretation and provide details where required, we present a new way of visualisation
that uses a modular and layered structure. Sleep parameters are set in context
by incorporating health status, phenotypical characteristics, users’ preferences, and
doctors’ recommendations.
The fourth contribution is a higher-granularity sleep position analysis approach. Re-
search on wearable devices has mainly considered just four basic sleep positions and
excluded the limbs. This is problematic, as leg positions are essential to describe
some of the most common positions. Our approach, which is applicable in the
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real-world, incorporates these leg positions and can accurately extract characteristic
patterns for individual positions. GMLVQ is applied on actigraphy data, provid-
ing a mobile assessment at low computational costs. We provided a comparative
study to see the differences in results between real-world and simulated settings. A
general model is promising for real-world application, as it captures the variability
of the positions well. More complex positions give additional information about
sleep, which is a starting point for behavioural interventions, e.g., treatment of sleep
apnoea. Standard medical assessments of sleep positions are based on subjective
questionnaires. Our approach provides objective assessment, opening the possibil-
ity of investigations on the correspondence between subjectively reported positions
and objectively recognised positions. Furthermore, this approach will enable future
researchers to explore the reasons behind waking up and falling asleep in particular
positions.
The fifth contribution is a fine-grained sleep stage detection approach. Standard
sleep stage approaches ignore known factors that influence sleep architecture, over-
look the advantage of personalisation, and are limited to information from just one
physiological data source. Influence factors can be represented through a fusion of
data sources, including sensor data, clinical history, and genetic information. Per-
sonal sleep-wake patterns are captured in models trained on groups of individuals.
This approach supersedes current one-model-fits-all approaches and is adaptable to
individuals and available data sources. Notably, the fusion of multiple data sources
has shown considerable advantages. Findings include the improvement of sleep-wake
recognition at home through the consideration of gender, health status, as well as
through the inclusion of multiple physiological data sources. The results demon-
strate the importance of personalised approaches in sleep-wake detection. Future
researchers could extend this approach and explore more complex sleep stage detec-
tion.
The sixth contribution is a personalised sleep parameter extraction process. We
addressed the current limitation of static thresholds for parameter extraction from
sleep-wake stages in actigraphy scoring. We did this by introducing dynamic thresh-
olds and incorporating race, gender, and health status information to achieve per-
sonalised sleep parameter extraction. Results indicate that our approach provides
a better match for SOL to the gold standard, PSG, than the method presented
in [201, 202]. Our new method of extracting sleep parameters should encourage fu-
ture researchers to deliver meaningful results that match the population of interest.
The seventh contribution is made up of the in-depth understanding on sleep and
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chronic disease relations. Generally, questionnaires are used to assess correlations
between sleep and chronic disease. Of course, questionnaires cannot match the
breadth of information available through interviews. Semi-structured interviews
were conducted on the currently under-represented Chinese population. We sought
to provide a comprehensive picture from individuals affected by a disease as well as
doctors, who are usually not consulted. This allows for examining the differences
between their opinions. Our thematic analysis on sleep issues, causes, impacts, as-
sessment, treatment, and technology usage, indicated relationships between sleep
behaviour and chronic diseases. Doctors and affected individuals generally agreed
on most topics and confirm these relationships. However, doctors were often un-
aware of their patients’ sleep issues; this stems from the lack of sleep assessment
and behavioural treatment. These findings should encourage future researchers to
objectively investigate chronic diseases and sleep-wake behaviour.
The eighth contribution is a sleep behaviour-based chronic disease detection approach.
There have been few serious approaches to use sleep-wake behaviour for chronic dis-
ease detection. However, medical knowledge and the temporal aspect of the data is
usually not integrated; hence, we construct multi-dimensional features from clinical
history and sensor data. An LSTM capable of handling temporal data is adapted
to consider sleep-wake behaviour information. We investigated early and advanced
stages of different diseases. The method showed promising results, though they
varied by use case due to differences in chronic disease characteristics. We pro-
vide significantly different clinical features which might improve the performance.
This should encourage future researchers to investigate these features in more detail.
Our work shows the potential and importance of early-stage disease detection from
sleep-wake behaviour. This approach emphasises the need for time-series analysis.
Furthermore, it demonstrates the value of fusing medical knowledge with computa-
tional approaches in chronic disease detection.
8.3 Open Issues and Future Work
Throughout this thesis, several opportunities and open issues have been identified
and highlighted. The proposed approaches to solve existing challenges in compu-
tational sleep behaviour analysis must be further investigated. In this section, we
discuss some of the areas that need improvement and potential directions for future
research.
First, we presented personalised approaches that achieve higher accuracy. However,
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to achieve a proper balance between personalised assessment and generalisability, we
provide models that can be used for groups of individuals. Personalisation can limit
direct comparisons between individuals from different groups. Nevertheless, this is
in line with the current assessment from doctors who differentiate between healthy
from diseased individuals with respect to sleep behaviour. Still, though, more en-
richment is required; approaches must consider other influence factors, including
comorbidities, age, and day of the week. This could be achieved by developing (1)
a health status feature that summarises individuals’ information and (2) a weekday
feature; these could be integrated as supplemental features. Most importantly, we
provide strong evidence that personalised models are ideal in many instances, and
this will influence future research.
Second, the combination of sensors was explored, and found to be successful, e.g., for
sleep stage detection. We explained how to fuse different data sources by merging
information into equal interval steps. Further work on our data fusion approach
is necessary and is an interesting area to pursue due to its observed performance
effects. However, the best possible combination of multiple sensors needs to be
determined to provide sufficient information but avoid discomfort and influence on
natural sleep habits. This is difficult but the insight that can be gained through
it is valuable, e.g., the supplementary information from more complex positions
in combination with doctor’s advice can help user’s in sleep-management. Future
research could assess other sensors or develop entirely new ways of monitoring. For
sleep stage detection, sensors which capture new features could be beneficial, e.g.,
which monitors breathing changes to detect when people go into a deeper sleep.
Trends indicate that smart clothing, single-channel EEG devices, and reliable non-
wearables will be available on the market in the next few years—researchers could
make use of them.
Third, our approaches can be easily adapted to suit other investigations in sleep
research. Bed exits, e.g., can be detected using our sleep positions approach with
some additional labels. Our sleep-wake detection approach can be use to train
models for other sleep stages by following multiple two-class problems. Our chronic
disease approach can be used to investigate other diseases, such as Parkinson’s, or
Alzheimer’s disease. It has shown promising results using time-series analysis in
combination with medical knowledge. Our work on disease detection in early and
advanced stages could encourage research to develop new techniques and features
for chronic disease diagnosis from sleep-wake behaviour. Furthermore, developed
approaches in this thesis could help to objectively measure certain parameters that
are currently only measured subjectively, such as sleep position.
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Fourth, improving home-based technologies is essential not only to address the afore-
mentioned issues but also to seamlessly integrate methods into existing smart homes
and devices. Therefore, the challenges facing data extraction, pre-processing, and
occupancy (discussed in Chapter 3) must be overcome by new solutions (e.g., the
presence of multiple individuals affecting measurements). For example, extracting
HRV from PPG instead of ECG (see Chapter 5) would allow it to be measured with
a smartwatch. Access to smart home devices is valuable to embed sleep behaviour
assessment in activity recognition approaches and to detect potential connections.
The correlations between sleep and various factors of daily life, are not yet exten-
sively incorporated. If embedded into existing environments, however, this could
soon become feasible. Nevertheless, the incorporation into existing environments
will help to make sleep assessment easier to interpret, when potential causes can be
targeted.
Fifth, in our framework, we integrate various elements of sleep, some of which re-
quire further attention. For example, a method that can reliably provide in-depth
information about the impact of the environment still needs to be developed. The
inclusion of IoT sensors and long-term monitoring will involve changes in healthcare,
such as in sleep disorder diagnosis, and alternative self-management approaches (in-
stead of medication). Hence, in future work, this framework must be tested in a
long-term study in a real-world setting. This will help to further acquire the best
set of to-be-determined parameters for the used LSTM and thresholds for the sleep
parameter extraction. Essentially, providing the information should not be the last
step—instead, the last step should be extracting adequate feedback, suggestions,
and potential interventions that can easily be followed by users in the future.
Sixth, standard approaches are limited by following existing guidelines. This in-
volves, e.g., assessment in 30-second intervals when a smaller range could potentially
detect shorter underlying structures, such as K-complexes and sleep spindles. The
detection of these could reveal behavioural changes and will be the focus of future
research. Methods are validated with data scored by one technician; multiple scores
have an interscorer agreement of 80% [160]. These could be replaced by (1) stan-
dards introduced from pattern recognition approaches or (2) models representing
different scorers’ styles and fusing the outcomes, if not a more accurate, at least a
more consistent labelling could be reached.
Seventh, data analysis is, of course, limited by the available data. Our sleep po-
sition detection is limited by the data only containing orientation, which could be
overcome, in the future, by more complex methods able to monitor the absolute
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or relative positions. In several studies throughout this thesis (chapters 3, 5, and
7), we assumed the availability of the necessary data. In reality, however, they are
not necessarily shared even though they can be easily obtained. Generally, smaller
datasets are restricted in that they result in the outcomes being less generalisable
(see Chapter 4). We found that the more diverse a dataset, the more representative
the performance. A potential solution is a crowdsourcing approach. Development
in consumer wearables will adapt to allow users to share sleep behaviour data with
researchers. Diverse datasets also make possible the investigation of influences from
comorbidities.
We expect that with the prevalence and maturity of daily technologies and the
availability of cloud-based computational power, the gap between clinic-based and
home-based sleep assessment will soon vanish, opening up opportunities that will
potentially lead to transformations in future healthcare. This change will, however,
require close collaboration and knowledge-sharing among healthcare professionals,
researchers, and users.
8.4 Concluding Remarks
This thesis has contributed significantly to knowledge in the areas of home-based
sleep behaviour analysis. This has been achieved through the development of en-
abling technologies within a comprehensive framework. Specifically, this thesis ad-
vances approaches such as more complex sleep position detection, fine-grained sleep
stage recognition, parameter-specific sleep regularity assessment, personalised sleep
parameter extraction, personalised data visualisation, and chronic disease detection
from sleep-wake behaviour, and a framework is provided through which researcher
can address various challenges. The literature was reviewed in-depth for the men-
tioned areas from which open issues were highlighted. These open issues were ad-
dressed by our five conducted studies, which culminated in eight contributions to the
literature (see Section 8.2). Importantly, several opportunities for future work were
indicated and discussed in Section 8.3 to encourage further research into this impor-
tant subject. Using computational methods to assess and interpret available sleep
behaviour data is key for the development of predictive and personalised healthcare
methods. Sleep-related issues add high costs to health care and affect individuals
differently. As more individuals than ever are affected by sleep problems, demand is
rapidly increasing for home-based sleep assessment that delivers adequate, reliable,
and personalised sleep evaluation. We are confident that future research will benefit
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from the approaches, algorithms, processes, and methods developed and evaluated
in this thesis.
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